
<html lang="en"     class="pb-page"  data-request-id="340e4fdd-a717-48cc-8159-1504110d6de5"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2019.62.issue-23;article:article:10.1021/acs.jmedchem.9b01290"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of Novel Celastrol Derivatives as Hsp90–Cdc37 Interaction Disruptors with Antitumor Activity" /></meta><meta name="dc.Creator" content="Na  Li" /></meta><meta name="dc.Creator" content="Manyi  Xu" /></meta><meta name="dc.Creator" content="Bing  Wang" /></meta><meta name="dc.Creator" content="Zhixian  Shi" /></meta><meta name="dc.Creator" content="Zihao  Zhao" /></meta><meta name="dc.Creator" content="Yunqing  Tang" /></meta><meta name="dc.Creator" content="Xinyue  Wang" /></meta><meta name="dc.Creator" content="Jianbo  Sun" /></meta><meta name="dc.Creator" content="Li  Chen" /></meta><meta name="dc.Description" content="To develop novel and efficient heat shock protein 90–cell division cycle 37 (Hsp90–Cdc37) interaction disruptors, several lipophilic fragments were introduced into celastrol (CEL) to synthesize 48 ..." /></meta><meta name="Description" content="To develop novel and efficient heat shock protein 90–cell division cycle 37 (Hsp90–Cdc37) interaction disruptors, several lipophilic fragments were introduced into celastrol (CEL) to synthesize 48 ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 14, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b01290" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01290" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b01290" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01290" /></link>
        
    
    

<title>Discovery of Novel Celastrol Derivatives as Hsp90–Cdc37 Interaction Disruptors with Antitumor Activity | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b01290" /></meta><meta property="og:title" content="Discovery of Novel Celastrol Derivatives as Hsp90–Cdc37 Interaction Disruptors with Antitumor Activity" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0017.jpeg" /></meta><meta property="og:description" content="To develop novel and efficient heat shock protein 90–cell division cycle 37 (Hsp90–Cdc37) interaction disruptors, several lipophilic fragments were introduced into celastrol (CEL) to synthesize 48 new CEL derivatives. Among all the target compounds, 41 was screened with superior antiproliferative activity on related cancer cells (IC50: 0.41–0.94 μM) and 41 could decrease the level of the Hsp90–Cdc37 complex in A549 cells. The capability to disrupt the Hsp90–Cdc37 interaction was stronger than that of CEL. Furthermore, pull-down assay, UV assay, and molecular docking analysis all showed that 41 might disrupt the interaction of the Hsp90–Cdc37 complex by preferentially binding to Cdc37 in cancer cells. Further studies showed that 41 could significantly regulate the levels of Hsp90–Cdc37 clients, thereby inducing the apoptosis of cancer cells. Together, 41 is a novel Hsp90–Cdc37 disruptor by binding to Cdc37 (hydrogen bond and/or covalent bond). Our results may provide reference for the discovery of effective Hsp90–Cdc37 disruptors." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b01290"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01290">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b01290&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b01290&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b01290&amp;href=/doi/10.1021/acs.jmedchem.9b01290" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 23</span><span class="cit-fg-pageRange">, 10798-10815</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/23" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01255" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b01291" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Novel Celastrol Derivatives as Hsp90–Cdc37 Interaction Disruptors with Antitumor Activity</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Na Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Na Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural Medicines, Department of Natural Medicinal Chemistry, School of Traditional Chinese Pharmacy, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, People’s Republic of China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Na++Li">Na Li</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Manyi Xu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Manyi Xu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural Medicines, Department of Natural Medicinal Chemistry, School of Traditional Chinese Pharmacy, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, People’s Republic of China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Manyi++Xu">Manyi Xu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Bing Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bing Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural Medicines, Department of Natural Medicinal Chemistry, School of Traditional Chinese Pharmacy, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, People’s Republic of China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bing++Wang">Bing Wang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zhixian Shi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhixian Shi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural Medicines, Department of Natural Medicinal Chemistry, School of Traditional Chinese Pharmacy, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, People’s Republic of China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhixian++Shi">Zhixian Shi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zihao Zhao</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zihao Zhao</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural Medicines, Department of Natural Medicinal Chemistry, School of Traditional Chinese Pharmacy, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, People’s Republic of China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zihao++Zhao">Zihao Zhao</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yunqing Tang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yunqing Tang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural Medicines, Department of Natural Medicinal Chemistry, School of Traditional Chinese Pharmacy, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, People’s Republic of China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yunqing++Tang">Yunqing Tang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xinyue Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xinyue Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural Medicines, Department of Natural Medicinal Chemistry, School of Traditional Chinese Pharmacy, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, People’s Republic of China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xinyue++Wang">Xinyue Wang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jianbo Sun</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jianbo Sun</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural Medicines, Department of Natural Medicinal Chemistry, School of Traditional Chinese Pharmacy, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, People’s Republic of China</div></div><span class="conrtib-corresp"><strong>*</strong>(J.S.) Phone: +86-25-83271447. E-mail: <a href="/cdn-cgi/l/email-protection#7201181011020732151f131b1e5c111d1f"><span class="__cf_email__" data-cfemail="8ffce5edecfffacfe8e2eee6e3a1ece0e2">[email protected]</span></a></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jianbo++Sun">Jianbo Sun</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Li Chen</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Li Chen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural Medicines, Department of Natural Medicinal Chemistry, School of Traditional Chinese Pharmacy, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, People’s Republic of China</div></div><span class="conrtib-corresp"><strong>*</strong>(L.C.) Phone: +86-25-83271447. E-mail: <a href="/cdn-cgi/l/email-protection#a1c2c9c4cfcdc8979396e1c2d1d48fc4c5d48fc2cf"><span class="__cf_email__" data-cfemail="64070c010a080d525653240714114a0100114a070a">[email protected]</span></a></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Li++Chen">Li Chen</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4655-9024" title="Orcid link">http://orcid.org/0000-0002-4655-9024</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01290&amp;href=/doi/10.1021%2Facs.jmedchem.9b01290" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 23</span><span class="cit-pageRange">, 10798–10815</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 14, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>7 August 2019</li><li><span class="item_label"><b>Published</b> online</span>14 November 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 December 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b01290" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01290</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D10798%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DNa%2BLi%252C%2BManyi%2BXu%252C%2BBing%2BWang%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D23%26contentID%3Dacs.jmedchem.9b01290%26title%3DDiscovery%2Bof%2BNovel%2BCelastrol%2BDerivatives%2Bas%2BHsp90%25E2%2580%2593Cdc37%2BInteraction%2BDisruptors%2Bwith%2BAntitumor%2BActivity%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D10815%26publicationDate%3DDecember%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b01290"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1286</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">9</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b01290" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Novel Celastrol Derivatives as Hsp90–Cdc37 Interaction Disruptors with Antitumor Activity&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Na&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Manyi&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Bing&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Zhixian&quot;,&quot;last_name&quot;:&quot;Shi&quot;},{&quot;first_name&quot;:&quot;Zihao&quot;,&quot;last_name&quot;:&quot;Zhao&quot;},{&quot;first_name&quot;:&quot;Yunqing&quot;,&quot;last_name&quot;:&quot;Tang&quot;},{&quot;first_name&quot;:&quot;Xinyue&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Jianbo&quot;,&quot;last_name&quot;:&quot;Sun&quot;},{&quot;first_name&quot;:&quot;Li&quot;,&quot;last_name&quot;:&quot;Chen&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;14&quot;,&quot;issue&quot;:&quot;23&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;10798-10815&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b01290&quot;},&quot;abstract&quot;:&quot;To develop novel and efficient heat shock protein 90–cell division cycle 37 (Hsp90–Cdc37) interaction disruptors, several lipophilic fragments were introduced into celastrol (CEL) to synthesize 48 new CEL derivatives. Among all the target compounds, 41 was screened with superior antiproliferative activity on related cancer cells (IC50: 0.41–0.94 μM) and 41 could decrease the level of the Hsp90–Cdc37 complex in A549 cells. The capability to disrupt the Hsp90–Cdc37 interaction was stronger than that of CEL. Furthermore, pull-down assay, UV assay, and molecular docking analysis all showed that 41 might disrupt the interaction of the Hsp90–Cdc37 complex by preferentially binding to Cdc37 in cancer cells. Further studies showed that 41 could significantly regulate the levels of Hsp90–Cdc37 clients, thereby inducing the apoptosis of cancer cells. Together, 41 is a novel Hsp90–Cdc37 disruptor by binding to Cdc37 (hydrogen bond and/or covalent bond). Our results may provide reference for the discovery of effective Hs&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01290&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01290" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01290&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01290" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01290&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01290" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01290&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01290&amp;href=/doi/10.1021/acs.jmedchem.9b01290" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b01290" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b01290" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (6 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b01290%26sid%3Dliteratum%253Aachs%26pmid%3D31725288%26genre%3Darticle%26aulast%3DLi%26date%3D2019%26atitle%3DDiscovery%2Bof%2BNovel%2BCelastrol%2BDerivatives%2Bas%2BHsp90%25E2%2580%2593Cdc37%2BInteraction%2BDisruptors%2Bwith%2BAntitumor%2BActivity%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D23%26spage%3D10798%26epage%3D10815%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=291120" title="Hydrophobicity">Hydrophobicity</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/23" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/jmcmar.2019.62.issue-23/20191212/jmcmar.2019.62.issue-23.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/medium/jm9b01290_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01290&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">To develop novel and efficient heat shock protein 90–cell division cycle 37 (Hsp90–Cdc37) interaction disruptors, several lipophilic fragments were introduced into celastrol (CEL) to synthesize 48 new CEL derivatives. Among all the target compounds, <b>41</b> was screened with superior antiproliferative activity on related cancer cells (IC<sub>50</sub>: 0.41–0.94 μM) and <b>41</b> could decrease the level of the Hsp90–Cdc37 complex in A549 cells. The capability to disrupt the Hsp90–Cdc37 interaction was stronger than that of CEL. Furthermore, pull-down assay, UV assay, and molecular docking analysis all showed that <b>41</b> might disrupt the interaction of the Hsp90–Cdc37 complex by preferentially binding to Cdc37 in cancer cells. Further studies showed that <b>41</b> could significantly regulate the levels of Hsp90–Cdc37 clients, thereby inducing the apoptosis of cancer cells. Together, <b>41</b> is a novel Hsp90–Cdc37 disruptor by binding to Cdc37 (hydrogen bond and/or covalent bond). Our results may provide reference for the discovery of effective Hsp90–Cdc37 disruptors.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45152" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45152" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Heat shock protein 90 (Hsp90, 90 kDa) is a protein chaperone that is considered as a promising anticancer target.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Generally, Hsp90 needs to form a complex with cochaperones to ensure the proper folding and maturation of the client proteins. These cochaperones include cell division cycle 37 (Cdc37), heat shock protein 70 (Hsp70), heat shock protein 40 (Hsp40), homeodomain only protein (Hop), and p23.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Among them, Cdc37 targets many protein kinases related to the occurrence and development of cancer, such as protein kinase B (Akt), cyclin-dependent kinases 4 (Cdk4), epidermal growth factor receptor (EGFR), human epidermal growth factor receptor-2 (Her-2), and tyrosine-protein kinase Met (c-Met).<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> Cdc37 can stabilize the catalytic domains of these kinases, while Hsp90 can maintain their correct conformation.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Thus, the functions of these oncogenic kinases depend on the Hsp90–Cdc37 complex. Disruption of the Hsp90−Cdc37 interaction could regulate the expression of kinases to inhibit the proliferation of cancer cells.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div><div class="NLM_p">Celastrol (CEL) has been reported to inhibit the proliferation of various tumors in vitro and in vivo, such as gliomas, hepatocellular carcinomas, and prostate cancer.<a onclick="showRef(event, 'ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9">(7−9)</a> The antiproliferative activity of CEL has been indicated to result from disruption of the interaction between Hsp90 and Cdc37, and this interaction is mainly located at the N-terminal domain of Hsp90 (Hsp90<sub>N</sub>) and the middle domain of Cdc37 (Cdc37<sub>M</sub>).<a onclick="showRef(event, 'ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12">(10−12)</a> In the structure of the human Hsp90<sub>N</sub>–Cdc37<sub>M</sub> complex, an important hydrogen bond between Q133 (Hsp90<sub>N</sub>) and R166/R167 (Cdc37<sub>M</sub>) was identified as the key interaction for the Hsp90<sub>N</sub>–Cdc37<sub>M</sub> complex.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> CEL was reported to disrupt this key hydrogen bond due to its location in the hydrophobic pocket.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10,11)</a> However, as a pentacyclic triterpenoid, the spatial structure of CEL is too large to embed the intersection angle of R166 and R167 in the structure of human Cdc37.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> In order to disrupt the key hydrogen bond more efficiently, Xu et al. recently reported a series of CEL hybrids incorporated with methyl ferulate and its derivatives (hydrophobic structures) and the antiproliferative activity of these hybrids was higher than that of CEL. The immunoprecipitation experiment showed that compound <b>29</b> (Xu’s study) disrupted the Hsp90–Cdc37 interaction more efficiently than CEL.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Thus, introduction of a hydrophobic structure to CEL may be a promising strategy in the discovery of CEL derivatives as Hsp90–Cdc37 interaction disruptors.</div><div class="NLM_p">To elucidate the structure–activity relationship of CEL derivatives as Hsp90–Cdc37 disruptors and to improve the druglike properties, Jiang et al.’s study reported a series of CEL derivatives and found a more potent compound CEL20.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Compared to CEL, although the solubility of CEL20 incorporating a polar group was greatly improved (51.2 vs 1.44 μg/mL), the Hsp90–Cdc37 disruption activity [IC<sub>50</sub> (4.71 vs 6.49 μM)] was only slightly improved.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> And the antiproliferative activity of CEL20 was similar to those of the most compounds incorporating hydrophobic groups [IC<sub>50</sub> (1.12 vs 1.20–1.97 μM]. Moreover, Jiang et al. still emphasized the importance of the hydrophobic interaction and a covalent bond between CEL and Cdc37 in the Hsp90–Cdc37 disruption activity in their design idea.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Based on the previous studies, we designed a series of CEL derivatives in which a 29-carboxyl group was modified with lipophilic fragments via different linkers and hoped that these new compounds disrupted the interaction of the Hsp90–Cdc37 complex by the noncovalent and/or covalent combination with the target protein.</div><div class="NLM_p">The structure of cinnamic acid (CA), which consists of a phenyl ring substituted with an acrylic acid, contains highly conjugated π-electron with high hydrophobicity. This structural characteristic allows it to easily bind to hydrophobic pockets.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a> Recent studies have reported that CA exhibits potential antitumor activity in several cancer cells.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> In terms of the modification of natural products, CA is widely used to enhance the antitumor activity of the parent compounds.<a onclick="showRef(event, 'ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20">(18−20)</a> Thus, CA and its analogues were first introduced to CEL to improve the capability of disrupting the Hsp90–Cdc37 complex and inhibiting cancer cells.</div><div class="NLM_p last">At present, the structural modifications of CEL mainly focus on the C-20 carboxylic acid functionality and alterations of the A, B rings.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21,22)</a> However, many derivatives modified at the A, B rings were unstable.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22,23)</a> These derivatives were oxidized to CEL quickly upon purification, storage, and incubation with culture medium.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Therefore, considering the stability of the target compounds, CA and its analogues were introduced to the 20-carboxylic acid of CEL by different linkers to afford in a total of 48 new compounds (<b>1</b>–<b>48</b>). Their antiproliferative activities were screened in vitro. The activity of <b>41</b> (IC<sub>50</sub>: 0.41 ∼ 0.94 μM) was comparable with that of bardoxolone methyl (CDDO-Me). Furthermore, the capability of <b>41</b> to disrupt the Hsp90–Cdc37 interaction was stronger than that of CEL. In addition, in-depth mechanistic studies of <b>41</b> were evaluated to explain the antiproliferative activity.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28254" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28254" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">The synthetic route of compounds <b>1</b>–<b>48</b> is shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. <i>trans</i>-Cinnamic acid (<b>1a</b>), 4-methylcinnamic acid (<b>1b</b>), 4-methoxycinnamic acid (<b>1c</b>), or 4-fluorocinnamic acid (<b>1d</b>) or 4-(trifluoromethyl) cinnamic acid (<b>1e</b>) was first treated by the indicated bromohydrins using 1-(3-(dimethylamino)propyl)-3-ethylcarbodiimide hydrochloride (EDCI) and dimethylaminopyridine (DMAP) as catalysts in dichloromethane (CH<sub>2</sub>Cl<sub>2</sub>) at room temperature to obtain compounds <b>2f</b>–<b>t</b>.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> In a similar way, compounds <b>6f</b>–<b>t</b> and <b>10f</b>–<b>t</b> were obtained under the treatment of <b>5a</b>–<b>e</b> and <b>9a</b>–<b>e</b>, respectively. Besides, intermediates <b>10u</b>–<b>w</b> were prepared with <i>trans</i>-1,4-dibromo-2-butene in acetone, catalyzed by potassium carbonate (K<sub>2</sub>CO<sub>3</sub>) and tetrabutylammonium bromide (Bu<sub>4</sub>N<sup>+</sup>Br<sup>–</sup>) at 50 °C.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> α-Cyano substituted cinnamic acids (α-CN CA) <b>5a</b>–<b>e</b> were furnished by the condensation of aryl formaldehydes <b>3a</b>–<b>e</b> and cyanoacetic acid <b>4a</b>, while β-cyano substituted cinnamic acids (β-CN CA) <b>9a</b>–<b>e</b> were synthesized by arylacetonitriles <b>7a</b>–<b>e</b> and glyoxylic acid <b>8a</b> with K<sub>2</sub>CO<sub>3</sub> in methanol (MeOH).<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26,27)</a> Subsequently, the target compounds <b>1</b>–<b>48</b> were accomplished through connecting <b>2f</b>–<b>t</b> or <b>6f</b>–<b>t</b> or <b>10f</b>–<b>w</b> to CEL at the C-20 position in the presence of sodium bicarbonate (NaHCO<sub>3</sub>) in <i>N</i>,<i>N</i>-dimethylformamide (DMF).<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> The substituent groups R<sup>1</sup>–R<sup>3</sup> of <b>1</b>–<b>48</b> are shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/medium/jm9b01290_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0015.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01290&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Various bromohydrin, EDCI, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, rt, 7 h; (b) NH<sub>4</sub>OAc, tolune, 100 °C, reflux, 12 h; (c) CH<sub>3</sub>OH, K<sub>2</sub>CO<sub>3</sub>, 60 °C, reflux, 6 h; (d) bromohydrin, EDCI, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, rt, 7 h or trans-1,4-dibromo-2-butene, K<sub>2</sub>CO<sub>3</sub>, Bu<sub>4</sub>N<sup>+</sup>Br<sup>–</sup>, acetone, 50 °C, reflux,7 h; (e) celastrol, NaHCO<sub>3</sub>, DMF, 60 °C, 7 h.</p></p></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Substituent Groups (R<sup>1</sup>–R<sup>3</sup>) of <b>1</b>–<b>48</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CN</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>3</sub></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CN</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>4</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>4</sub></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CN</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CN</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CN</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>4</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>4</sub></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CN</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">H</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>3</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">H</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>4</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>4</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">H</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">H</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>3</sub></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">H</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>4</sub></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>4</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">H</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">H</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>3</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">H</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>4</sub></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>4</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">H</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">H</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>3</sub></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">H</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>4</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>4</sub></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">H</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">H</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">H</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>4</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>4</sub></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">H</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CH = CHCH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">H</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>3</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CH = CHCH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">H</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>4</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CH = CHCH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">H</td></tr></tbody></table></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Biological Activity</h3><div id="sec2_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i7" class="anchor-spacer"></div><h4 class="article-section__title" id="_i7"> In Vitro Antiproliferative Activity of CEL Derivatives</h4><div class="NLM_p">We first synthesized compounds <b>1</b>–<b>45</b> with saturated linear alkyl chains as linkers in this study. The inhibition rates of <b>1</b>–<b>45</b> were determined in A549 cells at concentration of 1.5 μM (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). CEL was used as a positive control. As shown in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A, the inhibition rates of the CA–CEL hybrids <b>1</b>–<b>15</b> (blue, 6.19%–37.61%) and α-CN substituted CA–CEL hybrids <b>16</b>–<b>30</b> (red, 3.07%–34.68%) were lower than that of CEL (purple, 47.98%). These results indicated that the introduction of CA and α-CN-substituted CA decreased the antiproliferative activities of CEL. Surprisingly, when β-CN-substituted CA was introduced into CEL, the activities of several derivatives increased (green, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A). For example, the antiproliferative activities of <b>31</b> (59.65%), <b>32</b> (53.69%), <b>37</b> (48.11%), <b>38</b> (53.38%), <b>40</b> (65.87%), and <b>41</b> (78.45%) were higher than that of CEL (47.98%). In the β-CN-substituted CA–CEL hybrids (<b>31</b>–<b>45</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B), the substituent on the benzene ring could affect the activity following the order of F > H > OCH<sub>3</sub> > CF<sub>3</sub> > CH<sub>3</sub>. These results indicated that the introduction of an electron-withdrawing group (F, OCH<sub>3</sub>, and CF<sub>3</sub>) onto the benzene ring might enhance antiproliferative activity. However, as the presence of electron withdrawing substituents increases, the activity would decrease (F > OCH<sub>3</sub> and CF<sub>3</sub>). Furthermore, we found that the length of the linker also significantly regulated the activity (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>D). For example, the inhibition rates of <b>40</b> with a 2-carbon linker (65.87%) and <b>41</b> with a 3-carbon linker (78.45%) were much higher than that of <b>42</b> with a 4-carbon linker (32.15%). This phenomenon occurred with all target compounds in this study (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>D). These results suggested that once the length of linker reached four carbons, the inhibitory effects were reduced sharply (black arrows) (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>D).</div><figure id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/medium/jm9b01290_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Comparison of inhibition rates of target compounds. (A) Inhibition rates of <b>1</b>–<b>45</b> and CEL at 1.5 μM in A549 cells. IR: inhibition rate. (B) Average inhibition rates of <b>31</b>–<b>45</b> classified by the different groups in benzene. (C) Inhibition rate of <b>31</b>–<b>45</b><sub>.</sub> (D) Inhibition rate of <b>1</b>–<b>45</b> classified by lengths of linker.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01290&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Preliminary Inhibitory Effects of <b>1</b>–<b>45</b> and CEL in A549 Cells</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="left" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="±">IR<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="±">IR</th><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="±">IR</th><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="±">IR</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char="±">22.97 ± 1.65</td><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="char" char="±">25.97 ± 1.45</td><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="char" char="±">26.15 ± 1.82</td><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="char" char="±">48.11 ± 3.32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char="±">33.21 ± 2.33</td><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="char" char="±">37.61 ± 1.77</td><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="char" char="±">24.99 ± 1.95</td><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="char" char="±">53.38 ± 3.11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="char" char="±">13.27 ± 1.25</td><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="char" char="±">6.19 ± 1.02</td><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="char" char="±">19.00 ± 1.67</td><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="char" char="±">9.57 ± 1.08</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="char" char="±">28.65 ± 1.99</td><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="char" char="±">24.29 ± 1.34</td><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="char" char="±">16.03 ± 1.06</td><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="char" char="±">65.87 ± 3.43</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="char" char="±">29.06 ± 2.17</td><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="char" char="±">19.09 ± 1.38</td><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="char" char="±">19.40 ± 1.54</td><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="char" char="±">78.45 ± 3.59</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="char" char="±">19.87 ± 1.52</td><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="char" char="±">16.19 ± 1.43</td><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="char" char="±">7.85 ± 0.34</td><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="char" char="±">32.15 ± 2.67</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="char" char="±">35.32 ± 2.48</td><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="char" char="±">29.87 ± 1.54</td><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="char" char="±">59.65 ± 2.87</td><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="char" char="±">33.30 ± 1.98</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="char" char="±">34.11 ± 2.76</td><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="char" char="±">34.68 ± 2.75</td><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="char" char="±">53.69 ± 3.05</td><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="char" char="±">24.51 ± 1.26</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="char" char="±">20.65 ± 1.39</td><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="char" char="±">16.49 ± 1.22</td><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="char" char="±">3.19 ± 0.12</td><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="char" char="±">18.33 ± 1.38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="char" char="±">27.74 ± 1.88</td><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="char" char="±">16.59 ± 1.32</td><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="char" char="±">20.40 ± 2.43</td><td class="colsep0 rowsep0" align="left">CEL<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="±">47.98 ± 3.29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="char" char="±">37.63 ± 2.01</td><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="char" char="±">18.64 ± 1.05</td><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="char" char="±">21.59 ± 1.55</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="char" char="±">14.71 ± 1.04</td><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="char" char="±">3.07 ± 0.65</td><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="char" char="±">9.74 ± 1.03</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">IR: Inhibition rate (%) at 1.5 μM.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Positive control.</p></div></div></div><div class="NLM_p">According to what has been mentioned above, a F/H/OCH<sub>3</sub> group substituted onto the benzene ring of β-CN-substituted CA–CEL hybrids showed higher activity than that of the CF<sub>3</sub>/CH<sub>3</sub> groups. To study the effects of the unsaturated alkyl group on the antiproliferative activity, we replaced the linkers of the F/H/OCH<sub>3</sub>-substituted β-CN CA–CEL hybrids with unsaturated alkyl chains to obtain <b>46</b>–<b>48</b>, respectively. Then, compounds <b>31</b>, <b>32</b>, <b>37</b>, <b>38</b>, <b>40</b>, and <b>41</b>, with stronger inhibitory activities than that of CEL, along with <b>46</b>–<b>48</b> were evaluated to determine their IC<sub>50</sub> values against four tumor cell lines (A549, HOS, MCF-7, and HepG2) with the MTT method (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). As a triterpenoid derivative with multiple targets, CDDO-Me was used as a positive control. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, the antiproliferative activities of <b>46</b> (IC<sub>50</sub>: 2.86–3.54 μM), <b>47</b> (IC<sub>50</sub>: 1.34–2.71 μM), and <b>48</b> (IC<sub>50</sub>: 1.11–2.74 μM) had not improved significantly, which suggested that the unsaturated alkyl linker showed little effect on the activity in this study. Among all the compounds, <b>41</b>, which showed the highest activity (IC<sub>50</sub>: 0.41–0.94 μM) against cancer cells, attracted our attention. Therefore, <b>41</b> was selected for further investigation.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Antiproliferative Activity of the Selected Compounds against Four Cancer Cell Lines (IC<sub>50</sub>, μM)</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center" char="±">IC<sub>50</sub></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="±">A549</th><th class="colsep0 rowsep0" align="center" char="±">MCF-7</th><th class="colsep0 rowsep0" align="center" char="±">HOS</th><th class="colsep0 rowsep0" align="center" char="±">HepG2</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="char" char="±">1.02 ± 0.12</td><td class="colsep0 rowsep0" align="char" char="±">0.70 ± 0.08</td><td class="colsep0 rowsep0" align="char" char="±">0.54 ± 0.05</td><td class="colsep0 rowsep0" align="char" char="±">0.65 ± 0.15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="char" char="±">1.41 ± 0.17</td><td class="colsep0 rowsep0" align="char" char="±">0.98 ± 0.05</td><td class="colsep0 rowsep0" align="char" char="±">0.45 ± 0.07</td><td class="colsep0 rowsep0" align="char" char="±">0.76 ± 0.13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="char" char="±">1.79 ± 0.15</td><td class="colsep0 rowsep0" align="char" char="±">0.97 ± 0.09</td><td class="colsep0 rowsep0" align="char" char="±">1.14 ± 0.07</td><td class="colsep0 rowsep0" align="char" char="±">0.97 ± 0.10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="char" char="±">1.09 ± 0.13</td><td class="colsep0 rowsep0" align="char" char="±">1.10 ± 0.08</td><td class="colsep0 rowsep0" align="char" char="±">1.75 ± 0.05</td><td class="colsep0 rowsep0" align="char" char="±">1.27 ± 0.09</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="char" char="±">1.02 ± 0.15</td><td class="colsep0 rowsep0" align="char" char="±">2.35 ± 0.12</td><td class="colsep0 rowsep0" align="char" char="±">2.18 ± 0.14</td><td class="colsep0 rowsep0" align="char" char="±">3.89 ± 0.28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="char" char="±">0.41 ± 0.11</td><td class="colsep0 rowsep0" align="char" char="±">0.64 ± 0.07</td><td class="colsep0 rowsep0" align="char" char="±">0.90 ± 0.05</td><td class="colsep0 rowsep0" align="char" char="±">0.94 ± 0.23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="char" char="±">3.54 ± 0.11</td><td class="colsep0 rowsep0" align="char" char="±">2.86 ± 0.16</td><td class="colsep0 rowsep0" align="char" char="±">4.78 ± 0.19</td><td class="colsep0 rowsep0" align="char" char="±">3.45 ± 0.16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="char" char="±">1.34 ± 0.14</td><td class="colsep0 rowsep0" align="char" char="±">1.44 ± 0.14</td><td class="colsep0 rowsep0" align="char" char="±">1.79 ± 0.17</td><td class="colsep0 rowsep0" align="char" char="±">2.71 ± 0.18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="char" char="±">1.84 ± 0.17</td><td class="colsep0 rowsep0" align="char" char="±">1.11 ± 0.13</td><td class="colsep0 rowsep0" align="char" char="±">1.33 ± 0.15</td><td class="colsep0 rowsep0" align="char" char="±">2.74 ± 0.19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CEL</td><td class="colsep0 rowsep0" align="char" char="±">1.48 ± 0.18</td><td class="colsep0 rowsep0" align="char" char="±">2.04 ± 0.15</td><td class="colsep0 rowsep0" align="char" char="±">1.46 ± 0.14</td><td class="colsep0 rowsep0" align="char" char="±">3.18 ± 0.32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CDDO-Me<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char="±">0.52 ± 0.09</td><td class="colsep0 rowsep0" align="char" char="±">0.85 ± 0.13</td><td class="colsep0 rowsep0" align="char" char="±">0.66 ± 0.11</td><td class="colsep0 rowsep0" align="char" char="±">0.52 ± 0.08</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Positive control.</p></div></div></div></div><div id="sec2_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i10" class="anchor-spacer"></div><h4 class="article-section__title" id="_i10"> <b>41</b> Disrupted the Hsp90–Cdc37 Interaction in Vitro</h4><div class="NLM_p">Many studies have reported that CEL and its derivatives could disrupt the Hsp90–Cdc37 interaction. To verify whether <b>41</b> decreased the level of the Hsp90–Cdc37 complex in vitro, co-immunoprecipitation was carried out in the following experiments. First, we needed to confirm that <b>41</b> could not inhibit ATP binding to Hsp90. As shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A, Hsp90α was pulled down by γ-phosphate-linked ATP-sepharose. It has been reported that CEL could not block the ATP-binding pocket of Hsp90. Similar to CEL, <b>41</b> had no effect on ATP binding. Next, immunoblot analysis of Cdc37 was carried out after immunoprecipitation of Hsp90α. Compared with the DMSO group, <b>41</b> could decrease the amount of Cdc37 detected when Hsp90α was pulled down with <b>41</b> treatment for 6 h (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B). These results indicated that <b>41</b> could disrupt the Hsp90–Cdc37 interaction in A549 cells.</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/medium/jm9b01290_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Effects of <b>41</b> on the level of Hsp90–Cdc37 complex in vitro. (A) Effects of <b>41</b> on the binding of ATP and Hsp90. Purified Hsp90α was pulled down by γ-phosphate-linked ATP-Sepharose in the presence of <b>41</b> or CEL. Hsp90α was detected by Western blot. (B) Effects of <b>41</b> on the amount of Cdc37 associated with Hsp90. A549 cells were treated with DMSO or <b>41</b> for 6 h. Cell lysates were immunoprecipitated by Hsp90α antibody. Western blot was done for detection of Hsp90 and Cdc37. (C) Quantitative analysis of co-immunoprecipitation. Data are expressed as the mean ± SD (<i>n</i> = 3). **<i>P</i> < 0.01 vs DMSO group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01290&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11"> Comparison of the Regulations of <b>41</b> and CEL on Hsp90–Cdc37 Clients</h4><div class="NLM_p">Furthermore, the levels of the Hsp90–Cdc37 clients induced by <b>41</b> and CEL were compared. As shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A, <b>41</b> and CEL both inhibited the expression of p-Akt and Cdk4 at a concentration of 5 μM. The inhibitory activity of <b>41</b> was higher than that of CEL at the same concentration (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B). These results indicated that the capability of <b>41</b> to disrupt the Hsp90–Cdc37 interaction was stronger than that of CEL.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/medium/jm9b01290_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effects of <b>41</b> and CEL on Hsp90–Cdc37clients. A549 cells were treated with DMSO, <b>41</b>, and CEL for 12 h, and the relative levels of p-Akt and Cdk4 expression were determined by Western blot assays using Hsp90 as a control. Data are representative images and expressed as the means ± SD of each group of cells from three separate experiments. (A) Western blot analysis of the relative levels of p-AKT and Cdk4 expression. (B) Quantitative analysis. **<i>P</i> < 0.01 vs the DMSO group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01290&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12"> <b>41</b> Combined with Cdc37</h4><div class="NLM_p">A previous study reported that CEL might disrupt the Hsp90–Cdc37 interaction by binding to Cdc37.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11,12)</a> To determine whether <b>41</b> could play the same role, we first designed and synthesized an affinity probe (<b>41-Bio</b>) based on the structure of <b>41</b> to verify the binding capacity of <b>41</b> to Cdc37. The structure and synthetic route of <b>41-Bio</b> is shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. As shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>, Cdc37 was pulled down by <b>41-Bio</b> and <b>41</b> could compete with <b>41-Bio</b> in this assay. These results indicated that <b>41</b> could bind to Cdc37 directly.</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/medium/jm9b01290_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0016.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01290&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 3-Bromo-1-propanol, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, overnight; (b) K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>OH, 70 °C, 6 h; (c) 1,3-dibromopropane, K<sub>2</sub>CO<sub>3,</sub> acetone, reflux, overnight; (D) biotin, DCC, DMAP, DMF, 30 °C, 24 h. (e) CEL, NaHCO<sub>3</sub>, DMF, 60 °C, 12 h.</p></p></figure><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/medium/jm9b01290_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. <b>41-Bio</b> binds to Cdc37. The recombinant Cdc37 protein (5 mg) was incubated with different concentrations of <b>41</b> for 2 h before or after incubation with <b>41-Bio</b> (0.5 μM) for 2 h and then pulled down using streptavidin beads. The total proteins (input) and bound proteins (Bind P) were immunoblotted. Data are expressed as the mean ± SD (<i>n</i> = 3). **<i>P</i> < 0.01 vs <b>41</b> (0.5 μM) group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01290&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> Compound <b>41</b> Possessed a Higher Affinity for Cdc37 than Hsp90</h4><div class="NLM_p">To further evaluate the protein binding ability of <b>41</b>, the combination of <b>41</b>, Cdc37, and Hsp90 was detected by a UV method. This method was carried out because of the characteristic that bound thiol groups in proteins cause the UV absorption at 440 nm to disappear, as would be the case upon binding to <b>41</b> (A, B rings). First, we needed to confirm whether the CA moiety of <b>41</b> could interfere with the reaction. The addition of <b>41</b> to dithiothreitol (DTT) was monitored by <sup>1</sup>H NMR. As shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a> (<a class="ref internalNav" href="#notes1" aria-label="Figure S148, 149">Figure S148, 149</a>), the unsaturated hydrogen signal from the CA moiety was retained (green), indicating that the CA moiety did not affect the addition of the thiol group to <b>41</b>.</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/medium/jm9b01290_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Overlay of <sup>1</sup>H NMR spectrum of <b>41</b> with and without <span class="smallcaps smallerCapital">dl</span>-dithiothreitol (DTT) in DMSO-<i>d</i><sub>6</sub>. <b>41</b> (0.02 mmol) and DTT (0.04 mmol) were dissolved in DMSO-<i>d</i><sub>6</sub>. Then the <sup>1</sup>H NMR spectrum of the mixture was detected after reaction in ultrasound for 20 min.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01290&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Based on the results proposed above, <b>41</b> was added to the purified Hsp90α (full length) and Cdc37 (full length), respectively, and the UV spectrum of <b>41</b> (200–500 nm) was detected vs time. Glutathione (GSH) was used as a positive control. As shown in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A, GSH, Cdc37, and Hsp90 reduced the UV absorption of <b>41</b> at 440 nm, indicating that all three molecules could bind to <b>41</b>. Analysis of the UV assay (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B) showed that the binding of <b>41</b> to Cdc37 reached equilibrium within 5 min while the combination of <b>41</b> and Hsp90 needed 15 min to equilibrate, indicating that <b>41</b> possessed a higher affinity to Cdc37 than to Hsp90. These results suggested that the combination of <b>41</b> and cysteine (Cys) possessed poor selectivity in PBS. However, under physiological conditions, <b>41</b> might reach the target protein finally as the reaction is reversed.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Therefore, <b>41</b> might disrupt the interaction of the Hsp90–Cdc37 complex by preferentially binding to Cdc37 in cancer cells.</div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/medium/jm9b01290_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0006.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. UV spectrum of <b>41</b> monitored after addition of GSH, Cdc37, and Hsp90. <b>41</b> (100 μM) and GSH (100 μM) or Cdc37 (1.5 μM) or Hsp90 (1.5 μM) were dissolved in PBS (1% DMSO). Then the solution was incubated at 37 °C for 0, 5, 15, and 30 min. The UV spectrum of the solution (200–500 nm) was monitored. (A) The UV spectrum of <b>41</b> was monitored after incubation with GSH, Cdc37, and Hsp90. (B) Analysis of the UV assay. A0, absorbance of the solution at 440 nm with 0 min. A, absorbance of the solution at 440 nm with the corresponding time. Data are expressed as the mean ± SD (<i>n</i> = 3). **<i>P</i> < 0.01 vs 0 min group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01290&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> Molecular Docking of <b>41</b> to the Hsp90<sub>N</sub>-Cdc37<sub>M</sub> Complex</h4><div class="NLM_p">To further investigate the mechanism of <b>41</b> inhibiting Hsp90–Cdc37 interaction, molecular docking was first carried out to mimic the interaction between <b>41</b> (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A) and the hydrophobic pocket of the human Hsp90<sub>N</sub>–Cdc37<sub>M</sub> protein complex (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2K5B">2K5B</a>).<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> As shown in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B, <b>41</b> was docked in the hydrophobic pocket of Hsp90<sub>N</sub>–Cdc37<sub>M</sub>. Four H-bonds might be formed, including between the β-CN group of the CA moiety of <b>41</b> and R166 of Cdc37 (yellow, <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B), the carbonyl group of the CEL moiety and W168 of Cdc37 (purple, <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B), and the carbonyl group of the CA moiety (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B) and R166 (H-bond ×2). These hydrogen bonds might allow <b>41</b> to efficiently disrupt the key interaction (hydrogen bonds between Q133<sup>Hsp90</sup> and R166/R167<sup>Cdc37</sup>) of the Hsp90<sub>N</sub>–Cdc37<sub>M</sub> complex by binding to Cdc37 (noncovalent bond), thereby affecting the stability of Hsp90–Cdc37.</div><figure id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/medium/jm9b01290_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0007.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Molecular docking of <b>41</b> to Hsp90<sub>N</sub>-Cdc37<sub>M</sub>. (A) Chemical structure of <b>41</b>. (B) Binding mode of <b>41</b> with the Hsp90<sub>N</sub>–Cdc37<sub>M</sub> complex (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2K5B">2K5B</a>). The complex is shown in a cartoon representation. The side chain R166 (yellow), R167 (green), and W168 (purple) of Cdc37<sub>M</sub> and <b>41</b> (gray) are shown in a stick type. The expected hydrogen bonds are indicated by the dashed yellow lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01290&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> <b>41</b> Might Form a Covalent Bond with C203 of Cdc37<sub>M</sub></h4><div class="NLM_p">The reaction between quinone methide (A, B rings) and cysteine (Cys) has been considered as a key factor for the high activity of CEL derivatives. As Jiang et al. report, CEL derivatives might form a covalent bond with C203 of Cdc37 to disrupt the interaction of the Hsp90–Cdc37.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> In order to investigate the potential mechanism of <b>41</b> inhibiting the Hsp90–Cdc37 interaction, the A, B rings were further modified (<b>41-H</b>, <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>, <a class="ref internalNav" href="#notes1" aria-label="Scheme S1">Scheme S1</a>). As shown in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>, the inhibition rate of <b>41-H</b> (20.5%) was decreased compared to that of <b>41</b> (65.1%) and the mixture of <b>41</b> and methyl thioglycolate (68.3%) in A549 at 0.5 μM. These results indicated that the A, B rings were critical for the activity of <b>41</b>. Therefore, <b>41</b> might inhibit the activity of Hsp90 by the combination between A, B rings and Cys in the Hsp90–Cdc37 complex. This complex depends on a hydrophobic interaction which is mainly located in a hydrophobic core between Hsp90<sub>N</sub> and Cdc37<sub>M</sub>. And Hsp90<sub>N</sub> does not contain any Cys residues, while Cdc37<sub>M</sub> shows two Cys residues (C183 and C203) on the protein surface. As shown in <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>A, C183 is inaccessible as it is located in the depression on the protein surface. However, the position of C203 is closer to the hydrophobic core (cyans) in Cdc37 and is more easily approached by the compounds (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>B). Therefore, <b>41</b> most likely to combine with C203<sup>Cdc37</sup> by covalent bonding to disrupt the interaction of the Hsp90–Cdc37 complex.</div><figure id="fig8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/medium/jm9b01290_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0008.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Antiproliferative activity of <b>41-H</b> in comparison with that of <b>41</b>, methyl thioglycolate, and the mixture of <b>41</b> and methyl thioglycolate in A549 cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01290&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig9" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/medium/jm9b01290_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0009.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Structure of Cdc37<sub>M</sub> (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2W0G">2W0G</a>). (A) Location of Cys183. (B) Location of Cys203.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01290&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> Compound <b>41</b> Regulated the Hsp90–Cdc37 Clients and Apoptosis-Related Proteins</h4><div class="NLM_p">Based on prophase research, <b>41</b> could be considered as a Hsp90–Cdc37 disruptor. Disruption of Hsp90 and Cdc37 will downregulate the levels of Hsp90–Cdc37 clients, resulting in the induction of apoptosis-related proteins.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Thus, the effects of <b>41</b> on the levels of Hsp90–Cdc37 clients and apoptosis-related proteins were detected. As important clients of Hsp90–Cdc37, Cdk4 and p-Akt were selected to be measured by Western blotting. These proteins were tested after treatment with <b>41</b> in A549 cells. As shown in <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>A, <b>41</b> downregulated the levels of p-Akt and Cdk4 in a dose-dependent manner. The levels of Bax and cleaved caspase-3 were significantly increased. In contrast, as an antiapoptotic protein, Bcl-2 expression was inhibited (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>B). These results indicated that <b>41</b> regulated the levels of Hsp90–Cdc37 clients and the apoptosis-related proteins to induce cell apoptosis.</div><figure id="fig10" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/medium/jm9b01290_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0010.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Effects of <b>41</b> on clients of Hsp90–Cdc37 and apoptosis-related proteins in A549 cells. A549 cells were treated with DMSO or <b>41</b> for 12 h, and the relative levels of Hsp90, p-AKT, Cdk4, Bcl-2, Bax and Caspase-3 expression were determined by Western blot assays using β-actin as a control. Data are representative images and expressed as the means ± SD of each group of cells from three separate experiments. (A) Western blot analysis of the relative levels of Hsp90, p-Akt, Cdk4, Bcl-2, Bax and Caspase-3 expression. (B) Quantitative analysis. *<i>P</i> < 0.05, **<i>P</i> < 0.01, vs the DMSO-treated control group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01290&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> Compound <b>41</b> Decreased the Mitochondrial Membrane Potential (Δψ<sub>m</sub>)</h4><div class="NLM_p">As mentioned above, <b>41</b> could regulate the levels of Hsp90 clients and apoptosis-related proteins to induce cell apoptosis. Changes in the Δψ<sub>m</sub> are hallmark events of early apoptosis, regardless of whether it is extrinsic apoptosis or intrinsic apoptosis. Thus, to investigate the influence of <b>41</b> on the Δψm, JC-1 staining was used in A549 cells. As shown in <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>, an increase in the cell number with J-monomers (green fluorescence, depolarized mitochondria) and a concurrent decrease in the cell number with J-aggregates (red fluorescence, indicating hyperpolarized mitochondria) were exhibited in this assay. In addition, a significant loss in the Δψ<sub>m</sub> was induced by treatment of <b>41</b> at 0.2 μM, which indicated that <b>41</b> could significantly induce apoptosis in A549 cells at a low concentration.</div><figure id="fig11" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/medium/jm9b01290_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0011.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Effects on Δψ<sub>m</sub> of <b>41</b> in A549 cells. A549 cells were treated with DMSO or <b>41</b> for 24 h and then analyzed by fluorescence microscopy and flow cytometry after JC-1 staining. (A) Flow cytometry analysis of A549 cells treated with DMSO and <b>41</b>. (B) Quantification of cells (%) with red and green aggregates. The values are presented as mean ± SD (<i>n</i> = 3). **<i>P</i> < 0.01 vs the DMSO group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01290&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> The Morphological Apoptosis Induced by <b>41</b></h4><div class="NLM_p">Next, the morphological apoptosis induced by <b>41</b> was detected by Hoechst 33342 and propidium iodide (PI) staining. Hoechst 33342 stained the apoptotic cells bright blue, and PI stained the dead cells red. As shown in <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>, the cell density decreased significantly as drug concentration increased. Simultaneously, the number of apoptotic cells was increased. The characteristics of apoptotic cells were observed in apoptotic cells (white arrows), such as nuclear fragmentation and chromatin condensation.</div><figure id="fig12" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/medium/jm9b01290_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0012.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Morphological apoptosis induced by <b>41</b> in A549 cells. A549 cells were treated with <b>41</b> or DMSO for 48 h. Fluorescence microscopy images of A549 cells stained by Hoechst 33342 and PI. The apoptotic cells were stained by Hoechst 33342 in bright blue, and the dead cells were stained by PI in red.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01290&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> Effects of <b>41</b> on Cell Apoptosis</h4><div class="NLM_p">To examine whether apoptosis was induced by <b>41</b>, an annexin V-FITC/PI dual staining assay was performed in A549 cells. As shown in <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>A, after 48 h of treatment with <b>41</b>, significant apoptosis was induced in a dose-dependent manner, especially in late apoptotic cells (9.3%, 16.9%, and 25.2% at the concentrations). Furthermore, at a concentration of 1.2 μM, the apoptotic cells induced by treatment with <b>41</b> accounted for 32.6% of the cells, which was higher than that of CEL (23.1%) (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>B). These results suggested that the superior activity of <b>41</b> might be mainly through an apoptotic pathway.</div><figure id="fig13" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/medium/jm9b01290_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0013.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Apoptotic effects of <b>41</b> and CEL in A549 cells. After treatment with DMSO, <b>41</b>, or CEL for 48 h, A549 cells were collected and stained with Annexin V/PI, followed by flow cytometric analysis. (A) Flow cytometry analysis of A549 cells treated with DMSO, <b>41</b>, and CEL. (B) Representative histograms for the numbers of living cells and apoptotic cells (%). The values are presented as mean ± SD (<i>n</i> = 3). **<i>P</i> < 0.05 vs the DMSO group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01290&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> Effects of <b>41</b> on the Cell Cycle</h4><div class="NLM_p">Cdk4 is a key regulator of the cell cycle. Inhibition of Cdk4 expression will arrest the cell cycle in the G<sub>0</sub>/G<sub>1</sub> phase. Western blotting verified that <b>41</b> could decrease the amount of Cdk4. Thus, we further investigated the effects of <b>41</b> on cell cycle progression. As shown in <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>, <b>41</b> arrested the cell cycle in the G<sub>0</sub>/G<sub>1</sub> phase in a dose-dependent manner in A549 cells. These results indicated that the effects of <b>41</b> on the cell cycle were another pathway that induced the apoptosis in cancer cells.</div><figure id="fig14" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/medium/jm9b01290_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0014.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Effect of <b>41</b> on cell cycle progression of A549 cells. Treatment of A549 cells with DMSO and <b>41</b> (0.2, 0.4, and 0.8 μM) for 24 h, intracellular DNA was stained with PI. Cell cycle distribution was analyzed by flow cytometry. (A) Flow cytometry analysis of cell cycle distribution of <b>41</b> on A549. (B) Quantification of cells (%) in each cell phase. The values are presented as mean ± SD (<i>n</i> = 3). *<i>P</i> < 0.01, **<i>P</i> < 0.05 vs the DMSO group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01290&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03124" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03124" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Based on the analysis of the Hsp90<sub>N</sub>–Cdc37<sub>M</sub> structure, lipophilic fragments with small molecules (CA and α- or β-CN substituted CA) were introduced into CEL to synthesize 48 new derivatives. Their antiproliferative activities were evaluated against four cancer cell lines (A549, HOS, MCF-7, and HepG2), and the structure–activity relationship of these derivatives was discussed. Further study showed that <b>41</b> disrupted the interaction of the Hsp90–Cdc37 complex in A549 cells. Molecular docking analysis indicated that <b>41</b> might inhibit the interaction of Hsp90–Cdc37 by binding to Cdc37, and <b>41</b> bound to Cdc37 more efficiently than Hsp90 in UV assay. Pharmacological studies showed that <b>41</b> could regulate the levels of Hsp90–Cdc37 clients and the apoptosis-related proteins to induce the cell cycle arrest and the apoptosis in A549 cells. Jiang et al.’s study indicated that introduction of the polar groups in C29-carboxyl of CEL were favorable on Hsp90–Cdc37 disruption.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> However, a suitable hydrophobic group could also enhance Hsp90–Cdc37 disruption activity when introduced to this site in our study. These results suggested that mechanism of disrupting the Hsp90–Cdc37 interaction by small molecules was complex. The binding capability is not only related to the polarities of the compounds, but also the spatial structures, flexibility and electrical properties, etc. Overall, <b>41</b> displayed superior antiproliferative activity against cancer cells by disrupting the interaction of Hsp90–Cdc37 by preferentially binding to Cdc37 (hydrogen bond and/or covalent bond). The current finding may provide new insight into the design of CEL derivatives as novel Hsp90–Cdc37 disruptors.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Experimental Protocols</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44345" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44345" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Chemical Analysis</h3><div class="NLM_p last">Celastrol was purchased from Tuochukangyuan company (Hubei, China). Synthetic reagents were purchased from chemical and biological companies. The antibodies used for immunoprecipitation and Western blotting (Hsp90α, Cdc37; Hsp90, p-Akt, Cdk4, Bcl-2, Bax, and caspase 3) were purchased from Abcam. The purity of all tested compounds was characterized by HPLC analysis (LC-2030C HPLC system consisting of LC-2030C pumps and an SPD-2030C UV detector). Individual compounds with a purity of >95% were used for subsequent experiments (see the <a class="ref internalNav" href="#notes1" aria-label="Supporting Information">Supporting Information</a>).</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> General Procedures for the Preparation of Compounds <b>2f</b>–<b>t</b></h3><div class="NLM_p last"><b>1a</b>/<b>1b/1c/1d</b>/<b>1e</b> (1.2 mmol, 1.2 equiv), EDCI (288.0 mg, 1.5 mmol, 1.5 equiv), and DMAP (61.0 mg, 1.0 mmol, 0.5 equiv) were successively added to a solution of bromohydrin (1.0 mmol, 1.0 equiv) in CH<sub>2</sub>Cl<sub>2</sub> (6 mL), and this reaction mixture was stirred for 7 h at room temperature. The reaction mixture was concentrated under vacuum, and the residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was washed with 5% aqueous NaHCO<sub>3</sub> solution (60 mL) and aqueous saturated NaCl solution (30 mL). After drying over anhydrous Na<sub>2</sub>SO<sub>4</sub>, the CH<sub>2</sub>Cl<sub>2</sub> was removed in vacuum. The crude materials was purified by column chromatography on silica gel [petroleum ether (PE)/ethyl acetate (EA) = 16:1 (v/v)] to afford pure compounds <b>2f</b>–<b>t</b>.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> General Procedures for the Preparation of Compounds <b>5a</b>–<b>e</b></h3><div class="NLM_p last">NH<sub>4</sub>OAc (577.5 mg, 7.5 mmol, 0.5 equiv) and different aryl aldehydes <b>3a</b>–<b>e</b> (13.5 mmol, 0.9 equiv) were dissolved in a solution of <b>4a</b> (15.0 mmol, 1 equiv, 1.28g) in toluene (45 mL). The mixture was heated at 100 °C for 12 h. The reaction mixture was filtered to afford the crude products <b>5a</b>–<b>e</b>.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> General Procedures for the Preparation of Compounds <b>6f</b>–<b>t</b></h3><div class="NLM_p last"><b>6f</b>–<b>t</b> were synthesized from <b>5a</b>–<b>e</b> by using the methods employed in the case of <b>2f</b>–<b>t</b>. The crude materials were purified by column chromatography on silica gel [PE/EA = 16:1 (v/v)] to achieve <b>6f</b>–<b>t</b>.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> General Procedures for the Preparation of Compounds <b>9a</b>–<b>e</b></h3><div class="NLM_p last">K<sub>2</sub>CO<sub>3</sub> (3.11 g, 22.5 mmol, 1.5 equiv) and different aryl acetonitriles <b>7a</b>–<b>e</b> (15.0 mmol, 1.0 equiv) were added to a solution of <b>8a</b> (1.11 g, 15.0 mmol, 1.0 equiv) in CH<sub>3</sub>OH (50 mL). The mixture was refluxed at 60 °C for 6 h. The reaction mixture was filtered, and the filter cake was washed with CH<sub>2</sub>Cl<sub>2</sub> and then dissolved in water. The solution was acidified using 1 M hydrochloric acid solution to pH = 4 and filtered. The filter cake was the crude product <b>9a</b>–<b>e</b>.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> General Procedures for Synthesizing Compounds <b>10f</b>–<b>t</b></h3><div class="NLM_p last"><b>10f</b>–<b>t</b> were synthesized from <b>9a</b>–<b>e</b> by using the methods employed in the case of <b>2f</b>–<b>t</b>. The crude materials were separated by column chromatography on silica gel [PE/EA = 16:1 (v/v)] to achieve <b>10f</b>–<b>t</b>.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> General Procedures for Synthesizing Compounds <b>10u</b>–<b>w</b></h3><div class="NLM_p last"><b>9a/9c/9d</b> (0.5 mmol, 1.0 equiv), K<sub>2</sub>CO<sub>3</sub> (138.0 mg, 1.0 mmol, 2.0 equiv), Bu<sub>4</sub>N<sup>+</sup>Br<sup>–</sup> (9.7 mg, 0.06 equiv, 0.03 mmol), and <i>trans</i>-1,4-dibromo-2-butene (321.0 mg, 1.5 mmol, 3.0 equiv) were added into anhydrous acetone. The reaction mixture was refluxed for 7 h at 60 °C. The acetone was removed under reduced pressure and the residue was extracted with ethyl acetate (60 mL). The combined organic layers were dried over sodium sulfate, filtered, and the solvent was evaporated. The crude materials were purified by column chromatography on silica gel [PE/EA = 16:1 (v/v)] to afford <b>10u</b>–<b>w</b>.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> General Procedures for the Preparation of Target Compounds <b>1</b>–<b>48</b></h3><div class="NLM_p">A mixture of CEL (45.1 mg, 0.1 mmol, 1.0 equiv), <b>2a</b>–<b>o</b>, <b>6a</b>–<b>o</b>, or <b>10a</b>–<b>r</b> (0.3 mmol, 3.0 equiv) and NaHCO<sub>3</sub> (42.0 mg, 0.5 mmol, 5.0 equiv) in anhydrous DMF (6 mL) was stirred at 60 °C for 7 h. The reaction solution was washed with CH<sub>2</sub>Cl<sub>2</sub> (100 mL) for four times. The combined organic layers were washed with aqueous saturated NaCl solution (30 mL) and then dried over sodium sulfate, and filtered, and the solvent was evaporated. The crude product was purified by column chromatography [PE/EA = 6:1 (v/v)].</div><div id="sec5_8_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Compound <b>1</b></h4><div class="NLM_p last">Orange powder, 55% yield. Mp 149.3–151.7 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ<sub>H</sub>: 0.58 (3H, s), 1.11 (3H, s), 1.22 (3H, s), 1.26 (3H, s), 1.43 (3H, s), 2.21 (3H, s), 4.08–4.12 (1H, m), 4.30–4.46 (3H, m), 6.26 (1H, d, <i>J</i> = 7.1 Hz), 6.44 (1H, d, <i>J</i> = 16.0 Hz), 6.52 (1H, s), 6.95 (1H, d, <i>J</i> = 7.1 Hz), 7.43 (3H, m), 7.55 (2H, m), 7.72 (1H, d, <i>J</i> = 16.1 Hz); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ<sub>C</sub>: 178.2 (C × 2), 169.9, 166.8, 164.6, 146.0, 145.1, 134.2, 134.1, 130.3, 128.9 (C × 2), 128.1 (C × 2), 127.4, 119.6, 118.1, 117.7, 117.2, 61.0 (C × 2), 45.1, 44.3, 42.9, 40.5, 39.4, 38.2, 36.3, 34.8, 33.4, 32.8, 31.6, 30.9, 30.5, 29.8, 29.7, 28.6, 27.7, 21.6, 18.5, 10.3. HRMS (ESI) calculated for C<sub>40</sub>H<sub>49</sub>O<sub>6</sub> [M + H]<sup>+</sup> 625.3529, found 625.3529.</div></div><div id="sec5_8_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Compound <b>2</b></h4><div class="NLM_p last">Orange powder, 51% yield. Mp 135.2–137.1 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ<sub>H</sub>: 0.59 (3H, s), 1.12 (3H, s), 1.22 (3H, s), 1.28 (3H, s), 1.46 (3H, s), 2.19 (3H, s), 4.01–4.15 (2H, m), 4.23–4.34 (2H, m), 6.35 (1H, d, <i>J</i> = 7.1 Hz), 6.41 (1H, d, <i>J</i> = 15.9 Hz), 6.55 (1H, s), 6.99 (1H, d, <i>J</i> = 7.1 Hz), 7.41 (3H, m), 7.49 (2H, m), 7.67 (1H, d, <i>J</i> = 15.9 Hz); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ<sub>C</sub>: 178.3, 178.2, 169.9, 166.5, 164.6, 146.0, 145.4, 135.0, 134.3, 130.5, 128.9 (C × 2), 128.2 (C × 2), 127.4, 119.3, 118.3, 117.5, 117.2, 62.3, 61.7, 45.1, 44.3, 42.9, 40.5, 39.6, 38.2, 36.3, 34.8, 33.5, 32.8, 31.6, 30.9, 30.5, 29.7, 29.6, 28.6, 21.6, 18.6, 10.3. HRMS (ESI) calculated for C<sub>41</sub>H<sub>51</sub>O<sub>6</sub> [M + H]<sup>+</sup> 639.3686, found 639.3686.</div></div><div id="sec5_8_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Compound <b>3</b></h4><div class="NLM_p last">Orange powder, 46% yield. Mp 145.5–147.1 °C; 0.57 (3H, s), 1.10 (3H, s), 1.20 (3H, s), 1.30 (3H, s), 1.43 (3H, s), 2.21 (3H, s), 3.89–3.93 (1H, m), 4.04–4.07 (1H, m), 4.23–4.27 (2H, m), 6.34 (1H, d, <i>J</i> = 7.2 Hz), 6.46 (1H, d, <i>J</i> = 16.0 Hz), 6.54 (1H, s), 7.01 (1H, d, <i>J</i> = 7.2 Hz), 7.39 (3H, m), 7.55 (2H, m), 7.70 (1H, d, <i>J</i> = 16.0 Hz); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ<sub>C</sub>: 178.3, 178.2 169.9, 166.9, 164.7, 146.0, 144.9, 134.4, 134.0, 130.0, 128.9 (C × 2), 128.1 (C × 2), 127.4, 119.6, 118.1, 118.0, 117.1, 64.0 (C × 2), 45.0, 44.3, 42.9, 40.4, 39.4, 38.2, 36.4, 34.8, 33.5, 32.8, 31.6, 30.8, 30.6, 29.8, 29.7, 28.6, 25.6, 25.2, 21.6, 18.5, 10.3. HRMS (ESI) calculated for C<sub>42</sub>H<sub>53</sub>O<sub>6</sub> [M + H]<sup>+</sup> 653.2842, found 653.3842.</div></div><div id="sec5_8_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Compound <b>4</b></h4><div class="NLM_p last">Orange powder, 53% yield. Mp 143.9–146.1 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ<sub>H</sub>: 0.58 (3H, s), 1.11 (3H, s), 1.22 (3H, s), 1.26 (3H, s), 1.44 (3H, s), 2.22 (3H, s), 2.41 (3H, s), 4.08–4.13 (3H, m), 4.27–4.40 (1H, m), 6.27 (1H, d, <i>J</i> = 7.0 Hz), 6.39 (1H, d, <i>J</i> = 16.1 Hz), 6.53 (1H, s), 6.95 (1H, d, <i>J</i> = 7.1 Hz), 7.24 (2H, d, <i>J</i> = 7.9 Hz), 7.46 (2H, d, <i>J</i> = 7.7 Hz), 7.69 (1H, d, <i>J</i> = 16.0 Hz); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ<sub>C</sub>: 178.2 (C × 2), 170.3, 166.6, 164.7, 146.0, 145.4, 141.0, 134.3, 131.6, 129.7 (C × 2), 128.2 (C × 2), 127.4, 119.5, 118.2, 117.2, 116.4, 62.4, 61.7, 45.1, 44.3, 43.0, 40.5, 39.5, 38.2, 36.4, 34.8, 33.5, 32.8, 31.6, 30.9, 30.5, 29.7, 29.6, 28.6, 21.6, 21.5, 18.6, 10.3. HRMS (ESI) calculated for C<sub>41</sub>H<sub>51</sub>O<sub>6</sub> [M + H]<sup>+</sup> 639.3686, found 639.3673.</div></div><div id="sec5_8_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Compound <b>5</b></h4><div class="NLM_p last">Orange powder, 47% yield. Mp 145.8–147.6 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ<sub>H</sub>: 0.59 (3H, s), 1.12 (3H, s), 1.21 (3H, s), 1.28 (3H, s), 1.45 (3H, s), 2.18 (3H, s), 2.39 (3H, s), 4.01–4.14 (2H, m), 4.19–4.33 (2H, m), 6.34 (1H, d, <i>J</i> = 7.1 Hz), 6.36 (1H, d, <i>J</i> = 16.0 Hz), 6.54 (1H, s), 6.97 (1H, d, <i>J</i> = 7.0 Hz), 7.19 (2H, d, <i>J</i> = 7.8 Hz), 7.39 (2H, d, <i>J</i> = 7.7 Hz), 7.64 (1H, d, <i>J</i> = 15.9 Hz); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ<sub>C</sub>: 178.2, 178.1, 170.0, 167.0, 164.7, 146.0, 145.1, 140.8, 134.2, 131.5, 129.6 (C × 2), 128.1 (C × 2), 127.4, 119.5, 118.2, 117.2, 116.6, 61.0, 60.9, 45.1, 44.3, 43.0, 40.5, 39.5, 38.2, 36.4, 34.8, 33.4, 32.8, 31.6, 30.8, 30.5, 29.8, 29.7, 28.6, 27.9, 21.6, 21.5, 18.6, 10.3. HRMS (ESI) calculated for C<sub>42</sub>H<sub>53</sub>O<sub>6</sub> [M + H]<sup>+</sup> 653.3842, found 653.3845.</div></div><div id="sec5_8_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Compound <b>6</b></h4><div class="NLM_p last">Orange powder, 45% yield. Mp 137.8–139.2 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ<sub>H</sub>: 0.56 (3H, s), 1.10 (3H, s), 1.20 (3H, s), 1.26 (3H, s), 1.43 (3H, s), 2.20 (3H, s), 2.37 (3H, s), 3.87–3.95 (1H, m), 4.01–4.09 (1H, m), 4.22–4.26 (2H, m), 6.38 (1H, d, <i>J</i> = 7.1 Hz), 6.40 (1H, d, <i>J</i> = 16.0 Hz), 6.53 (1H, s), 7.00 (1H, d, <i>J</i> = 6.9 Hz), 7.19 (2H, d, <i>J</i> = 7.9 Hz), 7.43 (2H, d, <i>J</i> = 7.9 Hz), 7.67 (1H, d, <i>J</i> = 16.0 Hz); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ<sub>C</sub>: 178.3, 178.2, 169.8, 167.1, 164.6, 146.0, 144.8, 140.7, 134.0, 131.7, 129.6 (C × 2), 128.1 (C × 2), 127.4, 119.6, 118.1, 117.1, 116.9, 64.0, 63.9, 45.0, 44.3, 42.9, 40.4, 39.4, 38.2, 36.6, 34.8, 33.5, 32.8, 31.6, 30.8, 30.5, 29.8, 29.6, 28.6, 25.6, 25.2, 21.6, 21.5, 18.5, 10.2. HRMS (ESI) calculated for C<sub>43</sub>H<sub>55</sub>O<sub>6</sub> [M + H]<sup>+</sup> 667.3999, found 667.3998.</div></div><div id="sec5_8_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Compound <b>7</b></h4><div class="NLM_p last">Orange powder, 52% yield. Mp 144.2–146.3 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ<sub>H</sub>: 0.58 (3H, s), 1.12 (3H, s), 1.22 (3H, s), 1.36 (3H, s), 1.44 (3H, s), 2.23 (3H, s), 3.88 (3H, s), 4.07–4.14 (1H, m), 4.28–4.43 (3H, m), 6.30 (1H, d, <i>J</i> = 6.5 Hz), 6.32 (1H, d, <i>J</i> = 15.7 Hz), 6.56 (1H, s), 7.00 (2H, d, <i>J</i> = 8.5 Hz), 7.01 (1H, d, <i>J</i> = 6.4 Hz), 7.51 (2H, d, <i>J</i> = 8.4 Hz), 7.67 (1H, d, <i>J</i> = 15.7 Hz); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ<sub>C</sub>: 178.3 (C × 2), 169.7, 167.2, 164.7, 161.3, 146.0, 144.7, 133.9, 129.8 (C × 2), 127.4, 127.1, 119.6, 118.1, 117.1, 115.3, 114.3 (C × 2), 61.8, 61.0, 55.7, 45.0, 44.3, 42.9, 40.5, 39.4, 38.2, 36.4, 34.9, 33.4, 32.8, 31.6, 30.8, 30.5, 29.8 (C × 2), 28.6, 21.7, 18.6, 10.2. HRMS (ESI) calculated for C<sub>41</sub>H<sub>51</sub>O<sub>7</sub> [M + H]<sup>+</sup> 655.3635, found 655.3618.</div></div><div id="sec5_8_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> Compound <b>8</b></h4><div class="NLM_p last">Orange powder, 41% yield. Mp 129.4–131.7 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ<sub>H</sub>: 0.59 (3H, s), 1.12 (3H, s), 1.22 (3H, s), 1.28 (3H, s), 1.46 (3H, s), 2.19 (3H, s), 3.87 (3H, s), 4.01–4.15 (2H, m), 4.27–4.40 (2H, m), 6.27 (1H, d, <i>J</i> = 15.9 Hz), 6.34 (1H, d, <i>J</i> = 6.9 Hz), 6.54 (1H, s), 6.91 (2H, d, <i>J</i> = 8.3 Hz), 6.98 (1H, d, <i>J</i> = 7.1 Hz), 7.44 (2H, d, <i>J</i> = 8.3 Hz), 7.61 (1H, d, <i>J</i> = 16.0 Hz); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ<sub>C</sub>: 178.3, 178.2, 169.7, 167.1, 164.6, 161.5, 146.0, 144.7, 133.9, 129.7 (C × 2), 127.4, 127.0, 119.6, 118.1, 117.0, 115.2, 114.3 (C × 2), 61.0, 60.8, 55.4, 45.0, 44.3, 42.9, 40.5, 39.4, 38.2, 36.4, 34.9, 33.4, 32.8, 31.6, 30.8, 30.5, 29.8, 29.7, 28.6, 27.9, 21.7, 18.5, 10.2. HRMS (ESI) calculated for C<sub>42</sub>H<sub>53</sub>O<sub>7</sub> [M + H]<sup>+</sup> 669.3791, found 669.3794.</div></div><div id="sec5_8_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> Compound <b>9</b></h4><div class="NLM_p last">Orange powder, 49% yield. Mp 124.1–126.6 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ<sub>H</sub>: 0.56 (3H, s), 1.10 (3H, s), 1.20 (3H, s), 1.26 (3H, s), 1.43 (3H, s), 2.20 (3H, s), 3.84 (3H, s), 3.89–3.95 (1H, m), 4.01–4.09 (1H, m), 4.21–4.25 (2H, m), 6.32 (1H, d, <i>J</i> = 16.2 Hz), 6.34 (1H, d, <i>J</i> = 6.9 Hz), 6.53 (1H, s), 6.90 (2H, d, <i>J</i> = 8.7 Hz), 7.00 (1H, d, <i>J</i> = 7.1 Hz), 7.49 (2H, d, <i>J</i> = 8.7 Hz), 7.65 (1H, d, <i>J</i> = 15.9 Hz); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ<sub>C</sub>: 178.3, 178.2, 169.9, 167.2, 164.7, 161.4, 146.0, 144.5, 134.0, 129.8 (C × 2), 127.4, 127.1, 119.6, 118.1, 117.1, 115.5, 114.3 (C × 2), 64.0, 63.9, 55.4, 45.0, 44.2, 42.9, 40.4, 39.4, 38.2, 36.4, 34.8, 33.5, 32.8, 31.6, 30.8, 30.5, 29.8, 29.6, 28.6, 25.7, 25.2, 21.6, 18.5, 10.2. HRMS (ESI) calculated for C<sub>43</sub>H<sub>55</sub>O<sub>7</sub> [M + H]<sup>+</sup> 683.3948, found 683.3952.</div></div><div id="sec5_8_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> Compound <b>10</b></h4><div class="NLM_p last">Orange powder, 54% yield. Mp 138.0–140.7 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ<sub>H</sub>: <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>, TMS), δ ppm: 0.58 (3H, s), 1.11 (3H, s), 1.21 (3H, s), 1.26 (3H, s), 1.44 (3H, s), 2.21 (3H, s), 4.09–4.11 (1H, m), 4.28–4.44 (3H, m), 6.27 (1H, d, <i>J</i> = 15.9 Hz), 6.35 (1H, d, <i>J</i> = 7.2 Hz), 6.51 (1H, s), 6.98 (1H, d, <i>J</i> = 7.2 Hz), 7.12 (2H, t, <i>J</i> = 8.6 Hz), 7.54 (2H, t, <i>J</i> = 8.6 Hz), 7.76 (1H, d, <i>J</i> = 16.1 Hz); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ<sub>C</sub>: 178.1 (C × 2), 170.1, 166.3, 164.7, 162.3, 146.1, 144.1, 134.1, 130.1, 130.0 (C × 2), 127.4, 119.5, 118.1, 117.7, 117.3, 116.3, 116.0, 62.3, 61.9, 45.0, 44.2, 43.0, 40.5, 39.4, 38.2, 36.3, 34.8, 33.5, 32.8, 31.6, 30.8, 30.5, 29.7, 29.6, 28.6, 21.6, 18.6, 10.3. HRMS (ESI) calculated for C<sub>40</sub>H<sub>48</sub>FO<sub>6</sub> [M + H]<sup>+</sup> 643.3435, found 643.3434.</div></div><div id="sec5_8_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> Compound <b>11</b></h4><div class="NLM_p last">Orange powder, 44% yield. Mp 133.9–142.1 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ<sub>H</sub>: 0.57 (3H, s), 1.11 (3H, s), 1.20 (3H, s), 1.29 (3H, s), 1.43 (3H, s), 2.17 (3H, s), 3.99–4.13 (2H, m), 4.21–4.26 (1H, m), 4.31–4.36 (1H, m), 6.30 (1H, d, <i>J</i> = 15.9 Hz), 6.34 (1H, d, <i>J</i> = 6.0 Hz), 6.54 (1H, s), 6.98 (1H, d, <i>J</i> = 6.1 Hz), 7.06 (2H, t, <i>J</i> = 8.5 Hz), 7.46 (2H, m), 7.60 (1H, d, <i>J</i> = 16.1 Hz); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ<sub>C</sub>: 178.2 (C × 2), 170.0, 166.6, 164.7, 162.2, 146.0, 143.7, 134.1, 130.0, 129.9 (C × 2), 127.4, 119.5, 118.2, 117.5, 117.2, 116.2, 115.9, 61.0 (C × 2), 45.1, 44.3, 43.0, 40.5, 39.4, 38.2, 36.3, 34.8, 33.4, 32.8, 31.6, 30.8, 30.5, 29.8, 29.7, 28.6, 27.9, 21.7, 18.5, 10. HRMS (ESI) calculated for C<sub>41</sub>H<sub>50</sub>FO<sub>6</sub> [M + H]<sup>+</sup> 657.3591, found 657.3593.</div></div><div id="sec5_8_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> Compound <b>12</b></h4><div class="NLM_p last">Orange powder, 52% yield. Mp 142–144.9 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ<sub>H</sub>: 0.57 (3H, s), 1.11 (3H, s), 1.20 (3H, s), 1.27 (3H, s), 1.44 (3H, s), 2.21 (3H, s), 3.90–3.95 (1H, m), 4.04–4.10 (1H, m), 4.23–4.26 (2H, m), 6.35 (1H, d, <i>J</i> = 7.0 Hz), 6.47 (1H, d, <i>J</i> = 15.9 Hz), 6.54 (1H, s), 7.01 (1H, d, <i>J</i> = 7.0 Hz), 7.09 (2H, t, <i>J</i> = 8.6 Hz), 7.54 (2H, m), 7.67 (1H, d, <i>J</i> = 16.1 Hz); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ<sub>C</sub>: 178.4, 178.2, 170.0, 166.5, 164.7, 162.2, 146.0, 143.6, 134.0, 130.0, 129.9 (C × 2), 127.4, 119.5, 118.2, 117.8, 117.2, 116.2, 115.9, 64.1, 64.0, 45.0, 44.2, 42.9, 40.4, 39.4, 38.2, 36.3, 34.8, 33.5, 32.8, 31.6, 30.8, 30.6, 29.8, 29.7, 28.6, 25.6, 25.2, 21.6, 18.5, 10.2. HRMS (ESI) calculated for C<sub>42</sub>H<sub>52</sub>FO<sub>6</sub> [M + H]<sup>+</sup> 671.3748, found 671.3746.</div></div><div id="sec5_8_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> Compound <b>13</b></h4><div class="NLM_p last">Orange powder, 43% yield. Mp 144.5–145.9 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ<sub>H</sub>: 0.58 (3H, s), 1.12 (3H, s), 1.22 (3H, s), 1.27 (3H, s), 1.44 (3H, s), 2.21 (3H, s), 4.13–4.17 (1H, m), 4.29–4.40 (3H, m), 6.29 (1H, d, <i>J</i> = 7.1 Hz), 6.51 (1H, s), 6.53 (1H, d, <i>J</i> = 15.9 Hz), 6.97 (1H, d, <i>J</i> = 7.1 Hz), 7.66 (4H, m), 7.73 (1H, d, <i>J</i> = 16.0 Hz); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ<sub>C</sub>: 178.0 (C × 2), 169.9, 166.0, 164.8, 146.0, 143.5, 137.6, 134.5, 128.3 (C × 3), 127.4, 125.9 (C × 2), 124.2, 120.1, 119.4, 118.2, 117.2, 62.1 (C × 2), 45.0, 44.2, 43.1, 40.5, 39.5, 38.3, 36.3, 34.8, 33.5, 32.7, 31.6, 30.8, 30.6, 29.7, 29.6, 28.6, 21.6, 18.7, 10.2. HRMS (ESI) calculated for C<sub>41</sub>H<sub>48</sub>F<sub>3</sub>O<sub>6</sub> [M + H]<sup>+</sup> 693.3403, found 693.3408.</div></div><div id="sec5_8_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> Compound <b>14</b></h4><div class="NLM_p last">Orange powder, 55% yield. Mp 147.3–149.0 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ<sub>H</sub>: 0.59 (3H, s), 1.12 (3H, s), 1.22 (3H, s), 1.28 (3H, s), 1.46 (3H, s), 2.17 (3H, s), 4.03–4.11 (2H, m), 4.24–4.29 (1H, m), 4.35–4.40 (1H, m), 6.35 (1H, d, <i>J</i> = 7.1 Hz), 6.47 (1H, d, <i>J</i> = 16.1 Hz), 6.54 (1H, s), 6.99 (1H, d, <i>J</i> = 7.2 Hz), 7.58 (2H, d, <i>J</i> = 8.6 Hz), 7.65 (2H, d, <i>J</i> = 8.8 Hz), 7.66 (1H, d, <i>J</i> = 16.0 Hz); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ<sub>C</sub>: 178.2 (C × 2), 170.1, 166.1, 164.7, 146.0, 143.1, 137.8, 134.1, 128.2 (C × 3), 127.4, 125.8 (C × 2), 124.4, 120.3, 119.6, 118.2, 117.2, 61.3, 61.0, 45.0, 44.3, 43.0, 40.5, 39.4, 38.2, 36.3, 34.8, 33.4, 32.8, 31.6, 30.8, 30.5, 29.8 (C × 2), 28.6, 27.9, 21.6, 18.6, 10.2. HRMS (ESI) calculated for C<sub>42</sub>H<sub>50</sub>F<sub>3</sub>O<sub>6</sub> [M + H]<sup>+</sup> 707.3559, found 707.3553.</div></div><div id="sec5_8_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> Compound <b>15</b></h4><div class="NLM_p last">Orange powder, 46% yield. Mp 141.2–142.7 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ<sub>H</sub>: 0.57 (3H, s), 1.11 (3H, s), 1.20 (3H, s), 1.26 (3H, s), 1.44 (3H, s), 2.20 (3H, s), 3.89–3.95 (1H, m), 4.04–4.08 (1H, m), 4.24–4.28 (2H, m), 6.35 (1H, d, <i>J</i> = 7.2 Hz), 6.53 (1H, d, <i>J</i> = 16.0 Hz), 6.54 (1H, s), 7.01 (1H, d, <i>J</i> = 7.1 Hz), 7.65 (4H, m), 7.71 (1H, d, <i>J</i> = 16.0 Hz); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ<sub>C</sub>: 178.3, 178.2, 169.8, 166.3, 164.7, 146.0, 143.0, 137.8, 134.0, 128.2 (C × 3), 127.4, 125.9, 125.8, 124.0, 120.6, 119.5, 118.2, 117.1, 64.3, 64.0, 45.0, 44.3, 42.9, 40.4, 39.4, 38.2, 36.3, 34.8, 33.5, 32.8, 31.6, 30.8, 30.5, 29.8, 29.7, 28.6, 25.5, 25.2, 21.6, 18.5, 10.2. HRMS (ESI) calculated for C<sub>43</sub>H<sub>52</sub>F<sub>3</sub>O<sub>6</sub> [M + H]<sup>+</sup> 721.3716, found 721.3724.</div></div><div id="sec5_8_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> Compound <b>16</b></h4><div class="NLM_p last">Orange powder, 47% yield. Mp 135.7–137.9 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ<sub>H</sub>: 0.56 (3H, s), 1.10 (3H, s), 1.22 (3H, s), 1.25 (3H, s), 1.43 (3H, s), 2.19 (3H, s), 4.11–4.15 (1H, m), 4.32–4.39 (1H, m), 4.50–4.51 (2H, m), 6.28 (1H, d, <i>J</i> = 7.0 Hz), 6.52 (1H, s), 6.94 (1H, d, <i>J</i> = 6.9 Hz), 7.56 (2H, m), 8.02 (3H, m), 8.27 (1H, s); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ<sub>C</sub>: 178.3, 178.1, 169.9, 164.7, 162.2, 155.7, 146.0, 134.1, 133.6, 131.4, 131.3 (C × 2), 129.3 (C × 2), 127.4, 119.5, 118.1, 117.1, 115.1, 102.3, 63.8, 61.7, 45.0, 44.2, 42.9, 40.5, 39.4, 38.2, 36.3, 34.8, 33.5, 32.7, 31.6, 30.9, 30.5, 29.7 (C × 2), 28.6, 21.6, 18.7, 10.2. HRMS (ESI) calculated for C<sub>41</sub>H<sub>48</sub>NO<sub>6</sub> [M + H]<sup>+</sup> 650.3482, found 650.3478.</div></div><div id="sec5_8_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> Compound <b>17</b></h4><div class="NLM_p last">Orange powder, 46% yield. Mp 132.7–134.8 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ<sub>H</sub>: 0.59 (3H, s), 1.12 (3H, s), 1.22 (3H, s), 1.28 (3H, s), 1.46 (3H, s), 2.20 (3H, s), 4.03–4.16 (2H, m), 4.34–4.48 (2H, m), 6.36 (1H, d, <i>J</i> = 7.1 Hz), 6.55 (1H, s), 7.01 (1H, d, <i>J</i> = 7.1 Hz), 7.55 (3H, m), 7.98 (2H, d, <i>J</i> = 7.9 Hz), 8.25 (1H, s).; <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ<sub>C</sub>: 178.3, 178.2, 169.7, 164.7, 162.5, 155.5, 146.0, 134.0, 133.5, 131.4, 131.1 (C × 2), 129.3 (C × 2), 127.4, 119.6, 118.2, 117.1, 115.3, 102.3, 63.2, 60.8, 45.0, 44.3, 42.9, 40.5, 39.4, 38.2, 36.4, 34.8, 33.4, 32.8, 31.6, 30.8, 30.5, 29.8 (C × 2), 28.6, 27.7, 21.7, 18.5, 10.2. HRMS (ESI) calculated for C<sub>42</sub>H<sub>50</sub>NO<sub>6</sub> [M + H]<sup>+</sup> 664.3638, found 664.3640.</div></div><div id="sec5_8_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> Compound <b>18</b></h4><div class="NLM_p last">Orange powder, 55% yield. Mp 136.9–138.5 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ<sub>H</sub>: 0.57 (3H, s), 1.11 (3H, s), 1.21 (3H, s), 1.30 (3H, s), 1.45 (3H, s), 2.21 (3H, s), 3.90–3.96 (1H, m), 4.04–4.15 (1H, m), 4.35–4.39 (2H, m), 6.36 (1H, d, <i>J</i> = 7.2 Hz), 6.56 (1H, s), 7.02 (1H, d, <i>J</i> = 7.1 Hz), 7.55 (3H, m), 8.02 (2H, d, <i>J</i> = 7.8 Hz), 8.30 (1H, s); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ<sub>C</sub>: 178.4, 178.2, 169.9, 164.7, 162.4, 155.4, 146.0, 134.1, 133.4, 131.5, 131.2 (C × 2), 129.3 (C × 2), 127.4, 119.6, 118.2, 117.1, 115.1, 102.4, 66.1, 63.8, 45.0, 44.3, 42.9, 40.4, 39.4, 38.2, 36.4, 34.8, 33.5, 32.8, 31.6, 30.8, 30.6, 29.8, 29.7, 28.6, 25.4, 25.0, 21.6, 18.5, 10.3. HRMS (ESI) calculated for C<sub>43</sub>H<sub>52</sub>NO<sub>6</sub> [M + H]<sup>+</sup> 678.3795, found 678.3790.</div></div><div id="sec5_8_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> Compound <b>19</b></h4><div class="NLM_p last">Orange powder, 48% yield. Mp 141.1–142.5 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ<sub>H</sub>: 0.57 (3H, s), 1.11 (3H, s), 1.23 (3H, s), 1.26 (3H, s), 1.44 (3H, s), 2.20 (3H, s), 2.47 (3H, s), 4.11–4.17 (1H, m), 4.32–4.40 (1H, m), 4.50–4.53 (2H, m), 6.28 (1H, d, <i>J</i> = 7.1 Hz), 6.53 (1H, s), 6.95 (1H, d, <i>J</i> = 7.1 Hz), 7.34 (2H, d, <i>J</i> = 7.9 Hz), 7.94 (2H, d, <i>J</i> = 7.8 Hz), 8.23 (1H, s); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ<sub>C</sub>: 178.3, 178.2, 169.8, 164.7, 162.5, 155.6, 146.0, 145.0, 134.0, 131.5 (C × 2), 130.1 (C × 2), 128.8, 127.4, 119.6, 118.1, 117.0, 115.4, 100.9, 63.6, 61.8, 45.0, 44.2, 42.9, 40.5, 39.4, 38.2, 36.3, 34.8, 33.5, 32.7, 31.6, 30.9, 30.5, 29.7 (C × 2), 28.6, 21.9, 21.6, 18.7, 10.2. HRMS (ESI) calculated for C<sub>42</sub>H<sub>50</sub>NO<sub>6</sub> [M + H]<sup>+</sup> 664.3638, found 664.3640.</div></div><div id="sec5_8_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> Compound <b>20</b></h4><div class="NLM_p last">Orange powder, 51% yield. Mp 137.5–139.3 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ<sub>H</sub>: 0.58 (3H, s), 1.12 (3H, s), 1.21 (3H, s), 1.28 (3H, s), 1.46 (3H, s), 2.19 (3H, s), 2.46 (3H, s), 4.02–4.16 (2H, m), 4.32–4.38 (2H, m), 6.35 (1H, d, <i>J</i> = 7.1 Hz), 6.54 (1H, s), 7.00 (1H, d, <i>J</i> = 6.9 Hz), 7.31 (2H, d, <i>J</i> = 8.0 Hz), 7.89 (2H, d, <i>J</i> = 7.9 Hz), 8.20 (1H, s); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ<sub>C</sub>: 178.3, 178.1, 169.7, 164.7, 162.6, 155.4, 146.0, 144.8, 134.0, 131.3 (C × 2), 130.0 (C × 2), 128.8, 127.4, 119.6, 118.2, 117.0, 115.7, 101.1, 63.0, 60.8, 45.0, 44.3, 42.9, 40.5, 39.4, 38.2, 36.4, 34.9, 33.4, 32.8, 31.6, 30.8, 30.5, 29.8 (C × 2), 28.6, 27.8, 21.9, 21.7, 18.5, 10.2; ESI/HRMS (<i>m</i>/<i>z</i>) [M + H]<sup>+</sup> 574.1497. HRMS (ESI) calculated for C<sub>43</sub>H<sub>52</sub>NO<sub>6</sub> [M + H]<sup>+</sup> 678.3795, found 678.3788.</div></div><div id="sec5_8_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> Compound <b>21</b></h4><div class="NLM_p last">Orange powder, 49% yield. Mp 129–132.2 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ<sub>H</sub>: 0.57 (3H, s), 1.11 (3H, s), 1.21 (3H, s), 1.27 (3H, s), 1.45 (3H, s), 2.21 (3H, s), 2.45 (3H, s), 3.88–3.95 (1H, m), 4.03–4.11 (1H, m), 4.33–4.37 (2H, m), 6.36 (1H, d, <i>J</i> = 7.2 Hz), 6.56 (1H, s), 7.02 (1H, d, <i>J</i> = 7.0 Hz), 7.32 (2H, d, <i>J</i> = 8.0 Hz), 7.93 (2H, d, <i>J</i> = 8.0 Hz), 8.25 (1H, s); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ<sub>C</sub>: 178.4, 178.2, 169.9, 164.7, 162.7, 155.3, 146.0, 144.8, 134.1, 131.3 (C × 2), 130.1 (C × 2), 128.9, 127.4, 119.6, 118.2, 117.1, 115.7, 101.3, 65.9, 63.8, 45.0, 44.3, 42.9, 40.4, 39.4, 38.2, 36.4, 34.7, 33.5, 32.8, 31.6, 30.8, 30.6, 29.8, 29.7, 28.6, 25.5, 25.0, 21.9, 21.6, 18.5, 10.2. HRMS (ESI) calculated for C<sub>44</sub>H<sub>54</sub>NO<sub>6</sub> [M + H]<sup>+</sup> 692.3951, found 692.3944.</div></div><div id="sec5_8_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> Compound <b>22</b></h4><div class="NLM_p last">Orange powder, 47% yield. Mp 131.7–132.8 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ<sub>H</sub>: 0.56 (3H, s), 1.11 (3H, s), 1.20 (3H, s), 1.26 (3H, s), 1.43 (3H, s), 2.16 (3H, s), 3.88 (3H, s), 4.08–4.13 (2H, m), 4.35–4.48 (2H, m), 6.34 (1H, d, <i>J</i> = 7.1 Hz), 6.52 (1H, s), 6.95 (3H, m), 7.63 (2H, d, <i>J</i> = 9.0 Hz), 8.17 (1H, s); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ<sub>C</sub>: 78.3, 178.1, 170.0, 164.7, 161.1, 160.6, 153.7, 146.0, 134.0, 131.2 (C × 2), 127.4, 126.3, 126.2, 119.5, 118.2, 117.2, 114.5 (C × 2), 103.8, 64.2, 61.5, 56.1, 45.0, 44.2, 42.9, 40.5, 39.4, 38.2, 36.3, 34.8, 33.5, 32.7, 31.6, 30.9, 30.5, 29.8, 29.7, 28.6, 21.6, 18.7, 10.2. HRMS (ESI) calculated for C<sub>42</sub>H<sub>50</sub>NO<sub>7</sub> [M + H]<sup>+</sup> 680.3587, found 680.3591.</div></div><div id="sec5_8_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> Compound <b>23</b></h4><div class="NLM_p last">Orange powder, 55% yield. Mp 136.4–138.9 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ<sub>H</sub>: 0.58 (3H, s), 1.12 (3H, s), 1.21 (3H, s), 1.28 (3H, s), 1.46 (3H, s), 2.19 (3H, s), 3.92 (3H, s), 4.01–4.16 (2H, m), 4.31–4.45 (2H, m), 6.36 (1H, d, <i>J</i> = 7.1 Hz), 6.54 (1H, s), 7.00 (1H, d, <i>J</i> = 7.0 Hz), 7.02 (2H, d, <i>J</i> = 8.8 Hz), 7.99 (2H, d, <i>J</i> = 8.8 Hz), 8.15 (1H, s); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ<sub>C</sub>: 178.3, 178.1, 169.0, 164.7, 161.6, 160.3, 154.5, 146.0, 134.1, 131.1 (C × 2), 127.4, 126.2 (C × 2), 119.6, 118.2, 117.2, 114.6 (C × 2), 105.3, 63.5, 60.7, 56.8, 45.0, 44.3, 42.9, 40.5, 39.4, 38.2, 36.3, 34.8, 33.4, 32.8, 31.6, 30.8, 30.5, 29.8, 29.7, 28.6, 27.7, 21.6, 18.6, 10.22. HRMS (ESI) calculated for C<sub>43</sub>H<sub>52</sub>NO<sub>7</sub> [M + H]<sup>+</sup> 694.3744, found 694.3742.</div></div><div id="sec5_8_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> Compound <b>24</b></h4><div class="NLM_p last">Orange powder, 54% yield. Mp 139.2–140.5 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ<sub>H</sub>: 0.57 (3H, s), 1.11 (3H, s), 1.21 (3H, s), 1.27 (3H, s), 1.45 (3H, s), 2.21 (3H, s), 3.91 (3H, s), 4.03–4.10 (2H, m), 4.32–4.40 (2H, m), 6.36 (1H, d, <i>J</i> = 7.1 Hz), 6.56 (1H, s), 7.01 (1H, d, <i>J</i> = 7.0 Hz), 7.02 (2H, m), 8.04 (2H, m), 8.21 (1H, s); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ<sub>C</sub>: 178.4, 178.2, 170.0, 164.7, 163.9, 160.3, 154.7, 146.0, 134.1, 133.7 (C × 2), 127.4, 124.5, 124.4, 119.6, 119.1, 118.2, 116.1, 114.8 (C × 2), 102.3, 65.8, 63.8, 55.6, 45.1, 44.3, 43.0, 40.4, 39.5, 38.2, 36.4, 34.8, 33.5, 32.8, 31.5, 30.8, 30.6, 29.8, 29.7, 28.7, 25.5, 25.0, 21.6, 18.5, 10.2. HRMS (ESI) calculated for C<sub>44</sub>H<sub>54</sub>NO<sub>7</sub> [M + H]<sup>+</sup> 708.3900, found 708.3891.</div></div><div id="sec5_8_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> Compound <b>25</b></h4><div class="NLM_p last">Orange powder, 47% yield. Mp 138.4–139.7 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ<sub>H</sub>: 0.58 (3H, s), 1.11 (3H, s), 1.23 (3H, s), 1.27 (3H, s), 1.45 (3H, s), 2.21 (3H, s), 4.13–4.17 (1H, m), 4.33–4.40 (1H, m), 4.49–4.54 (2H, m), 6.31 (1H, d, <i>J</i> = 7.2 Hz), 6.52 (1H, s), 6.98 (1H, d, <i>J</i> = 7.0 Hz), 7.24 (2H, t, <i>J</i> = 8.4 Hz), 8.08 (2H, dd, <i>J</i> = 8.5 Hz), 8.24 (1H, s); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ<sub>C</sub>: 178.3, 178.1, 169.8, 164.7, 162.1, 161.3, 154.2, 146.0, 133.9 (C × 2), 133.8, 127.8, 127.4, 119.6, 118.1, 117.1, 116.9, 116.6, 115.1, 102.1, 63.9, 61.6, 45.0, 44.2, 42.9, 40.5, 39.4, 38.2, 36.3, 34.8, 33.5, 32.7, 31.6, 30.9, 30.5, 29.8, 29.7, 28.6, 21.6, 18.7, 10.2. HRMS (ESI) calculated for C<sub>41</sub>H<sub>47</sub>FNO<sub>6</sub> [M + H]<sup>+</sup> 668.3387, found 668.3391.</div></div><div id="sec5_8_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> Compound <b>26</b></h4><div class="NLM_p last">Orange powder, 49% yield. Mp 129.4–131.0 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ<sub>H</sub>: 0.59 (3H, s), 1.12 (3H, s), 1.22 (3H, s), 1.28 (3H, s), 1.46 (3H, s), 2.19 (3H, s), 4.02–4.17 (2H, m), 4.30–4.50 (2H, m), 6.36 (1H, d, <i>J</i> = 7.2 Hz), 6.54 (1H, s), 7.01 (1H, d, <i>J</i> = 7.1 Hz), 7.21 (2H, t, <i>J</i> = 8.6 Hz), 8.03 (2H, d, <i>J</i> = 8.8 Hz), 8.20 (1H, s); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ<sub>C</sub>: 178.4, 178.2, 169.8, 164.7, 162.3, 161.3, 153.9, 146.0, 134.1, 133.8, 133.6, 127.8, 127.5, 119.6, 118.2, 117.1, 116.9, 116.7, 115.3, 103.5, 63.2, 60.8, 45.0, 44.3, 42.9, 40.5, 39.4, 38.2, 36.3, 34.8, 33.4, 32.8, 31.6, 30.8, 30.5, 29.8 (C × 2), 28.6, 27.7, 21.7, 18.5, 10.2. HRMS (ESI) calculated for C<sub>42</sub>H<sub>49</sub>FNO<sub>6</sub> [M + H]<sup>+</sup> 682.3544, found 682.3544.</div></div><div id="sec5_8_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> Compound <b>27</b></h4><div class="NLM_p last">Orange powder, 50% yield. Mp 135.7–137.8 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ<sub>H</sub>: 0.58 (3H, s), 1.12 (3H, s), 1.21 (3H, s), 1.28 (3H, s), 1.46 (3H, s), 2.19 (3H, s), 4.00–4.17 (2H, m), 4.30–4.50 (2H, m), 6.36 (1H, d, <i>J</i> = 7.1 Hz), 6.54 (1H, s), 7.02 (1H, d, <i>J</i> = 7.1 Hz), 7.21 (2H, t, <i>J</i> = 8.7 Hz), 8.03 (2H, d, <i>J</i> = 8.7 Hz), 8.20 (1H, s); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ<sub>C</sub>: 178.3, 178.2, 169.9, 164.7, 162.2, 161.3, 154.5, 146.0, 134.0, 133.9, 133.7, 127.7, 127.4, 119.6, 118.2, 117.2, 116.9, 116.7, 115.2, 103.2, 64.3, 64.0, 45.0, 44.2, 42.9, 40.4, 39.4, 38.2, 36.3, 34.8, 33.5, 32.8, 31.6, 30.8, 30.5, 29.8, 29.7, 28.6, 25.5, 25.2, 21.6, 18.5, 10.2. HRMS (ESI) calculated for C<sub>43</sub>H<sub>51</sub>FNO<sub>6</sub> [M + H]<sup>+</sup> 696.3700, found 696.3709.</div></div><div id="sec5_8_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> Compound <b>28</b></h4><div class="NLM_p last">Orange powder, 51% yield. Mp 136.1–138.4 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ<sub>H</sub>: 0.58 (3H, s), 1.11 (3H, s), 1.24 (3H, s), 1.27 (3H, s), 1.45 (3H, s), 2.21 (3H, s), 4.13–4.20 (1H, m), 4.34–4.42 (1H, m), 4.53–4.62 (2H, m), 6.32 (1H, d, <i>J</i> = 7.1 Hz), 6.53 (1H, s), 6.98 (1H, d, <i>J</i> = 7.0 Hz), 7.80 (2H, d, <i>J</i> = 8.3 Hz), 8.13 (2H, d, <i>J</i> = 8.2 Hz), 8.31 (1H, s); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ<sub>C</sub>: 178.3, 178.1, 169.8, 164.7, 162.1, 153.6, 146.0, 135.3, 133.9, 131.2 (C × 2), 129.1, 127.8, 126.3, 126.2, 125.5, 119.6, 118.1, 117.1, 114.5, 106.2, 64.2, 61.5, 45.0, 44.2, 42.9, 40.5, 39.4, 38.2, 36.3, 34.8, 33.6, 32.7, 31.6, 30.9, 30.5, 29.8, 29.7, 28.6, 21.6, 18.7, 10.2. HRMS (ESI) calculated for C<sub>42</sub>H<sub>47</sub>F<sub>3</sub>NO<sub>6</sub> [M + H]<sup>+</sup> 718.3355, found 718.3364.</div></div><div id="sec5_8_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> Compound <b>29</b></h4><div class="NLM_p last">Orange powder, 47% yield. Mp 135.6–136.4 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ<sub>H</sub>: 0.59 (3H, s), 1.12 (3H, s), 1.22 (3H, s), 1.30 (3H, s), 1.46 (3H, s), 2.18 (3H, s), 4.03–4.15 (2H, m), 4.34–4.50 (2H, m), 6.36 (1H, d, <i>J</i> = 7.2 Hz), 6.54 (1H, s), 7.02 (1H, d, <i>J</i> = 7.0 Hz), 7.77 (2H, d, <i>J</i> = 8.3 Hz), 8.07 (2H, d, <i>J</i> = 8.4 Hz), 8.27 (1H, s); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ<sub>C</sub>: 178.3, 178.1, 170.0, 164.7, 161.7, 153.5, 146.0, 135.1, 134.2, 131.1 (C × 2), 129.1, 127.4, 126.2 (C × 2), 124.7, 119.6, 118.2, 117.6, 116.7, 105.5, 63.5, 60.7, 45.1, 44.3, 43.0, 40.5, 39.4, 38.2, 36.3, 34.8, 33.4, 32.8, 31.6, 30.8, 30.5, 29.8, 29.7, 28.6, 27.7, 21.6, 18.6, 10.2. HRMS (ESI) calculated for C<sub>43</sub>H<sub>49</sub>F<sub>3</sub>NO<sub>6</sub> [M + H]<sup>+</sup> 732.3512, found 732.3513.</div></div><div id="sec5_8_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> Compound <b>30</b></h4><div class="NLM_p last">Orange powder, 51% yield. Mp 138.4–139.8 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ<sub>H</sub>: 0.55 (3H, s), 1.08 (3H, s), 1.18 (3H, s), 1.24 (3H, s), 1.42 (3H, s), 2.16 (3H, s), 3.18–4.12 (2H, m), 4.27–4.42 (2H, m), 6.34 (1H, d, <i>J</i> = 7.1 Hz), 6.52 (1H, s), 6.91 (1H, d, <i>J</i> = 7.1 Hz), 7.71 (2H, d, <i>J</i> = 8.8 Hz), 8.07 (2H, d, <i>J</i> = 8.8 Hz), 8.40 (1H, s); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ<sub>C</sub>: 178.3, 178.1, 170.0, 164.7, 161.8, 153.4, 146.0, 135.2, 134.2, 131.5 (C × 2), 130.7, 127.5, 126.4 (C × 2), 125.5, 119.5, 118.2, 117.2, 116.3, 105.2, 63.9, 61.8, 45.0, 44.2 42.9, 40.5, 39.4, 38.3, 36.3, 34.7, 33.5, 32.8, 31.6, 30.8, 30.5, 29.7 (C × 2), 28.6, 25.4, 25.1, 21.6, 18.5, 10.3. HRMS (ESI) calculated for C<sub>44</sub>H<sub>51</sub>F<sub>3</sub>NO<sub>6</sub> [M + H]<sup>+</sup> 746.3668, found 746.3656.</div></div><div id="sec5_8_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> Compound <b>31</b></h4><div class="NLM_p last">Orange powder, 55% yield. Mp 143.3–145.1 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ<sub>H</sub>: 0.57 (3H, s), 1.11 (3H, s), 1.21 (3H, s), 1.30 (3H, s), 1.43 (3H, s), 2.21 (3H, s), 4.10–4.17 (1H, m), 4.31–4.39 (1H, m), 4.44–4.56 (2H, m), 6.28 (1H, d, <i>J</i> = 7.1 Hz), 6.51 (1H, s), 6.88 (1H, s), 6.97 (1H, d, <i>J</i> = 7.1 Hz), 7.53 (3H, m), 7.76 (2H, m); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ<sub>C</sub>: 178.3, 178.1, 169.8, 164.6, 162.8, 146.0, 134.0, 133.9, 131.9, 129.4 (C × 2), 128.4, 127.4, 127.1 (C × 2), 127.0, 119.5, 118.1, 117.1, 114.8, 62.9, 61.9, 45.0, 44.2, 42.9, 40.5, 39.4, 38.2, 36.3, 34.8, 33.5, 32.8, 31.6, 30.9, 30.5, 29.7, 29.6, 28.6, 21.6, 18.7, 10.3. HRMS (ESI) calculated for C<sub>41</sub>H<sub>48</sub>NO<sub>6</sub> [M + H]<sup>+</sup> 650.3482, found 650.3485.</div></div><div id="sec5_8_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> Compound <b>32</b></h4><div class="NLM_p last">Orange powder, 54% yield. Mp 133.9–136.7 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ<sub>H</sub>: 0.58 (3H, s), 1.12 (3H, s), 1.22 (3H, s), 1.30 (3H, s), 1.46 (3H, s), 2.18 (3H, s), 4.02–4.18 (2H, m), 4.32–4.45 (2H, m), 6.36 (1H, d, <i>J</i> = 7.3 Hz), 6.54 (1H, s), 6.86 (1H, s), 7.00 (1H, d, <i>J</i> = 7.1 Hz), 7.49 (3H, m), 7.69 (2H, d, <i>J</i> = 7.9 Hz); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ<sub>C</sub>: 178.3, 178.2, 169.8, 164.7, 163.1, 146.0, 134.1, 133.5, 131.7, 129.3 (C × 2), 129.2, 128.8, 127.4, 127.0 (C × 2), 119.5, 118.2, 117.1, 116.8, 62.3, 60.8, 45.1, 44.3, 43.0, 40.5, 39.4, 38.2, 36.3, 34.8, 33.4, 32.8, 31.6, 30.8, 30.5, 29.8, 29.7, 28.6, 27.6, 21.7, 18.6, 10.2. HRMS (ESI) calculated for C<sub>42</sub>H<sub>50</sub>NO<sub>6</sub> [M + H]<sup>+</sup> 664.3638, found 664.3641.</div></div><div id="sec5_8_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> Compound <b>33</b></h4><div class="NLM_p last">Orange powder, 52% yield. Mp 143.4–145.7 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ<sub>H</sub>: 0.57 (3H, s), 1.12 (3H, s), 1.21 (3H, s), 1.27 (3H, s), 1.45 (3H, s), 2.22 (3H, s), 3.89–3.97 (1H, m), 4.05–4.13 (2H, m), 4.26–4.29 (1H, m), 6.36 (1H, d, <i>J</i> = 6.8 Hz), 6.55 (1H, s), 6.92 (1H, s), 7.04 (1H, d, <i>J</i> = 7.0 Hz), 7.50 (3H, m), 7.75 (2H, m); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ<sub>C</sub>: 178.3, 178.2, 169.9, 164.7, 163.0, 146.0, 134.1, 133.6, 131.7, 129.4 (C × 2), 129.1, 128.6, 127.4, 127.0 (C × 2), 119.4, 118.2, 117.1, 116.4, 62.8, 60.8, 45.0, 44.3, 42.9, 40.5, 39.4, 38.2, 36.3, 34.8, 33.4, 32.8, 31.6, 30.8, 30.5, 29.8, 29.7, 28.7, 25.5, 25.0, 21.6, 18.6, 10.3. HRMS (ESI) calculated for C<sub>43</sub>H<sub>52</sub>NO<sub>6</sub> [M + H]<sup>+</sup> 678.3795, found 678.3788.</div></div><div id="sec5_8_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> Compound <b>34</b></h4><div class="NLM_p last">Orange powder, 53% yield. Mp 136.9–138.2 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ<sub>H</sub>: 0.57 (3H, s), 1.11 (3H, s), 1.21 (3H, s), 1.30 (3H, s), 1.44 (3H, s), 2.21 (3H, s), 2.44 (3H, s), 4.08–4.15 (1H, m), 4.31–4.38 (1H, m), 4.46–4.52 (2H, m), 6.29 (1H, d, <i>J</i> = 7.2 Hz), 6.51 (1H,), 6.83 (1H, s), 6.97 (1H, d, <i>J</i> = 7.1 Hz), 7.31 (2H, d, <i>J</i> = 8.0 Hz), 7.65 (2H, d, <i>J</i> = 8.0 Hz); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ<sub>C</sub>: 178.3, 178.1, 169.7, 164.6, 163.0, 146.0, 142.7, 133.9, 130.1 (C × 2), 129.0, 127.9, 127.4, 127.0 (C × 2), 126.9, 119.5, 118.1, 117.1, 114.9, 62.8, 61.9, 45.0, 44.2, 42.9, 40.5, 39.4, 38.2, 36.3, 34.8, 33.6, 32.7, 31.6, 30.9, 30.5, 29.7, 29.6, 28.7, 21.6, 21.4, 18.6, 10.2. HRMS (ESI) calculated for C<sub>42</sub>H<sub>50</sub>NO<sub>6</sub> [M + H]<sup>+</sup> 664.3638, found 664.3643.</div></div><div id="sec5_8_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> Compound <b>35</b></h4><div class="NLM_p last">Orange powder, 49% yield. Mp 143.3–145.7 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ<sub>H</sub>: 0.58 (3H, s), 1.12 (3H, s), 1.22 (3H, s), 1.28 (3H, s), 1.46 (3H, s), 2.17 (3H, s), 2.24 (3H, s), 4.02–4.17 (2H, m), 4.28–4.36 (2H, m), 6.36 (1H, d, <i>J</i> = 7.0 Hz), 6.54 (1H, s), 6.81 (1H, s), 6.99 (1H, d, <i>J</i> = 7.1 Hz), 7.27 (2H, d, <i>J</i> = 8.2 Hz), 7.59 (2H, d, <i>J</i> = 8.2 Hz); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ<sub>C</sub>: 178.3, 178.2, 169.9, 164.7, 163.3, 146.0, 142.6, 134.0, 130.1 (C × 2), 129.1, 127.9, 127.4, 127.0 (C × 2), 126.5, 119.5, 118.2, 117.2, 115.0, 64.1, 63.0, 45.0, 44.2, 42.9, 40.4, 39.4, 38.2, 36.4, 34.8, 33.5, 32.8, 31.6, 30.8, 30.5, 29.8, 29.7, 28.7, 27.6, 21.6, 21.4, 18.6, 10.2. HRMS (ESI) calculated for C<sub>43</sub>H<sub>52</sub>NO<sub>6</sub> [M + H]<sup>+</sup> 678.3795, found 678.3793.</div></div><div id="sec5_8_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> Compound <b>36</b></h4><div class="NLM_p last">Orange powder, 55% yield. Mp 141.7–142.8 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ<sub>H</sub>: 0.56 (3H, s), 1.11 (3H, s), 1.20 (3H, s), 1.27 (3H, s), 1.44 (3H, s), 2.21 (3H, s), 2.42 (3H, s), 3.88–3.94 (1H, m), 4.04–4.09 (1H, m), 4.31–4.35 (2H, m), 6.36 (1H, d, <i>J</i> = 7.2 Hz), 6.53 (1H, s), 6.88 (1H, s), 7.02 (1H, d, <i>J</i> = 7.3 Hz), 7.28 (2H, d, <i>J</i> = 8.0 Hz), 7.64 (2H, d, <i>J</i> = 8.1 Hz); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ<sub>C</sub>: 178.3, 178.2, 170.0, 164.7, 163.4, 146.0, 142.4, 134.1, 130.0 (C × 2), 129.1, 127.9, 127.4, 127.0 (C × 2), 126.2, 119.5, 118.2, 117.2, 115.1, 65.2, 63.9, 45.0, 44.3, 42.9, 40.4, 39.4, 38.2, 36.3, 34.8, 33.5, 32.8, 31.6, 30.8, 30.5, 29.8, 29.7, 28.6, 25.4, 25.1, 21.6, 21.4, 18.5, 10.2. HRMS (ESI) calculated for C<sub>44</sub>H<sub>54</sub>NO<sub>6</sub> [M + H]<sup>+</sup> 692.3951, found 692.3943.</div></div><div id="sec5_8_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> Compound <b>37</b></h4><div class="NLM_p last">Orange powder, 52% yield. Mp 137.3–139.5 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ<sub>H</sub>: 0.57 (3H, s), 1.11 (3H, s), 1.21 (3H, s), 1.26 (3H, s), 1.44 (3H, s), 2.21 (3H, s), 3.89 (3H, s), 4.08–4.15 (1H, m), 4.30–4.38 (1H, m), 4.45–4.51 (2H, m), 6.29 (1H, d, <i>J</i> = 7.2 Hz), 6.51 (1H, s), 6.75 (1H, s), 6.98 (1H, d, <i>J</i> = 7.2 Hz), 7.01 (2H, d, <i>J</i> = 8.9 Hz), 7.72 (2H, d, <i>J</i> = 9.0 Hz); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ<sub>C</sub>: 178.3, 178.1, 169.9, 164.6, 163.1, 162.6, 146.0, 133.9, 131.0, 128.9 (C × 2), 127.4, 126.4, 125.3, 119.5, 118.1, 117.8, 117.1, 114.8 (C × 2), 62.7, 62.0, 55.6, 45.0, 44.2, 42.9, 40.5, 39.4, 38.2, 36.3, 34.8, 33.6, 32.8, 31.6, 30.8, 30.5, 29.7 (C × 2), 28.6, 21.6, 18.6, 10.2. HRMS (ESI) calculated for C<sub>42</sub>H<sub>50</sub>NO<sub>7</sub> [M + H]<sup>+</sup> 680.3587, found 680.3589.</div></div><div id="sec5_8_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> Compound <b>38</b></h4><div class="NLM_p last">Orange powder, 51% yield. Mp 134.8–136.5 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ<sub>H</sub>: 0.57 (3H, s), 1.12 (3H, s), 1.21 (3H, s), 1.27 (3H, s), 1.44 (3H, s), 2.17 (3H, s), 3.89 (3H, s), 3.99–4.19 (2H, m), 4.26–4.45 (2H, m), 6.35 (1H, d, <i>J</i> = 7.1 Hz), 6.53 (1H, s), 6.72 (1H, s), 6.96 (2H, d, <i>J</i> = 8.9 Hz), 6.99 (1H, d, <i>J</i> = 7.0 Hz), 7.64 (2H, d, <i>J</i> = 8.9 Hz); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ<sub>C</sub>: 178.3 (C × 2), 169.8, 164.7, 163.8, 163.2, 146.0, 134.1, 130.0 (C × 2), 129.0, 127.5, 127.0, 125.0, 119.5, 118.1, 117.8, 117.1, 114.9 (C × 2), 62.2, 60.8, 54.7, 45.1, 44.3, 42.9, 40.5, 39.4, 38.2, 36.3, 34.8, 33.4, 32.8, 31.6, 30.8, 30.5, 29.8, 29.7, 28.6, 27.6, 21.7, 18.6, 10.2. HRMS (ESI) calculated for C<sub>43</sub>H<sub>52</sub>NO<sub>7</sub> [M + H]<sup>+</sup> 694.3744, found 694.3746.</div></div><div id="sec5_8_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> Compound <b>39</b></h4><div class="NLM_p last">Orange powder, 53% yield. Mp 139.7–141.3 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ<sub>H</sub>: 0.57 (3H, s), 1.11 (3H, s), 1.21 (3H, s), 1.27 (3H, s), 1.44 (3H, s), 2.22 (3H, s), 3.89 (3H, s), 3.89–3.92 (1H, m), 4.04–4.08 (1H, m), 4.31–4.33 (2H, m), 6.36 (1H, d, <i>J</i> = 6.8 Hz), 6.54 (1H, s), 6.81 (1H, s), 6.98 (2H, d, <i>J</i> = 8.5 Hz), 7.03 (1H, d, <i>J</i> = 7.1 Hz), 7.71 (2H, d, <i>J</i> = 8.3 Hz); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ<sub>C</sub>: 178.3, 178.2, 169.9, 164.9, 163.6, 163.0, 146.0, 134.0, 130.3, 128.8 (C × 2), 127.3, 126.2, 124.5, 119.5, 118.1, 117.7, 117.0, 114.7 (C × 2), 65.1, 63.9, 55.5, 45.0, 44.3, 43.0, 40.4, 39.4, 38.2, 36.4, 34.8, 33.5, 32.8, 31.6, 30.8, 30.6, 29.8, 29.7, 28.7, 25.4, 25.2, 21.7, 18.5, 10.2. HRMS (ESI) calculated for C<sub>44</sub>H<sub>54</sub>NO<sub>7</sub> [M + H]<sup>+</sup> 708.3900, found 708.3903.</div></div><div id="sec5_8_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> Compound <b>40</b></h4><div class="NLM_p last">Orange powder, 54% yield. Mp 136.8–138.3 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ<sub>H</sub>: 0.57 (3H, s), 1.11 (3H, s), 1.22 (3H, s), 1.27 (3H, s), 1.44 (3H, s), 2.22 (3H, s), 4.11–4.17 (1H, m), 4.32–4.38 (1H, m), 4.44–4.54 (2H, m), 6.32 (1H, d, <i>J</i> = 6.8 Hz), 6.51 (1H, s), 6.82 (1H, s), 7.00 (1H, d, <i>J</i> = 6.6 Hz), 7.22 (2H, t, <i>J</i> = 8.4 Hz), 7.77 (2H, m); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ<sub>C</sub>: 178.3, 178.2, 169.9, 166.4, 164.7, 163.0, 146.0, 134.1 (C × 2), 129.3, 129.2, 128.7, 127.3, 125.3, 119.5, 118.2, 117.1, 116.8, 116.5, 114.9, 63.4, 61.7, 45.0, 44.2, 42.9, 40.4, 39.4, 38.2, 36.3, 34.8, 33.4, 32.8, 31.6, 30.8, 30.5, 29.8, 29.7, 28.6, 27.6, 21.6, 18.5, 10.3. HRMS (ESI) calculated for C<sub>41</sub>H<sub>47</sub>FNO<sub>6</sub> [M + H]<sup>+</sup> 668.3387, found 668.3387.</div></div><div id="sec5_8_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> Compound <b>41</b></h4><div class="NLM_p last">Orange powder, 49% yield. Mp 129.0–131.9 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ<sub>H</sub>: 0.56 (3H, s), 1.11 (3H, s), 1.20 (3H, s), 1.27 (3H, s), 1.44 (3H, s), 2.17 (3H, s), 4.01–4.16 (2H, m), 4.30–4.44 (2H, m), 6.34 (1H, d, <i>J</i> = 7.2 Hz), 6.52 (1H, s), 6.78 (1H, s), 7.00 (1H, d, <i>J</i> = 7.1 Hz), 7.16 (2H, t, <i>J</i> = 8.4 Hz), 7.68 (2H, m); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ<sub>C</sub>: 178.3, 178.2, 169.8, 166.4, 164.7, 163.0, 146.0, 134.1 (C × 2), 129.3, 129.2, 128.5, 127.3, 125.3, 119.5, 118.2, 117.1, 116.8, 116.5, 114.9, 62.4, 60.7, 45.1, 44.2, 42.9, 40.8, 39.4, 38.2, 36.3, 34.8, 33.4, 32.8, 31.6, 30.8, 30.5, 29.8, 29.7, 28.6, 27.6, 21.7, 18.6, 10.2. HRMS (ESI) calculated for C<sub>42</sub>H<sub>49</sub>FNO<sub>6</sub> [M + H]<sup>+</sup> 682.3544, found 682.3544.</div></div><div id="sec5_8_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> Compound <b>42</b></h4><div class="NLM_p last">Orange powder, 48% yield. Mp 131.2–133.4 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ<sub>H</sub>: 0.57 (3H, s), 1.12 (3H, s), 1.20 (3H, s), 1.27 (3H, s), 1.45 (3H, s), 2.22 (3H, s), 3.89–3.95 (1H, m), 4.04–4.10 (1H, m), 4.32–4.36 (2H, m), 6.36 (1H, d, <i>J</i> = 7.2 Hz), 6.53 (1H, s), 6.87 (1H, s), 7.02 (1H, d, <i>J</i> = 7.0 Hz), 7.18 (2H, t, <i>J</i> = 8.3 Hz), 7.76 (2H, m); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ<sub>C</sub>: 178.3 (C × 2), 169.9, 166.6, 164.8, 163.1, 146.0, 134.0 (C × 2), 129.3, 129.2, 128.9, 127.3, 125.3, 119.5, 118.2, 117.1, 116.8, 116.5, 114.9, 65.4, 63.9, 45.0, 44.3, 42.9, 40.4, 39.4, 38.2, 36.3, 34.8, 33.5, 32.8, 31.6, 30.8, 30.5, 29.8, 29.7, 28.6, 25.4, 25.1, 21.6, 18.5, 10.2. HRMS (ESI) calculated for C<sub>43</sub>H<sub>51</sub>FNO<sub>6</sub> [M + H]<sup>+</sup> 696.3700, found 696.3698.</div></div><div id="sec5_8_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> Compound <b>43</b></h4><div class="NLM_p last">Orange powder, 47% yield. Mp 137.9–138.8 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ<sub>H</sub>: 0.57 (3H, s), 1.12 (3H, s), 1.22 (3H, s), 1.28 (3H, s), 1.45 (3H, s), 2.23 (3H, s), 4.10–4.18 (1H, m), 4.35–4.39 (1H, m), 4.49–4.52 (2H, m), 6.34 (1H, d, <i>J</i> = 7.1 Hz), 6.55 (1H, s), 6.95 (1H, s), 7.03 (1H, d, <i>J</i> = 6.9 Hz), 7.79 (2H, d, <i>J</i> = 8.1 Hz), 7.88 (2H, d, <i>J</i> = 8.1 Hz); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ<sub>C</sub>: 178.3, 178.0, 169.7, 164.6, 162.3, 146.1, 135.1, 133.8, 130.7 (C × 2), 127.3 (C × 2), 126.4 (C × 2), 125.5, 124.5, 119.5, 118.1, 117.1, 114.3, 63.3, 61.8, 45.0, 44.2, 42.9, 40.5, 39.4, 38.2, 36.3, 34.8, 33.6, 32.7, 31.5, 30.8, 30.5, 29.7 (C × 2), 28.6, 21.6, 18.7, 10.2. HRMS (ESI) calculated for C<sub>42</sub>H<sub>47</sub>F<sub>3</sub>NO<sub>6</sub> [M + H]<sup>+</sup> 718.3355, found 718.3361.</div></div><div id="sec5_8_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> Compound <b>44</b></h4><div class="NLM_p last">Orange powder, 49% yield. Mp 133.3–135.6 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ<sub>H</sub>: 0.57 (3H, s), 1.12 (3H, s), 1.21 (3H, s), 1.28 (3H, s), 1.45 (3H, s), 2.17 (3H, s), 4.02–4.17 (2H, m), 4.33–4.47 (2H, m), 6.36 (1H, d, <i>J</i> = 7.1 Hz), 6.52 (1H, s), 6.92 (1H, s), 7.01 (1H, d, <i>J</i> = 7.1 Hz), 7.74 (2H, d, <i>J</i> = 8. 5 Hz), 7.80 (2H, d, <i>J</i> = 8.3 Hz); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ<sub>C</sub>: 178.2, 178.1, 169.8, 164.7, 162.6, 146.0, 135.4, 134.0, 131.0 (C × 2), 127.5 (C × 2), 127.2, 126.4, 126.3, 125.1, 124.2, 119.5, 118.2, 117.1, 114.5, 62.7, 60.7, 45.0, 44.3, 42.9, 40.5, 39.4, 38.2, 36.3, 34.8, 33.4, 32.8, 31.6, 30.8, 30.5, 29.8, 29.7, 28.6, 27.6, 21.6, 18.6, 10.2. HRMS (ESI) calculated for C<sub>43</sub>H<sub>49</sub>F<sub>3</sub>NO<sub>6</sub> [M + H]<sup>+</sup> 732.3512, found 732.3507.</div></div><div id="sec5_8_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> Compound <b>45</b></h4><div class="NLM_p last">Orange powder, 50% yield. Mp 142.1–143.7 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ<sub>H</sub>: 0.57 (3H, s), 1.12 (3H, s), 1.21 (3H, s), 1.27 (3H, s), 1.46 (3H, s), 2.22 (3H, s), 3.89–3.97 (1H, m), 4.05–4.13 (1H, m), 4.34–4.38 (2H, m), 6.37 (1H, d, <i>J</i> = 7.0 Hz), 6.54 (1H, s), 7.01 (1H, s), 7.04 (1H, d, <i>J</i> = 7.0 Hz), 7.76 (2H, d, <i>J</i> = 8.3 Hz), 7.88 (2H, d, <i>J</i> = 8.3 Hz); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ<sub>C</sub>: 178.3, 178.2, 170.18, 164.6, 162.8, 146.0, 140.2, 135.2, 134.2, 131.5 (C × 2), 127.5 (C × 2), 127.2, 126.4, 126.3, 124.8, 124.3, 119.5, 118.2, 117.4, 114.6, 65.6, 63.9, 45.0, 44.3, 42.9, 40.4, 39.4, 38.2, 36.3, 34.8, 33.5, 32.8, 31.6, 30.8, 30.5, 29.8, 29.7, 28.6, 25.4, 25.1, 21.6, 18.5, 10.2. HRMS (ESI) calculated for C<sub>44</sub>H<sub>50</sub>F<sub>3</sub>NO<sub>6</sub> [M + H]<sup>+</sup> 746.3668, found 746.3663.</div></div><div id="sec5_8_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> Compound <b>46</b></h4><div class="NLM_p last">Orange powder, 49% yield. Mp 142.5–143.6 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ<sub>H</sub>: 0.56 (3H, s), 1.12 (3H, s), 1.22 (3H, s), 1.27 (3H, s), 1.44 (3H, s), 2.21 (3H, s), 4.48 (2H, m), 4.81 (2H, m), 5.93 (2H,s), 6.35 (1H, d, <i>J</i> = 7.4 Hz), 6.53 (1H, s), 6.95 (1H, s), 7.01 (1H, d, <i>J</i> = 6.8 Hz), 7.19 (3H, m), 7.76 (2H, m); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ<sub>C</sub>: 178.3, 177.8, 170.1, 164.7, 162.9, 146.0, 134.1 (C × 2), 131.7, 129.4 (C × 2), 129.2, 128.8, 127.4, 127.1 (C × 2), 126.8, 126.6, 119.5, 118.2, 117.2, 115.0, 65.1, 63.7, 45.0, 44.2, 42.9, 40.5, 39.4, 38.3, 36.3, 34.7, 33.5, 32.8, 31.6, 30.9, 30.6, 29.8, 29.6, 28.6, 21.6, 18.6, 10.3. HRMS (ESI) calculated for C<sub>43</sub>H<sub>50</sub>NO<sub>6</sub> [M + H]<sup>+</sup> 676.3638, found 676.3633.</div></div><div id="sec5_8_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> Compound <b>47</b></h4><div class="NLM_p last">Orange powder, 48% yield. Mp 139.4–142.1 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ<sub>H</sub>: 0.56 (3H, s), 1.12 (3H, s), 1.22 (3H, s), 1.27 (3H, s), 1.44 (3H, s), 2.21 (3H, s), 3.89 (3H, s), 4.47 (2H, m), 4.79 (2H, m), 5.92 (2H,s), 6.36 (1H, d, <i>J</i> = 7.1 Hz), 6.53 (1H, s), 6.83 (1H, s), 6.98 (2H, d, <i>J</i> = 9.0 Hz), 7.02 (1H, d, <i>J</i> = 7.0 Hz), 7.72 (2H, d, <i>J</i> = 8.9 Hz); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ<sub>C</sub>: 178.3, 177.9, 170.1, 164.8, 162.5, 160.3, 146.0, 134.1, 129.0, 128.9 (C × 2), 127.9, 127.4, 126.8, 126.1, 125.8, 119.5, 118.2, 117.9, 117.2, 114.7 (C × 2), 64.9, 63.7, 55.6, 45.1, 44.2, 42.9, 40.5, 39.4, 38.3, 36.3, 34.7, 33.5, 32.8, 31.6, 30.9, 30.6, 29.8, 29.6, 28.6, 21.6, 18.6, 10.3. HRMS (ESI) calculated for C<sub>44</sub>H<sub>52</sub>NO<sub>7</sub> [M + H]<sup>+</sup> 706.3744, found 706.3744.</div></div><div id="sec5_8_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> Compound <b>48</b></h4><div class="NLM_p last">Orange powder, 54% yield. Mp 138.6–140.1 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ<sub>H</sub>: 0.56 (3H, s), 1.12 (3H, s), 1.22 (3H, s), 1.28 (3H, s), 1.45 (3H, s), 2.22 (3H, s), 4.48 (2H, m), 4.81 (2H, m), 5.92 (2H,s), 6.37 (1H, d, <i>J</i> = 7.1 Hz), 6.54 (1H, s), 6.90 (1H, s), 7.04 (1H, d, <i>J</i> = 7.1 Hz), 7.19 (2H, t, <i>J</i> = 8.6 Hz), 7.77 (2H, m).; <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ<sub>C</sub>: 178.3, 177.8, 169.9, 166.4, 164.9, 162.8, 146.0, 134.3 (C × 2), 129.4, 129.3, 129.1, 128.6, 127.4, 126.6, 125.5, 119.4, 118.2, 117.1, 116.8, 116.5, 114.9, 65.2, 63.7, 45.1, 44.2, 43.0, 40.5, 39.4, 38.2, 36.3, 34.7, 33.5, 32.8, 31.6, 30.8, 30.6, 29.8, 29.6, 28.6, 21.6, 18.6, 10.3. HRMS (ESI) calculated for C<sub>43</sub>H<sub>49</sub>FNO<sub>6</sub> [M + H]<sup>+</sup> 694.3538, found 694.3554.</div></div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> Procedures for the Preparation of Compound <b>41-Bio</b></h3><div class="NLM_p">A mixture of <b>11a</b> (1.0 equiv), 3-bromo-1-propanol (1.1 equiv), and K<sub>2</sub>CO<sub>3</sub> (5.0 equiv) in acetone was refluxed overnight and evaporated. The crude product was purified by column chromatography [PE/EA = 2:1 to 1:1 (v/v)] to afford <b>11b</b>. <b>11b</b> (1 equiv), <b>8a</b> (1 equiv), and K<sub>2</sub>CO<sub>3</sub> (3 equiv) were dissolved in MeOH. The reaction was reluxed at 70 °C for 6 h. The reaction mixture was washed by EtOAc (×2). Then the water layer was acidified using 1 M hydrochloric acid solution to pH = 4 and filtered. The filter cake was the crude product <b>11c</b>. <b>11c</b> (1 equiv), 1,3-dibromopropane (1 equiv), and K<sub>2</sub>CO<sub>3</sub> (3 equiv) were added in acetone, and this reaction mixture was refluxed overnight. Then the solution was evaporated. The crude product was purified by column chromatography [PE/EA = 2:1 (v/v)] to afford <b>11d</b>. <b>11d</b> (1 equiv), biotin (2 equiv), DCC (1 equiv), and DMAP (5 mg) were reacted in DMF at 30 °C for 24 h.The reaction was washed with CH<sub>2</sub>Cl<sub>2</sub> (100 mL) for four times. The combined organic layers were washed with aqueous saturated NaCl solution (30 mL) and then dried over sodium sulfate and filtered, and the solvent was evaporated. The crude product was purified by column chromatography [DCM:MeOH = 20:1 to 10:1 (v:v)] to afford <b>11e</b>. <b>41-Bio</b> was synthesized using <b>11e</b> and CEL via the methods of <b>1</b>–<b>48</b>. The crude product was purified by column chromatography [DCM:MeOH = 20:1 to 10:1 (v:v)] to afford <b>41-Bio</b>.</div><div id="sec5_9_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> Compound <b>41-Bio</b></h4><div class="NLM_p last">Orange powder, 10% yield. Mp 138.6–140.1 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ<sub>H</sub>: 0.57 (3H, s), 0.91 (3H, s), 1.12 (3H, s), 1.27 (3H, s), 1.45 (3H, s), 2.16 (3H, s), 4.12–4.32 (10H, m), 6.37 (1H, d, <i>J</i> = 7.2 Hz), 6.53 (1H, s), 6.72 (1H, s),6.94 (3H, m), 7.53 (1H, dd, <i>J</i> = 3.3, 5.5 Hz), 7.60 (1H, br s), 7.64 (1H, br s), 7.72 (1H, dd, <i>J</i> = 3.3, 5.5 Hz); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ<sub>C</sub>: 178.4, 178.2, 173.5, 169.7, 164.7, 163.4, 161.7, 146.1, 134.0, 130.9, 128.8, 125.9, 124.3, 119.6, 118.2, 117.2, 115.3, 114.5, 68.2, 64.8, 62.1, 60.9, 60.8, 60.2, 55.3, 44.5, 40.5, 38.8, 38.2, 36.4, 35.0, 33.9, 32.9,31.6, 30.9, 30.4, 28.6, 27.7,24.8, 23.8, 21.7, 18.6, 14.1, 10.2. HRMS (ESI) calculated for C<sub>55</sub>H<sub>69</sub>N<sub>3</sub>O<sub>10</sub>S [M + H]<sup>+</sup> 964.4782, found 964.4779.</div></div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> Procedures for the Preparation of Compound <b>41-H</b></h3><div class="NLM_p">A mixture of <b>41</b> (1.0 equiv) and methyl thioglycolate (1.1 equiv) in MeOH was stirred for 15 min. The reaction mixture was concentrated under vacuum, and the residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub>. Then the crude product and acetic anhydride (1 mL) was added in pyridine. The mixture reacted in room temperature for 12 h. Then the reaction mixture was suspended in CH<sub>2</sub>Cl<sub>2</sub> and washed by water (×2). Then the organic layer was washed by aqueous saturated CuSO<sub>4</sub> and NaCl solution (30 mL), and then dried over sodium sulfate, filtered, and the solvent was evaporated. The crude product was purified by column chromatography [PE/EA = 3:1–1.5:1 (v/v)] to afford <b>41-H</b>.</div><div id="sec5_10_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> Compound <b>41-H</b></h4><div class="NLM_p last">Colorless powder, 54% yield. Mp 132.6–133.7 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ<sub>H</sub>: 0.58 (3H, s), 1.11 (3H, s), 1.20 (3H, s), 1.27 (3H, s), 1.60 (3H, s), 2.26 (6H, s), 2.32 (3H, s), 3.25 (1H, d, <i>J</i> = 14.7 Hz), 3.50 (1H, d, <i>J</i> = 14.7 Hz), 3.78 (3H, s), 4.03 (1H, m), 4.12 (1H, m), 4.38 (2H, m), 4.74 (1H, d, <i>J</i> = 6.03 Hz), 6.03 (1H, d, <i>J</i> = 6.0 Hz), 6.81 (1H, s), 7.16 (1H, dd, <i>J</i> = 5.0, 8.5 Hz), 7.72 (1H, dd, <i>J</i> = 5.0, 8.8 Hz); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ<sub>C</sub>: 178.2, 171.1, 168.3, 168.1, 166.3, 162.9, 153.5, 149.7, 141.8, 138.7, 129.7, 129.5, 129.3, 129.2, 128.8, 128.7, 118.2, 117.3, 116.7, 116.4, 114.8, 62.5, 60.8, 52.3, 45.3 (C × 2), 44.6, 44.5, 38.3, 37.8, 36.6, 35.1, 34.8, 34.4, 32.9, 31.5, 30.6, 30.5, 30.2 (C × 2), 29.8, 28.8, 27.7, 22.6, 22.1, 20.6, 20.3, 18.6, 11.9., 173.5, 169.7, 164.7, 163.4, 161.7, 146.1, 134.0, 130.9, 128.8, 125.9, 124.3, 119.6, 118.2, 117.2, 115.3, 114.5, 68.2, 64.8, 62.1, 60.9, 60.8, 60.2, 55.3, 44.5, 40.5, 38.8, 38.2, 36.4, 35.0, 33.9, 32.9,31.6, 30.9, 30.4, 28.6, 27.7,24.8, 23.8, 21.7, 18.6, 14.1, 10. HRMS (ESI) calculated for C<sub>49</sub>H<sub>58</sub>FNNaO<sub>10</sub>S [M + Na]<sup>+</sup> 894.3663, found 894.3648.</div></div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> MTT Assay</h3><div class="NLM_p last">All hybrids were evaluated for their inhibitory activities against A549, MCF-7, HOS, and HepG2 cells by MTT method. Briefly, 100 μL of each cell type (5.0 × 10<sup>4</sup> cells/mL) was seeded into 96-well plates and incubated for 24 h. Different concentrations of the drug were added into the 96-well plates. Respective concentrations of DMSO were used as control. Then these plates were incubated for 48 h. MTT solution (5 mg/mL) was added and cultured (4 h). Supernatant was removed before adding 100 mL of DMSO to each well. The OD at 570 nm was measured using a microplate reader (POLARstar Omega, Offenburg, Germany). Every assay was performed in triplicate. Data are presented as the mean ± SD (<i>n</i> = 3).</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> ATP-Sepharose Binding Assay</h3><div class="NLM_p last">The assay was described previously.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> A total of 5 mg of human Hsp90α protein with DMSO, CEL, or <b>41</b> (5/10 μM) was incubated on ice in 200 mL of incubation buffer consisting of 10 mM Tris-HCl, 50 mM KCl, 5 mM MgCl<sub>2</sub>, 2 mM DTT, 20 mM Na<sub>2</sub>MoO<sub>4</sub>, 0.01% Nonidet P-40, pH 7.5. After 30 min, 25 mL of pre-equilibrated γ-phosphate-linked ATP-sepharose (Jena Bioscience GmbH, Jena, Germany) was added to the tubes, which were then incubated at 37 °C for another 30 min with frequent mixing to resuspend the resin. Following incubation, the sepharose was washed, pelleted, and analyzed by SDS-PAGE.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> Immunoprecipitation</h3><div class="NLM_p last">A549 cells were seeded (5 × 10<sup>5</sup> cells) in 6 cm dishes and incubated with 24 h. DMSO and <b>41</b> were added to the dishes at 5 μM, and then these dishes were incubated for 6 h. The cells were lysed, and the proteins were extracted. Then Cdc37 was pulled down by Hsp90α-sepharose. Equal amounts of total protein were subjected to SDS-PAGE to evaluate the levels of the target proteins. Monoclonal antibodies were purchased (Abcam, Cambridge, UK).</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> Western Blotting Analysis</h3><div class="NLM_p last">A549 cells were seeded (5 × 10<sup>5</sup> cells) in 6 cm dishes and incubated for 12 h. Then these cells were incubated with DMSO/<b>41</b>/CEL with indicated concentrations for another 12 h. The cells were lysed, and the proteins were extracted. Then the proteins were diluted to 3 mg/mL (BCA method). Each sample (10 μL) was analyzed by SDS-PAGE (10% gel). Then the proteins were detected by the conventional method.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> <b>41-Bio</b> Pull-Down Experiment</h3><div class="NLM_p last">Recombinant Cdc37 protein (5 mg) was incubated with biotin for 2 h at 10 °C or different concentrations of <b>41</b> for 2 h before or after incubation with <b>41-Bio</b> (0.5 μM) for 2 h at 10 °C. Then the protein was pulled down using streptavidin beads. The beads were washed with PBS (1% DMSO, including compound). The total proteins (input) and bound proteins were immunoblotted.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> Thiol-Binding Experiment</h3><div class="NLM_p last"><b>41</b> (0.02 mmol) with or without DTT (0.04 mmol) was dissolved in an NMR tube using DMSO-<i>d</i><sub>6</sub> (600 μL). Then the <sup>1</sup>H NMR spectrum of the mixture was detected after reaction in ultrasound for 20 min.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> UV Absorption Experiment</h3><div class="NLM_p last"><b>41</b> (100 μM) and GSH (100 μM), Cdc37 (1.5 μM), or Hsp90 (1.5 μM) were dissolved in PBS (1% DMSO). Then the solution was incubated at 37 °C for 0, 5, 15, and 30 min. The UV spectrum of the solution (200–500 nm) was monitored.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> Molecular Modeling</h3><div class="NLM_p last">The X-ray structure of the human Hsp90<sub>N</sub>–Cdc37<sub>M</sub> protein (2K5B) was used. The molecular docking software used in this study was Autodock Vina 1.1.2.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> The parameters were set to “center x = 2.094; center y = 1.667; center z = −3.372; size x = 30; size y = 30; size z = 30”. The X-ray structure of the human Cdc37<sub>M</sub> protein (2W0G) was used.</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> Mitochondrial Membrane Potential</h3><div class="NLM_p last">A549 cells (4 × 10<sup>5</sup> cells) were incubated in a 6 cm dish for 24 h. Then DMSO/<b>41</b> was added to the cells with indicated concentrations for 24 h. Cells were harvested at 2000 rpm for 5 min and then washed twice with ice-cold PBS, followed by resuspension in JC-1 (5 mg/mL) and incubation at 37 °C for 15 min. After the cells were rinsed three times and suspended in PBS, the JC-1 fluorescence was analysis by flow cytometry.</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> Hoechst-33342&PI Staining</h3><div class="NLM_p last">A549 cells (4 × 10<sup>5</sup> cells) were incubated in a 6 cm dish for 24 h. Then A549 cells were treated with the DMSO/<b>41</b> at indicated concentrations for 48 h. Cells were washed twice by PBS. Then cells were incubated with Hoechst-33342 (10 μg/mL) and PI for 5 min at room temperature in the darkness. After incubation, stained cells were observed under a fluorescent microscope (Nikon, Japan).</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> Cell Apoptosis Analysis</h3><div class="NLM_p last">A549 cells (4 × 10<sup>5</sup> cells) were incubated in 6 cm dish for 24 h. Then DMSO/<b>41/</b>CEL was added to the cells with indicated concentrations. After another incubation of 48 h, the cells were harvested softly and washed twice with cold PBS (2000<i>g</i> for 5 min). Then the cells were added to 250 μL of binding buffer containing 2.5 μL of PI and 2.5 μL of Annexin V (KeyGEN, China). The mixture was incubated at room temperature for 15 min in the dark and then analyzed by flow cytometry.</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94"> Cell Cycle Analysis</h3><div class="NLM_p last">A549 cells (4 × 10<sup>5</sup> cells) were incubated in 6 cm dishes for 24 h. Then DMSO/<b>41/</b>CEL was added to the dishes with different concentrations. After incubation for 24 h, the cells were harvested and washed twice with cold PBS. Then the cells were fixed in ethanol (75%) at −20 °C for at least 12 h. The cells were washed with buffer A to remove the ethanol. The cells were then suspended in buffer A (250 μL) containing 250 mg/mL RNase A and cultured at 37 °C for 30 min. Finally, 2.5 μL of propidium iodide (PI) (KeyGEN, China) was added and incubated at room temperature in the dark for 15 min. The cells were analyzed by flow cytometry (BD Accuri C6 flow cytometer, Franklin Lakes, NJ).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i95"><a href="/doi/suppl/10.1021/acs.jmedchem.9b01290" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80116" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80116" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.9b01290?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01290</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Structural characterization of the compounds (<sup>1</sup>H NMR, <sup>13</sup>C NMR, ESI/HRMS spectra of the final compounds <b>1</b>–<b>48</b>, <b>41-H</b>, and <b>41-Bio</b>); synthetic route of compound <b>41-H</b>; HPLC analysis of target compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01290/suppl_file/jm9b01290_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular string files for all the final target compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01290/suppl_file/jm9b01290_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01290/suppl_file/jm9b01290_si_001.pdf">jm9b01290_si_001.pdf (4.4 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01290/suppl_file/jm9b01290_si_002.csv">jm9b01290_si_002.csv (8.2 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b01290" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46531" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46531" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jianbo Sun</span> - <span class="hlFld-Affiliation affiliation">State Key Laboratory of Natural
Medicines, Department of Natural Medicinal Chemistry, School of Traditional
Chinese Pharmacy, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, People’s Republic of China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#92e1f8f0f1e2e7d2f5fff3fbfebcf1fdff"><span class="__cf_email__" data-cfemail="2e5d444c4d5e5b6e49434f4742004d4143">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Li Chen</span> - <span class="hlFld-Affiliation affiliation">State Key Laboratory of Natural
Medicines, Department of Natural Medicinal Chemistry, School of Traditional
Chinese Pharmacy, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, People’s Republic of China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4655-9024" title="Orcid link">http://orcid.org/0000-0002-4655-9024</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#a4c7ccc1cac8cd929693e4c7d4d18ac1c0d18ac7ca"><span class="__cf_email__" data-cfemail="36555e53585a5f0004017655464318535243185558">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Na Li</span> - <span class="hlFld-Affiliation affiliation">State Key Laboratory of Natural
Medicines, Department of Natural Medicinal Chemistry, School of Traditional
Chinese Pharmacy, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, People’s Republic of China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Manyi Xu</span> - <span class="hlFld-Affiliation affiliation">State Key Laboratory of Natural
Medicines, Department of Natural Medicinal Chemistry, School of Traditional
Chinese Pharmacy, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, People’s Republic of China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bing Wang</span> - <span class="hlFld-Affiliation affiliation">State Key Laboratory of Natural
Medicines, Department of Natural Medicinal Chemistry, School of Traditional
Chinese Pharmacy, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, People’s Republic of China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhixian Shi</span> - <span class="hlFld-Affiliation affiliation">State Key Laboratory of Natural
Medicines, Department of Natural Medicinal Chemistry, School of Traditional
Chinese Pharmacy, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, People’s Republic of China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zihao Zhao</span> - <span class="hlFld-Affiliation affiliation">State Key Laboratory of Natural
Medicines, Department of Natural Medicinal Chemistry, School of Traditional
Chinese Pharmacy, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, People’s Republic of China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yunqing Tang</span> - <span class="hlFld-Affiliation affiliation">State Key Laboratory of Natural
Medicines, Department of Natural Medicinal Chemistry, School of Traditional
Chinese Pharmacy, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, People’s Republic of China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xinyue Wang</span> - <span class="hlFld-Affiliation affiliation">State Key Laboratory of Natural
Medicines, Department of Natural Medicinal Chemistry, School of Traditional
Chinese Pharmacy, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, People’s Republic of China</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>N.L. and M.X. contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i97">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27455" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27455" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was financially supported by “Double First Class” Subject Innovation Team Construction Project of China Pharmaceutical University (CPU2018GY12) and College Students Innovation Project for the R&D of Novel Drugs (No. J1310032).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">Hsp90–Cdc37</td><td class="NLM_def"><p class="first last">heat shock protein 90-cell division cycle 37</p></td></tr><tr><td class="NLM_term">CEL</td><td class="NLM_def"><p class="first last">celastrol</p></td></tr><tr><td class="NLM_term">Cdc37</td><td class="NLM_def"><p class="first last">cycle 37</p></td></tr><tr><td class="NLM_term">Hop</td><td class="NLM_def"><p class="first last">homeodomain only protein</p></td></tr><tr><td class="NLM_term">Akt</td><td class="NLM_def"><p class="first last">protein kinase B</p></td></tr><tr><td class="NLM_term">Cdk4</td><td class="NLM_def"><p class="first last">cyclin-dependent kinases 4</p></td></tr><tr><td class="NLM_term">Her-2</td><td class="NLM_def"><p class="first last">human epidermal growth factor receptor-2</p></td></tr><tr><td class="NLM_term">c-Met</td><td class="NLM_def"><p class="first last">tyrosine-protein kinase Met</p></td></tr><tr><td class="NLM_term">Hsp90<sub>N</sub></td><td class="NLM_def"><p class="first last">terminal domain of Hsp90</p></td></tr><tr><td class="NLM_term">Cdc37<sub>M</sub></td><td class="NLM_def"><p class="first last">the middle domain of Cdc37</p></td></tr><tr><td class="NLM_term">CA</td><td class="NLM_def"><p class="first last">cinnamic acid</p></td></tr><tr><td class="NLM_term">CDDO-Me</td><td class="NLM_def"><p class="first last">bardoxolone methyl</p></td></tr><tr><td class="NLM_term">EDCI</td><td class="NLM_def"><p class="first last">1-(3-(dimethylamino)propyl)-3-ethylcarbodiimide hydrochloride</p></td></tr><tr><td class="NLM_term">DMAP</td><td class="NLM_def"><p class="first last">dimethylaminopyridine</p></td></tr><tr><td class="NLM_term">α-CN CA</td><td class="NLM_def"><p class="first last">α-cyano substituted cinnamic acids</p></td></tr><tr><td class="NLM_term">β-CN CA</td><td class="NLM_def"><p class="first last">β-cyano substituted cinnamic acids</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">Bind P</td><td class="NLM_def"><p class="first last">bound proteins</p></td></tr><tr><td class="NLM_term">GSH</td><td class="NLM_def"><p class="first last">Glutathione</p></td></tr><tr><td class="NLM_term">PI</td><td class="NLM_def"><p class="first last">propidium iodide</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i99">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80043" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80043" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 31 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferrarini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heltai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zocchi, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rugarli, C.</span></span> <span> </span><span class="NLM_article-title">Unusual expression and localization of heat-shock proteins in human tumor cells</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">613</span>– <span class="NLM_lpage">619</span>, <span class="refDoi"> DOI: 10.1002/ijc.2910510418</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.1002%2Fijc.2910510418" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1601523" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADyaK38XlvV2hs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1992&pages=613-619&author=M.+Ferrariniauthor=S.+Heltaiauthor=M.+R.+Zocchiauthor=C.+Rugarli&title=Unusual+expression+and+localization+of+heat-shock+proteins+in+human+tumor+cells&doi=10.1002%2Fijc.2910510418"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Unusual expression and localization of heat-shock proteins in human tumor cells</span></div><div class="casAuthors">Ferrarini, Marina; Heltai, Silvia; Zocchi, M. Raffaella; Rugarli, Claudio</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">613-19</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    </div><div class="casAbstract">It has been suggested that members of HSP families represent the surface target of immune responses leading to tumor rejection in mice.  The authors report that tumor cells, compared with normal cells, constitutively expressed 2- to 10-fold higher levels of intracellular HSP90.  Moreover, in the absence of environmental stress, 2 lines (out of 6) expressed the "inducible" HSP72, which was also detectable in fresh tumor cells.  HSP72 expression was not regulated during the cell cycle, in contrast with what has been obsd. with normal cells.  Both HSP90 and HSP72 proteins exhibited a heterogeneous pattern of intracellular distribution in most cells, HSP72 being confined mainly to the nuclear compartment.  Finally, both HSP90 and, to a lesser extent, HSP72 (that are generally believed to be located intracellularly) were detected at the surface of some tumor cell lines.  It is concluded that tumor cells differ from normal cells in their pattern of HSP expression; this might imply a role of HSPs in eliciting an immune response against cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdlQHEKHA7jLVg90H21EOLACvtfcHk0li-YfWbT1Y8wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XlvV2hs7s%253D&md5=4ace8651e9b125c68985102a0b3055f3</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1002%2Fijc.2910510418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.2910510418%26sid%3Dliteratum%253Aachs%26aulast%3DFerrarini%26aufirst%3DM.%26aulast%3DHeltai%26aufirst%3DS.%26aulast%3DZocchi%26aufirst%3DM.%2BR.%26aulast%3DRugarli%26aufirst%3DC.%26atitle%3DUnusual%2520expression%2520and%2520localization%2520of%2520heat-shock%2520proteins%2520in%2520human%2520tumor%2520cells%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D1992%26volume%3D51%26spage%3D613%26epage%3D619%26doi%3D10.1002%2Fijc.2910510418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kosano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stensgard, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlesworth, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toft, D.</span></span> <span> </span><span class="NLM_article-title">The assembly of progesterone receptor-hsp90 complexes using purified proteins</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>273</i></span>,  <span class="NLM_fpage">32973</span>– <span class="NLM_lpage">32979</span>, <span class="refDoi"> DOI: 10.1074/jbc.273.49.32973</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.1074%2Fjbc.273.49.32973" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=9830049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADyaK1cXnvFOms70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=32973-32979&author=H.+Kosanoauthor=B.+Stensgardauthor=M.+C.+Charlesworthauthor=N.+McMahonauthor=D.+Toft&title=The+assembly+of+progesterone+receptor-hsp90+complexes+using+purified+proteins&doi=10.1074%2Fjbc.273.49.32973"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The assembly of progesterone receptor-hsp90 complexes using purified proteins</span></div><div class="casAuthors">Kosano, Hiroshi; Stensgard, Bridget; Charlesworth, M. Cristine; McMahon, Nancy; Toft, David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">273</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">32973-32979</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The progesterone receptor can be reconstituted into hsp90-contg. complexes in vitro, and the resulting complexes are needed to maintain hormone binding activity.  This process requires ATP/Mg2+, K+, and several axillary proteins.  The authors have developed a defined system for the assembly of progesterone receptor complexes using purified proteins.  Five proteins are needed to form complexes that are capable of maintaining hormone binding activity.  These include hsp70 and its cochaperone, hsp40, the hsp70/hsp90-binding protein, Hop, hsp90, and the hsp90-binding protein, p23.  The proteins Hip and FKBP52 were not required for this in vitro process even though they have been obsd. in receptor complexes.  Each of the five proteins showed a characteristic concn. dependence.  Similar concns. of hsp70, hsp90, and p23 were needed for optimal assembly, but hsp40 and Hop were effective at about 1/10 the concn. of the other proteins, suggesting that these two proteins act catalytically or are needed at levels similar to the receptor concn.  ATP was required for the functioning of both hsp70 and hsp90.  The binding of hsp70 to the receptor requires hsp40 and about 10 μM ATP; however, hsp90 binding appears to occur subsequent to hsp70 binding and is optimal with 1 mM ATP.  A three-step model is presented to describe the assembly process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_LWDQTbsh57Vg90H21EOLACvtfcHk0lgoT7gLrj7igg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnvFOms70%253D&md5=1a2a42e700ef3e6a8b624934e6e8f58c</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1074%2Fjbc.273.49.32973&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.273.49.32973%26sid%3Dliteratum%253Aachs%26aulast%3DKosano%26aufirst%3DH.%26aulast%3DStensgard%26aufirst%3DB.%26aulast%3DCharlesworth%26aufirst%3DM.%2BC.%26aulast%3DMcMahon%26aufirst%3DN.%26aulast%3DToft%26aufirst%3DD.%26atitle%3DThe%2520assembly%2520of%2520progesterone%2520receptor-hsp90%2520complexes%2520using%2520purified%2520proteins%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D32973%26epage%3D32979%26doi%3D10.1074%2Fjbc.273.49.32973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fliss, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrett, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caplan, A. J.</span></span> <span> </span><span class="NLM_article-title">The Cdc37 protein kinase-binding domain is sufficient for protein kinase activity and cell viability</span>. <i>J. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>159</i></span>,  <span class="NLM_fpage">1051</span>– <span class="NLM_lpage">1059</span>, <span class="refDoi"> DOI: 10.1083/jcb.200210121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.1083%2Fjcb.200210121" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=12499358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjt1eh" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=2002&pages=1051-1059&author=P.+Leeauthor=J.+Raoauthor=A.+Flissauthor=E.+Yangauthor=S.+Garrettauthor=A.+J.+Caplan&title=The+Cdc37+protein+kinase-binding+domain+is+sufficient+for+protein+kinase+activity+and+cell+viability&doi=10.1083%2Fjcb.200210121"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The Cdc37 protein kinase-binding domain is sufficient for protein kinase activity and cell viability</span></div><div class="casAuthors">Lee, Paul; Rao, Jie; Fliss, Albert; Yang, Emy; Garrett, Stephen; Caplan, Avrom J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">159</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1051-1059</span>CODEN:
                <span class="NLM_cas:coden">JCLBA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9525</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Cdc37 is a mol. chaperone required for folding of protein kinases.  It functions in assocn. with Hsp90, although little is known of its mechanism of action or where it fits into a folding pathway involving other Hsp90 cochaperones.  Using a genetic approach with Saccharomyces cerevisiae, we show that CDC37 over-expression suppressed a defect in v-Src folding in yeast deleted for STI1, which recruits Hsp90 to misfolded clients.  Expression of CDC37 truncation mutants that were deleted for the Hsp90-binding site stabilized v-Src and led to some folding in both sti1Δ and hsc82Δ strains.  The protein kinase-binding domain of Cdc37 was sufficient for yeast cell viability and permitted efficient signaling through the yeast MAP kinase-signaling pathway.  We propose a model in which Cdc37 can function independently of Hsp90, although its ability to do so is restricted by its normally low expression levels.  This may be a form of regulation by which cells restrict access to Cdc37 until it has passed through a triage involving other chaperones such as Hsp70 and Hsp90.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2L6CbtJfYKbVg90H21EOLACvtfcHk0lgoT7gLrj7igg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjt1eh&md5=060e9efc016e1db0c7a5a85d05d8dd5f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1083%2Fjcb.200210121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.200210121%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DP.%26aulast%3DRao%26aufirst%3DJ.%26aulast%3DFliss%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DE.%26aulast%3DGarrett%26aufirst%3DS.%26aulast%3DCaplan%26aufirst%3DA.%2BJ.%26atitle%3DThe%2520Cdc37%2520protein%2520kinase-binding%2520domain%2520is%2520sufficient%2520for%2520protein%2520kinase%2520activity%2520and%2520cell%2520viability%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2002%26volume%3D159%26spage%3D1051%26epage%3D1059%26doi%3D10.1083%2Fjcb.200210121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pearl, L. H.</span></span> <span> </span><span class="NLM_article-title">Hsp90 and Cdc37 -- a chaperone cancer conspiracy</span>. <i>Curr. Opin. Genet. Dev.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">61</span>, <span class="refDoi"> DOI: 10.1016/j.gde.2004.12.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.1016%2Fj.gde.2004.12.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=15661534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmvFersw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=55-61&author=L.+H.+Pearl&title=Hsp90+and+Cdc37+%2D%2D+a+chaperone+cancer+conspiracy&doi=10.1016%2Fj.gde.2004.12.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp90 and Cdc37 - a chaperone cancer conspiracy</span></div><div class="casAuthors">Pearl, Laurence H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Genetics & Development</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-61</span>CODEN:
                <span class="NLM_cas:coden">COGDET</span>;
        ISSN:<span class="NLM_cas:issn">0959-437X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The Hsp90 mol. chaperone system is involved in the activation of an important set of cell regulatory proteins, including many whose dysregulation drives cancer.  Recruitment of protein kinases to the Hsp90 system is mediated by the co-chaperone adaptor Cdc37 - an essential protein whose overexpression is itself, oncogenic.  Current structural, biochem. and biol. studies of Cdc37 are beginning to unravel the nature of its interactions with Hsp90 and protein kinase clients, and implicate it as a key permissive factor in cell transformation by dysregulated protein kinases.  The central role of the Hsp90-Cdc37 chaperone complex makes it an important target for future anti-cancer drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsaofLA0wLnrVg90H21EOLACvtfcHk0lgHPjAuBaCDAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmvFersw%253D%253D&md5=2795e3e44b6b0bbbe12dda55cb335769</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.gde.2004.12.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.gde.2004.12.011%26sid%3Dliteratum%253Aachs%26aulast%3DPearl%26aufirst%3DL.%2BH.%26atitle%3DHsp90%2520and%2520Cdc37%2520--%2520a%2520chaperone%2520cancer%2520conspiracy%26jtitle%3DCurr.%2520Opin.%2520Genet.%2520Dev.%26date%3D2005%26volume%3D15%26spage%3D55%26epage%3D61%26doi%3D10.1016%2Fj.gde.2004.12.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calderwood, S. K.</span></span> <span> </span><span class="NLM_article-title">Cdc37 as a co-chaperone to Hsp90</span>. <i>Subcell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">103</span>– <span class="NLM_lpage">112</span>, <span class="refDoi"> DOI: 10.1007/978-3-319-11731-7_5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.1007%2F978-3-319-11731-7_5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=25487018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADC%252BC28XmsVOls7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2015&pages=103-112&author=S.+K.+Calderwood&title=Cdc37+as+a+co-chaperone+to+Hsp90&doi=10.1007%2F978-3-319-11731-7_5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Cdc37 as a Co-chaperone to Hsp90</span></div><div class="casAuthors">Calderwood, Stuart K.</div><div class="citationInfo"><span class="NLM_cas:title">Subcellular Biochemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">Networking of Chaperones by Co-Chaperones</span>),
    <span class="NLM_cas:pages">103-112</span>CODEN:
                <span class="NLM_cas:coden">SBCBAG</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The co-chaperone p50/Cdc37 is an important partner for Hsp90, assisting in mol. chaperone activities, particularly with regard to the regulation of protein kinases.  The Hsp90/Cdc37complex controls the folding of a large proportion of protein kinases and thus stands at the hub of a multitude of intracellular signaling networks.  Its effects thus reach beyond the housekeeping pathways of protein folding into regulation of a wide range of cellular processes.  Due to its influence in cell growth pathways Cdc37 has attracted much attention as a potential intermediate in carcinogenesis.  Cdc37 is an attractive potential target in cancer due to: (1) it may be expressed to high level in some types of cancer and (2) Cdc37 controls multiple signaling pathways.  This indicates a potential for: (1) selectivity due to its elevated expression and (2) robustness as the co-chaperone may control multiple growth signaling pathways and thus be less prone to evolution of resistance than other oncoproteins.  Cdc37 may also be involved in other aspects of pathophysiol.  Protein aggregation disorders have been linked to mol. chaperones and to age related declines in mol. chaperones and co-chaperones.  Cdc37 appears to be a potential agent in longevity due to its links to protein folding and autophagy and it will be informative to study the role of Cdc37 maintenance/decline in aging organisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTkfM0nCIL_7Vg90H21EOLACvtfcHk0lgHPjAuBaCDAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmsVOls7Y%253D&md5=7b5f610cd03de410184737db89c38cd7</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1007%2F978-3-319-11731-7_5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-319-11731-7_5%26sid%3Dliteratum%253Aachs%26aulast%3DCalderwood%26aufirst%3DS.%2BK.%26atitle%3DCdc37%2520as%2520a%2520co-chaperone%2520to%2520Hsp90%26jtitle%3DSubcell.%2520Biochem.%26date%3D2015%26volume%3D78%26spage%3D103%26epage%3D112%26doi%3D10.1007%2F978-3-319-11731-7_5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q. D.</span></span> <span> </span><span class="NLM_article-title">Targeting Hsp90-Cdc37: a promising therapeutic strategy by inhibiting Hsp90 chaperone function</span>. <i>Curr. Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1572</span>– <span class="NLM_lpage">1585</span>, <span class="refDoi"> DOI: 10.2174/1389450117666160527125522</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.2174%2F1389450117666160527125522" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=27231111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Sru7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=1572-1585&author=L.+Wangauthor=L.+Liauthor=K.+Guauthor=X.+L.+Xuauthor=Y.+Sunauthor=Q.+D.+You&title=Targeting+Hsp90-Cdc37%3A+a+promising+therapeutic+strategy+by+inhibiting+Hsp90+chaperone+function&doi=10.2174%2F1389450117666160527125522"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Hsp90-Cdc37: A Promising Therapeutic Strategy by Inhibiting Hsp90 Chaperone Function</span></div><div class="casAuthors">Wang, Lei; Li, Li; Gu, Kai; Xu, Xiao-Li; Sun, Yuan; You, Qi-Dong</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1572-1585</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Background & Objective: The Hsp90 chaperone protein regulates the folding, maturation and stability of a wide variety of oncoproteins.  In recent years, many Hsp90 inhibitors have entered into the clin. trials while all of them target ATPase showing similar binding capacity and kinds of side-effects so that none have reached to the market.  During the regulation progress, numerous protein- protein interactions (PPI) such as Hsp90 and client proteins or cochaperones are involved.  With the Hsp90-cochaperones PPI networks being more and more clear, many cancerous proteins have been reported to be tightly correlated to Hsp90-cochaperones PPI.  Among them, Hsp90-Cdc37 PPI has been widely reported to assoc. with numerous protein kinases, making it a novel target for the treatment of cancers.  Results and Conclusion: In this paper, we briefly review the strategies and modulators targeting Hsp90-Cdc37 complex including direct and indirect regulation mechanism.  Through these discussions we expect to present inspirations for new insights into an alternative way to inhibit Hsp90 chaperone function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpi2anLn7Vf0LVg90H21EOLACvtfcHk0lhx5vc-kzNFkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Sru7nO&md5=a6636ba125e2894ba7ccdafc04c9e3b1</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2174%2F1389450117666160527125522&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389450117666160527125522%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DGu%26aufirst%3DK.%26aulast%3DXu%26aufirst%3DX.%2BL.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DYou%26aufirst%3DQ.%2BD.%26atitle%3DTargeting%2520Hsp90-Cdc37%253A%2520a%2520promising%2520therapeutic%2520strategy%2520by%2520inhibiting%2520Hsp90%2520chaperone%2520function%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2017%26volume%3D18%26spage%3D1572%26epage%3D1585%26doi%3D10.2174%2F1389450117666160527125522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y. L.</span></span> <span> </span><span class="NLM_article-title">Antiangiogenic effect of celastrol on the growth of human glioma: An <i>in vitro</i> and <i>in vivo</i> study</span>. <i>Chin. Med. J. (Engl.)</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">1666</span>– <span class="NLM_lpage">1673</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=19719969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVGqtLjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2009&pages=1666-1673&author=Y.+X.+Zhouauthor=Y.+L.+Huang&title=Antiangiogenic+effect+of+celastrol+on+the+growth+of+human+glioma%3A+An+in+vitro+and+in+vivo+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Antiangiogenic effect of celastrol on the growth of human glioma: an in vitro and in vivo study</span></div><div class="casAuthors">Zhou, You-xin; Huang, Yu-lun</div><div class="citationInfo"><span class="NLM_cas:title">Chinese Medical Journal (Beijing, China, English Edition)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1666-1673</span>CODEN:
                <span class="NLM_cas:coden">CMJODS</span>;
        ISSN:<span class="NLM_cas:issn">0366-6999</span>.
    
            (<span class="NLM_cas:orgname">Chinese Medical Association</span>)
        </div><div class="casAbstract">Background: Celastrol is a major active component of Tripterygium wilfordii named "Thunder God Vine", which is widely used to treat rheumatoid arthritis in China.  The present study aims to demonstrate that celastrol has potent anticancer activity against glioma in vitro and in vivo.  Methods: Proliferation, migration, and tube formation of ECV-304 cells were detd. by MTT and matrigel assays.  The antiangiogenesis effect of celastrol was assessed by the chick chorioallantoic membrane assay and the in vivo matrigel plug assay.  Tumor microvessels (MVD) were detd. immunohistochem. with anti-CD34 antibody.  Vascular endothelial growth factor (VEGF) expression was defined as pos. if distinct staining of the cytoplasm was obsd. in at least 10% of tumor cells at the deepest invasive site, central portion and superficial part of the tumor.  MVD was estd. by averaging the counts of three times at a ×200 field in the most vascularized area of the deepest invasive site.  Results: Celastrol purified from T. wilfordii inhibited the proliferation of vascular endothelial cells (ECV-304) with an IC50 value of 1.33 μg/mL.  Celastrol, at the concn. of 0.2 μg/mL, significantly inhibited cell migration and tube formation.  Celastrol inhibited angiogenesis in a dose-dependent manner both in vitro and in vivo.  S.c. administration of celastrol 5 days a week for 4 consecutive weeks significantly reduced tumor vol. in a dose-dependent manner in the SHG-44 xenograft model.  Celastrol at each different dose level lowered the d. of MVD significantly in tumor bearing nude mice compared to the control group.  Immunohistochem. expts. further revealed that celastrol also decreased the level of VEGFR-1 and VEGFR-2 expression, but not the level of VEGF expression.  Conclusions: Celastrol elicits antiangiogenic effects in vitro and in vivo, and could be of potential use in the treatment of malignant cancers such as glioblastoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoH_0tUNx9XkrVg90H21EOLACvtfcHk0lhx5vc-kzNFkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVGqtLjL&md5=80bd61d59a05723a8b714186f3278f11</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DY.%2BX.%26aulast%3DHuang%26aufirst%3DY.%2BL.%26atitle%3DAntiangiogenic%2520effect%2520of%2520celastrol%2520on%2520the%2520growth%2520of%2520human%2520glioma%253A%2520An%2520in%2520vitro%2520and%2520in%2520vivo%2520study%26jtitle%3DChin.%2520Med.%2520J.%2520%2528Engl.%2529%26date%3D2009%26volume%3D122%26spage%3D1666%26epage%3D1673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, J.</span></span> <span> </span><span class="NLM_article-title">Celastrol exerts synergistic effects with PHA-665752 and inhibits tumor growth of c-Met-deficient hepatocellular carcinoma <i>in vivo</i></span>. <i>Mol. Biol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">4203</span>– <span class="NLM_lpage">4209</span>, <span class="refDoi"> DOI: 10.1007/s11033-013-2501-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.1007%2Fs11033-013-2501-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=23649759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADC%252BC3sXps1Cntrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2013&pages=4203-4209&author=H.+L.+Jiangauthor=J.+Z.+Jinauthor=D.+Wuauthor=D.+Xuauthor=G.+F.+Linauthor=H.+Yuauthor=D.+Y.+Maauthor=J.+Liang&title=Celastrol+exerts+synergistic+effects+with+PHA-665752+and+inhibits+tumor+growth+of+c-Met-deficient+hepatocellular+carcinoma+in+vivo&doi=10.1007%2Fs11033-013-2501-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Celastrol exerts synergistic effects with PHA-665752 and inhibits tumor growth of c-Met-deficient hepatocellular carcinoma in vivo</span></div><div class="casAuthors">Jiang, Hong-Lei; Jin, Jun-Zhe; Wu, Dan; Xu, Dong; Lin, Guo-Fu; Yu, Hao; Ma, Dong-Yan; Liang, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology Reports</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">4203-4209</span>CODEN:
                <span class="NLM_cas:coden">MLBRBU</span>;
        ISSN:<span class="NLM_cas:issn">0301-4851</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">PHA665752 (PHA), a selective small mol. c-Met Inhibitor, potently inhibited HGF-stimulated and constitutive c-Met phosphorylation, as well as HGF and c-Met-driven phenotypes of a variety of tumor cells including hepatocellular carcinoma cells.  However, these effects were impaired in c-Met-deficient cancer cells.  In the present study, we investigated the potential anti-human c-Met-deficient hepatocellular carcinoma effects of Celastrol, a novel triterpene, and its combination with PHA.  Human hepatocellular carcinoma cells BEL-7402 (c-Met-pos.) and Huh7 (c-Met-deficient) were treated with different dose of PHA with or without equal dose of Celastrol, and cell growth, cell cycle and apoptosis were evaluated, resp., by MTT assay, flow cytometry and Caspase3/7 activity.  Nude mice bearing Huh7 xenografts were used to assess the in vivo anti-tumor activity.  Our results showed that Celastrol at high concn. (>1.0 μM) induced G2/M arrest and apoptosis with the activation of Caspase3/7 in Huh7 cells whereas at low concn. (<1.0 μM) had no obvious effects.  Low concn. Celastrol presented significant combined effects with PHA on Huh7 cells and Huh7 xenografts in terms of growth inhibition, migration inhibition and apoptosis induction.  These results suggest that Celastrol and its combination with PHA present the therapeutic potential on c-Met-deficient hepatocellular carcinoma, and deserve further preclin. and clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrO8hrtfMWjIrVg90H21EOLACvtfcHk0lgjY6AOce6RuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXps1Cntrk%253D&md5=095b2df1c1b758ff9ebd547351ac5abf</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1007%2Fs11033-013-2501-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11033-013-2501-y%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DH.%2BL.%26aulast%3DJin%26aufirst%3DJ.%2BZ.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DD.%26aulast%3DLin%26aufirst%3DG.%2BF.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DMa%26aufirst%3DD.%2BY.%26aulast%3DLiang%26aufirst%3DJ.%26atitle%3DCelastrol%2520exerts%2520synergistic%2520effects%2520with%2520PHA-665752%2520and%2520inhibits%2520tumor%2520growth%2520of%2520c-Met-deficient%2520hepatocellular%2520carcinoma%2520in%2520vivo%26jtitle%3DMol.%2520Biol.%2520Rep.%26date%3D2013%26volume%3D40%26spage%3D4203%26epage%3D4209%26doi%3D10.1007%2Fs11033-013-2501-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, Q. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dou, Q. P.</span></span> <span> </span><span class="NLM_article-title">Celastrol, a triterpene extracted from the Chinese “Thunder of God Vine,” is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">4758</span>– <span class="NLM_lpage">4765</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-05-4529</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.1158%2F0008-5472.CAN-05-4529" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=16651429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvF2ktrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=4758-4765&author=H.+Yangauthor=D.+Chenauthor=Q.+C.+Cuiauthor=X.+Yuanauthor=Q.+P.+Dou&title=Celastrol%2C+a+triterpene+extracted+from+the+Chinese+%E2%80%9CThunder+of+God+Vine%2C%E2%80%9D+is+a+potent+proteasome+inhibitor+and+suppresses+human+prostate+cancer+growth+in+nude+mice&doi=10.1158%2F0008-5472.CAN-05-4529"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Celastrol, a Triterpene Extracted from the Chinese "Thunder of God Vine," Is a Potent Proteasome Inhibitor and Suppresses Human Prostate Cancer Growth in Nude Mice</span></div><div class="casAuthors">Yang, Huanjie; Chen, Di; Cui, Qiuzhi Cindy; Yuan, Xiao; Dou, Q. Ping</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4758-4765</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Interest in the use of traditional medicines for cancer prevention and treatment is increasing.  In vitro, in vivo, and clin. studies suggest the potential use of proteasome inhibitors as novel anticancer drugs.  Celastrol, an active compd. extd. from the root bark of the Chinese medicine "Thunder of God Vine" (Tripterygium wilfordii Hook F.), was used for years as a natural remedy for inflammatory conditions.  Although Celastrol has been shown to induce leukemia cell apoptosis, the mol. target involved has not been identified.  Furthermore, whether Celastrol has antitumor activity in vivo has never been conclusively shown.  Here, we report, for the first time, that Celastrol potently and preferentially inhibits the chymotrypsin-like activity of a purified 20S proteasome (IC50 = 2.5 μmol/L) and human prostate cancer cellular 26S proteasome (at 1-5 μmol/L).  Inhibition of the proteasome activity by Celastrol in PC-3 (androgen receptor- or AR-neg.) or LNCaP (AR-pos.) cells results in the accumulation of ubiquitinated proteins and three natural proteasome substrates (IκB-α, Bax, and p27), accompanied by suppression of AR protein expression (in LNCaP cells) and induction of apoptosis.  Treatment of PC-3 tumor-bearing nude mice with Celastrol (1-3 mg/kg/d, i.p., 1-31 days) resulted in significant inhibition (65-93%) of the tumor growth.  Multiple assays using the animal tumor tissue samples from both early and end time points showed in vivo inhibition of the proteasomal activity and induction of apoptosis after Celastrol treatment.  Our results show that Celastrol is a natural proteasome inhibitor that has a great potential for cancer prevention and treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfMTz0hvh_grVg90H21EOLACvtfcHk0lgjY6AOce6RuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvF2ktrs%253D&md5=08d3772b69fa1e92dc313266b9968a1d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-05-4529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-05-4529%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DCui%26aufirst%3DQ.%2BC.%26aulast%3DYuan%26aufirst%3DX.%26aulast%3DDou%26aufirst%3DQ.%2BP.%26atitle%3DCelastrol%252C%2520a%2520triterpene%2520extracted%2520from%2520the%2520Chinese%2520%25E2%2580%259CThunder%2520of%2520God%2520Vine%252C%25E2%2580%259D%2520is%2520a%2520potent%2520proteasome%2520inhibitor%2520and%2520suppresses%2520human%2520prostate%2520cancer%2520growth%2520in%2520nude%2520mice%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D4758%26epage%3D4765%26doi%3D10.1158%2F0008-5472.CAN-05-4529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sreeramulu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gande, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Göbel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwalbe, H.</span></span> <span> </span><span class="NLM_article-title">Molecular mechanism of inhibition of the human protein complex Hsp90-Cdc37, a kinome chaperone-cochaperone, by Triterpene Celastrol</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">5853</span>– <span class="NLM_lpage">5855</span>, <span class="refDoi"> DOI: 10.1002/anie.200900929</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.1002%2Fanie.200900929" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=19585625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptFGltb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=5853-5855&author=S.+Sreeramuluauthor=S.+L.+Gandeauthor=M.+G%C3%B6belauthor=H.+Schwalbe&title=Molecular+mechanism+of+inhibition+of+the+human+protein+complex+Hsp90-Cdc37%2C+a+kinome+chaperone-cochaperone%2C+by+Triterpene+Celastrol&doi=10.1002%2Fanie.200900929"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Mechanism of Inhibition of the Human Protein Complex Hsp90-Cdc37, a Kinome Chaperone-Cochaperone, by Triterpene Celastrol</span></div><div class="casAuthors">Sreeramulu, Sridhar; Gande, Santosh Lakshmi; Goebel, Michael; Schwalbe, Harald</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">5853-5855, S5853/1-S5853/11</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Inhibition of the ATPase activity of the kinome chaperone Hsp90 (kinome = set of all protein kinases in an organism) has long been known as mol. target for anticancer therapy.  Cdc37, a cochaperone of Hsp90 in mammalian cells, targets protein kinases and is upregulated in various cancers.  Gene-based expression studies have identified the triterpene celastrol, which represents a new class of non ATP-competitive inhibitors of Hsp90.  Herein, we describe in detail how celastrol disrupts the human Hsp90-Cdc37 complex.  We report that celastrol binds to Cdc37 but not to HSP90N as previously described.  This study is important as it will shift efforts in medicinal chem. towards the correct target within the protein-protein complex.  Our results indicates that the N-terminal kinase- binding and middle Hsp90N-binding domain of Cdc37 are the mol. target for the triterpene celastrol.  In light of the considerable potential of Cdc37 as a drug target and the binding of celastrol to it, these results can now be used to further understand the mol. basis for inhibiting this key Cdc37-Hsp90 complex in cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWgmOS-yFB6rVg90H21EOLACvtfcHk0lgjY6AOce6RuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptFGltb4%253D&md5=d5264a2213c19a8b33ca56305ac2a29c</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1002%2Fanie.200900929&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200900929%26sid%3Dliteratum%253Aachs%26aulast%3DSreeramulu%26aufirst%3DS.%26aulast%3DGande%26aufirst%3DS.%2BL.%26aulast%3DG%25C3%25B6bel%26aufirst%3DM.%26aulast%3DSchwalbe%26aufirst%3DH.%26atitle%3DMolecular%2520mechanism%2520of%2520inhibition%2520of%2520the%2520human%2520protein%2520complex%2520Hsp90-Cdc37%252C%2520a%2520kinome%2520chaperone-cochaperone%252C%2520by%2520Triterpene%2520Celastrol%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2009%26volume%3D48%26spage%3D5853%26epage%3D5855%26doi%3D10.1002%2Fanie.200900929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span> <span> </span><span class="NLM_article-title">A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">162</span>– <span class="NLM_lpage">170</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-07-0484</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.1158%2F1535-7163.MCT-07-0484" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=18202019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsVyhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=162-170&author=T.+Zhangauthor=A.+Hamzaauthor=X.+Caoauthor=B.+Wangauthor=S.+Yuauthor=C.+Zhanauthor=D.+Sun&title=A+novel+Hsp90+inhibitor+to+disrupt+Hsp90%2FCdc37+complex+against+pancreatic+cancer+cells&doi=10.1158%2F1535-7163.MCT-07-0484"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells</span></div><div class="casAuthors">Zhang, Tao; Hamza, Adel; Cao, Xianhua; Wang, Bing; Yu, Shuwen; Zhan, Chang-Guo; Sun, Duxin</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">162-170</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Pancreatic cancer is an aggressive disease with multiple biochem. and genetic alterations.  Thus, a single agent to hit one mol. target may not be sufficient to treat this disease.  The purpose of this study is to identify a novel Hsp90 inhibitor to disrupt protein-protein interactions of Hsp90 and its cochaperones for down-regulating many oncogenes simultaneously against pancreatic cancer cells.  Here, we reported that celastrol disrupted Hsp90-Cdc37 interaction in the superchaperone complex to exhibit antitumor activity in vitro and in vivo.  Mol. docking and mol. dynamic simulations showed that celastrol blocked the crit. interaction of Glu33 (Hsp90) and Arg167 (Cdc37).  Immunopptn. confirmed that celastrol (10 μmol/L) disrupted the Hsp90-Cdc37 interaction in the pancreatic cancer cell line Panc-1.  In contrast to classic Hsp90 inhibitor (geldanamycin), celastrol (0.1-100 μmol/L) did not interfere with ATP binding to Hsp90.  However, celastrol (1-5 μmol/L) induced Hsp90 client protein degrdn. (Cdk4 and Akt) by 70% to 80% and increased Hsp70 expression by 12-fold.  Celastrol induced apoptosis in vitro and significantly inhibited tumor growth in Panc-1 xenografts.  Moreover, celastrol (3 mg/kg) effectively suppressed tumor metastasis by more than 80% in RIP1-Tag2 transgenic mouse model with pancreatic islet cell carcinogenesis.  The data suggest that celastrol is a novel Hsp90 inhibitor to disrupt Hsp90-Cdc37 interaction against pancreatic cancer cells. [Mol Cancer Ther 2008;7(1):162-70].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYaUNr9Bi1cbVg90H21EOLACvtfcHk0ljeFJa2-gNu5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsVyhtQ%253D%253D&md5=2af27701d6ccd4397c7a7486d1335730</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-07-0484&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-07-0484%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DHamza%26aufirst%3DA.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DZhan%26aufirst%3DC.%26aulast%3DSun%26aufirst%3DD.%26atitle%3DA%2520novel%2520Hsp90%2520inhibitor%2520to%2520disrupt%2520Hsp90%252FCdc37%2520complex%2520against%2520pancreatic%2520cancer%2520cells%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D162%26epage%3D170%26doi%3D10.1158%2F1535-7163.MCT-07-0484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sreeramulu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonker, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lancaster, C. R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwalbe, H.</span></span> <span> </span><span class="NLM_article-title">The human Cdc37-Hsp90 complex studied by NMR</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">3885</span>– <span class="NLM_lpage">3896</span>, <span class="refDoi"> DOI: 10.1074/jbc.M806715200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.1074%2Fjbc.M806715200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=19073599" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Oru7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=3885-3896&author=S.+Sreeramuluauthor=H.+R.+Jonkerauthor=T.+Langerauthor=C.+Richterauthor=C.+R.+D.+Lancasterauthor=H.+Schwalbe&title=The+human+Cdc37-Hsp90+complex+studied+by+NMR&doi=10.1074%2Fjbc.M806715200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The Human Cdc37·Hsp90 Complex Studied by Heteronuclear NMR Spectroscopy</span></div><div class="casAuthors">Sreeramulu, Sridhar; Jonker, Hendrik R. A.; Langer, Thomas; Richter, Christian; Lancaster, C. Roy D.; Schwalbe, Harald</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3885-3896</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The cell division cycle protein 37 (Cdc37) and the 90-kDa heat shock protein (Hsp90) are mol. chaperones, which are crucial elements in the protein signaling pathway.  The largest class of client proteins for Cdc37 and Hsp90 are protein kinases.  The catalytic domains of these kinases are stabilized by Cdc37, and their proper folding and functioning is dependent on Hsp90.  Here, we present the x-ray crystal structure of the 16-kDa middle domain of human Cdc37 at 1.88 Å resoln. and the structure of this domain in complex with the 23-kDa N-terminal domain of human Hsp90 based on heteronuclear soln. state NMR data and docking.  Our results demonstrate that the middle domain of Cdc37 exists as a monomer.  NMR and mutagenesis expts. reveal Leu-205 in Cdc37 as a key residue enabling complex formation.  These findings can be very useful in the development of small mol. inhibitors against cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0h2OpThcpv7Vg90H21EOLACvtfcHk0ljeFJa2-gNu5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Oru7g%253D&md5=aa7c4ab0d6585cd00dedca91c37372ea</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M806715200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M806715200%26sid%3Dliteratum%253Aachs%26aulast%3DSreeramulu%26aufirst%3DS.%26aulast%3DJonker%26aufirst%3DH.%2BR.%26aulast%3DLanger%26aufirst%3DT.%26aulast%3DRichter%26aufirst%3DC.%26aulast%3DLancaster%26aufirst%3DC.%2BR.%2BD.%26aulast%3DSchwalbe%26aufirst%3DH.%26atitle%3DThe%2520human%2520Cdc37-Hsp90%2520complex%2520studied%2520by%2520NMR%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D3885%26epage%3D3896%26doi%3D10.1074%2Fjbc.M806715200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and antitumor evaluation of novel celastrol derivatives</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>174</i></span>,  <span class="NLM_fpage">265</span>– <span class="NLM_lpage">276</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.04.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.1016%2Fj.ejmech.2019.04.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=31051401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADC%252BC1MXovVOhurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=174&publication_year=2019&pages=265-276&author=M.+Xuauthor=N.+Liauthor=Z.+Zhaoauthor=Z.+Shiauthor=J.+Sunauthor=L.+Chen&title=Design%2C+synthesis+and+antitumor+evaluation+of+novel+celastrol+derivatives&doi=10.1016%2Fj.ejmech.2019.04.050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and antitumor evaluation of novel celastrol derivatives</span></div><div class="casAuthors">Xu, Manyi; Li, Na; Zhao, Zihao; Shi, Zhixian; Sun, Jianbo; Chen, Li</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">174</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">265-276</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">On the basis of the hybridization strategy of natural products, a total of 32 novel celastrol hybrids, I [X = (CH2)3, (CH2)2, (CH2)4, trans-CH2CH:CHCH2, R1, R2 = H, Me, OMe, F, R3 = H, MeO, R4 = CN, H] and II [R5 = H, MeO, R6 = CN, H], were designed, synthesized and evaluated for their antitumor activities.  Most of these derivs. exhibited significant antiproliferative activities compared to celastrol, among which compd. II [X = (CH2)2, R5 = MeO, R6 = H] (III) displayed the strongest inhibitory capability [IC50 = 0.15 ± 0.03 μM (A549), 0.17 ± 0.03 μM (MCF-7), 0.26 ± 0.02 μM (HepG2)], which exhibited equal or superior anti-cancer activities in comparison to 2-cyano-3,12-dioxoolean-1,9(11)-dien-28-oic acid Me ester (CDDO-Me).  The mechanism of pharmacol. activity indicated that III possessed the ability to disrupt Hsp90-Cdc37 complex, which was stronger than celastrol.  Meanwhile, compd. III could induce abnormal regulation of clients (p-Akt and Cdk4) of Hsp90 and cell cycle arrest at G0/G1 phase in a concn.-dependent manner.  In addn., compd. III could also induce cell apoptosis through the death receptor pathway on A549 cells.  Taken together, our results demonstrated that III might be a promising novel candidate for further drugability research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreDY1adjaE3LVg90H21EOLACvtfcHk0ljeFJa2-gNu5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXovVOhurk%253D&md5=3bb63a9f19a1c64d4ba20bb51eb6f9ee</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.04.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.04.050%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DShi%26aufirst%3DZ.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DL.%26atitle%3DDesign%252C%2520synthesis%2520and%2520antitumor%2520evaluation%2520of%2520novel%2520celastrol%2520derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D174%26spage%3D265%26epage%3D276%26doi%3D10.1016%2Fj.ejmech.2019.04.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, Q. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X. L.</span></span> <span> </span><span class="NLM_article-title">Optimization and biological evaluation of celastrol derivatives as Hsp90-Cdc37 interaction disruptors with improved druglike properties</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">5431</span>– <span class="NLM_lpage">5439</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.08.070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.1016%2Fj.bmc.2016.08.070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=27647369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFamurrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=5431-5439&author=F.+Jiangauthor=H.+J.+Wangauthor=Q.+C.+Baoauthor=L.+Wangauthor=Y.+H.+Jinauthor=Q.+Zhangauthor=D.+Jiangauthor=Q.+D.+Youauthor=X.+L.+Xu&title=Optimization+and+biological+evaluation+of+celastrol+derivatives+as+Hsp90-Cdc37+interaction+disruptors+with+improved+druglike+properties&doi=10.1016%2Fj.bmc.2016.08.070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization and biological evaluation of celastrol derivatives as Hsp90-Cdc37 interaction disruptors with improved druglike properties</span></div><div class="casAuthors">Jiang, Fen; Wang, Hui-Jie; Bao, Qi-Chao; Wang, Lei; Jin, Yu-Hui; Zhang, Qiong; Jiang, Di; You, Qi-Dong; Xu, Xiao-Li</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5431-5439</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) as a mol. target for oncol. therapeutics has attracted much attention in the last decade.  The Hsp90 multichaperone complex has important roles in the growth and/or survival of cancer cells.  Cdc37, as a cochaperone, assocs. kinase clients to Hsp90 and promotes the development of malignant tumors.  Disrupting the Hsp90-Cdc37 interaction provides an alternative strategy to inhibit the function of Hsp90 for cancer therapy.  Celastrol, as a natural product, can disrupt the Hsp90-Cdc37 interaction and induce degrdn. of kinase clients.  The study conducted here attempted to elucidate the structure-activity relationship of celastrol derivs. as Hsp90-Cdc37 disruptors and to improve the druglike properties.  23 Celastrol derivs. were designed, synthesized, and the biol. activities and physicochem. properties were detd.  The deriv. CEL20 showed improved Hsp90-Cdc37 disruption activity, anti-proliferative activities as well as druglike properties.  Addnl., CEL20 induced clients degrdn., cell cycle arrest and apoptosis in Panc-1 cells.  This study can provide ref. for the discovery of novel Hsp90-Cdc37 disruptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzu8IFI5qzR7Vg90H21EOLACvtfcHk0ljeFJa2-gNu5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFamurrL&md5=94fadc51317b113c4e79fdb1e338c6ab</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.08.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.08.070%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DH.%2BJ.%26aulast%3DBao%26aufirst%3DQ.%2BC.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DJin%26aufirst%3DY.%2BH.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DJiang%26aufirst%3DD.%26aulast%3DYou%26aufirst%3DQ.%2BD.%26aulast%3DXu%26aufirst%3DX.%2BL.%26atitle%3DOptimization%2520and%2520biological%2520evaluation%2520of%2520celastrol%2520derivatives%2520as%2520Hsp90-Cdc37%2520interaction%2520disruptors%2520with%2520improved%2520druglike%2520properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D5431%26epage%3D5439%26doi%3D10.1016%2Fj.bmc.2016.08.070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sayama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikubo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otani, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uwamizu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kishi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makide, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirokawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohwada, T.</span></span> <span> </span><span class="NLM_article-title">Probing the hydrophobic binding pocket of G-protein-coupled lysophosphatidylserine receptor GPR34/LPS1 by docking-aided structure-activity analysis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">6384</span>– <span class="NLM_lpage">6399</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00693</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00693" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFOitr3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=6384-6399&author=M.+Sayamaauthor=A.+Inoueauthor=S.+Nakamuraauthor=S.+Jungauthor=M.+Ikuboauthor=Y.+Otaniauthor=A.+Uwamizuauthor=T.+Kishiauthor=K.+Makideauthor=J.+Aokiauthor=T.+Hirokawaauthor=T.+Ohwada&title=Probing+the+hydrophobic+binding+pocket+of+G-protein-coupled+lysophosphatidylserine+receptor+GPR34%2FLPS1+by+docking-aided+structure-activity+analysis&doi=10.1021%2Facs.jmedchem.7b00693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Probing the Hydrophobic Binding Pocket of G-Protein-Coupled Lysophosphatidylserine Receptor GPR34/LPS1 by Docking-Aided Structure-Activity Analysis</span></div><div class="casAuthors">Sayama, Misa; Inoue, Asuka; Nakamura, Sho; Jung, Sejin; Ikubo, Masaya; Otani, Yuko; Uwamizu, Akiharu; Kishi, Takayuki; Makide, Kumiko; Aoki, Junken; Hirokawa, Takatsugu; Ohwada, Tomohiko</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6384-6399</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The ligands of certain G-protein-coupled receptors (GPCRs) have been identified as endogenous lipids, such as lysophosphatidylserine (LysoPS).  Here, the authors analyzed the mol. basis of the structure-activity relationship of ligands of GPR34, one of the LysoPS receptor subtypes, focusing on recognition of the long-chain fatty acid moiety by the hydrophobic pocket.  By introducing benzene ring(s) into the fatty acid moiety of 2-deoxy-LysoPS, the authors explored the binding site's preference for the hydrophobic shape.  A tribenzene-contg. fatty acid surrogate with modifications of the terminal arom. moiety showed potent agonistic activity toward GPR34.  Computational docking of these derivs. with a homol. modeling/mol. dynamics-based virtual binding site of GPR34 indicated that a kink in the benzene-based lipid surrogates matches the L-shaped hydrophobic pocket of GPR34.  A tetrabenzene-based lipid analog bearing a bulky tert-Bu group at the 4-position of the terminal benzene ring exhibited potent GPR34 agonistic activity, validating the present hydrophobic binding pocket model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyzugwFt3kErVg90H21EOLACvtfcHk0ljCoUtsQnNV7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFOitr3L&md5=4ac2932dfe0071b589cbea4e028c1641</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00693%26sid%3Dliteratum%253Aachs%26aulast%3DSayama%26aufirst%3DM.%26aulast%3DInoue%26aufirst%3DA.%26aulast%3DNakamura%26aufirst%3DS.%26aulast%3DJung%26aufirst%3DS.%26aulast%3DIkubo%26aufirst%3DM.%26aulast%3DOtani%26aufirst%3DY.%26aulast%3DUwamizu%26aufirst%3DA.%26aulast%3DKishi%26aufirst%3DT.%26aulast%3DMakide%26aufirst%3DK.%26aulast%3DAoki%26aufirst%3DJ.%26aulast%3DHirokawa%26aufirst%3DT.%26aulast%3DOhwada%26aufirst%3DT.%26atitle%3DProbing%2520the%2520hydrophobic%2520binding%2520pocket%2520of%2520G-protein-coupled%2520lysophosphatidylserine%2520receptor%2520GPR34%252FLPS1%2520by%2520docking-aided%2520structure-activity%2520analysis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D6384%26epage%3D6399%26doi%3D10.1021%2Facs.jmedchem.7b00693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giroud, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haap, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapp, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweizer, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schirmeister, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diederich, F.</span></span> <span> </span><span class="NLM_article-title">Fluorine scan of inhibitors of the cysteine protease human cathepsin L: dipolar and quadrupolar effects in the π-stacking of fluorinated phenyl rings on peptide amide bonds</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1042</span>– <span class="NLM_lpage">1047</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201600132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.1002%2Fcmdc.201600132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=27095165" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtlSit7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=1042-1047&author=M.+Giroudauthor=M.+Harderauthor=B.+Kuhnauthor=W.+Haapauthor=N.+Trappauthor=W.+B.+Schweizerauthor=T.+Schirmeisterauthor=F.+Diederich&title=Fluorine+scan+of+inhibitors+of+the+cysteine+protease+human+cathepsin+L%3A+dipolar+and+quadrupolar+effects+in+the+%CF%80-stacking+of+fluorinated+phenyl+rings+on+peptide+amide+bonds&doi=10.1002%2Fcmdc.201600132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine Scan of Inhibitors of the Cysteine Protease Human Cathepsin L: Dipolar and Quadrupolar Effects in the π-Stacking of Fluorinated Phenyl Rings on Peptide Amide Bonds</span></div><div class="casAuthors">Giroud, Maude; Harder, Michael; Kuhn, Bernd; Haap, Wolfgang; Trapp, Nils; Schweizer, W. Bernd; Schirmeister, Tanja; Diederich, Francois</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1042-1047</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The π-stacking of fluorinated benzene rings on protein backbone amide groups was investigated, using a dual approach comprising enzyme-ligand binding studies complemented by high-level quantum chem. calcns.  In the exptl. study, the Ph substituent of triazine nitrile inhibitors of human cathepsin L (hCatL), which stacks onto the peptide amide bond Gly67-Gly68 at the entrance of the S3 pocket, was systematically fluorinated, and differences in inhibitory potency were measured in a fluorimetric assay.  Binding affinity is influenced by lipophilicity (clog P), the dipole and quadrupole moments of the fluorinated rings, but also by addnl. interactions of the introduced fluorine atoms with the local environment of the pocket.  Generally, the higher the degree of fluorination, the better the binding affinities.  Gas phase calcns. strongly support the contributions of the mol. quadrupole moments of the fluorinated Ph rings to the π-stacking interaction with the peptide bond.  These findings provide useful guidelines for enhancing π-stacking on protein amide fragments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpc4SJd8KW76LVg90H21EOLACvtfcHk0liVhM6PhFGCTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtlSit7o%253D&md5=298c19d0abfdee7fa7c9593b21da62f0</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201600132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201600132%26sid%3Dliteratum%253Aachs%26aulast%3DGiroud%26aufirst%3DM.%26aulast%3DHarder%26aufirst%3DM.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DHaap%26aufirst%3DW.%26aulast%3DTrapp%26aufirst%3DN.%26aulast%3DSchweizer%26aufirst%3DW.%2BB.%26aulast%3DSchirmeister%26aufirst%3DT.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DFluorine%2520scan%2520of%2520inhibitors%2520of%2520the%2520cysteine%2520protease%2520human%2520cathepsin%2520L%253A%2520dipolar%2520and%2520quadrupolar%2520effects%2520in%2520the%2520%25CF%2580-stacking%2520of%2520fluorinated%2520phenyl%2520rings%2520on%2520peptide%2520amide%2520bonds%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D1042%26epage%3D1047%26doi%3D10.1002%2Fcmdc.201600132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baltas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedos-Belval, F.</span></span> <span> </span><span class="NLM_article-title">Cinnamic acid derivatives as anticancer agents</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1672</span>– <span class="NLM_lpage">1703</span>, <span class="refDoi"> DOI: 10.2174/092986711795471347</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.2174%2F092986711795471347" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=21434850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpslOiu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=1672-1703&author=P.+Deauthor=M.+Baltasauthor=F.+Bedos-Belval&title=Cinnamic+acid+derivatives+as+anticancer+agents&doi=10.2174%2F092986711795471347"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Cinnamic acid derivatives as anticancer agents-A review</span></div><div class="casAuthors">De, P.; Baltas, M.; Bedos-Belval, F.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1672-1703</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Cinnamic acid and its phenolic analogs are natural substances.  Chem., in cinnamic acids the 3-Ph acrylic acid functionality offers three main reactive sites; substitution at the Ph ring, addn. at the α,β- unsatn. and the reactions of the carboxylic acid functionality.  Owing to these chem. aspects cinnamic acid derivs. received much attention in medicinal research as traditional as well as recent synthetic antitumor agents.  We obsd. that in spite of their rich medicinal tradition, cinnamic acid derivs. and their anticancer potentials remained underutilized for several decades since the first published clin. use in 1905.  In last two decades, there has been huge attention towards various cinnamoyl derivs. and their antitumor efficacy.  This review provides a comprehensive and unprecedented literature compilation concerning the synthesis and biol. evaluation of various cinnamoyl acids, esters, amides, hydrazides and related derivs. in anticancer research.  We envisage that our effort in this review contributes a much needed and timely addn. to the literature of medicinal research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofVNxBeUgmSbVg90H21EOLACvtfcHk0liVhM6PhFGCTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpslOiu7g%253D&md5=cf3c672b3ca0e9fa010877c8de234a34</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.2174%2F092986711795471347&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711795471347%26sid%3Dliteratum%253Aachs%26aulast%3DDe%26aufirst%3DP.%26aulast%3DBaltas%26aufirst%3DM.%26aulast%3DBedos-Belval%26aufirst%3DF.%26atitle%3DCinnamic%2520acid%2520derivatives%2520as%2520anticancer%2520agents%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D1672%26epage%3D1703%26doi%3D10.2174%2F092986711795471347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pei, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ju, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, G.</span></span> <span> </span><span class="NLM_article-title">Synthesis and in vitro and in vivo antitumour activity study of 11-hydroxyl esterified bergenin/cinnamic acid hybrids</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">319</span>– <span class="NLM_lpage">328</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.03.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.1016%2Fj.ejmech.2017.03.053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=28395218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlvVCru70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2017&pages=319-328&author=C.+Liangauthor=S.+Peiauthor=W.+Juauthor=M.+Jiaauthor=D.+Tianauthor=Y.+Tangauthor=G.+Mao&title=Synthesis+and+in+vitro+and+in+vivo+antitumour+activity+study+of+11-hydroxyl+esterified+bergenin%2Fcinnamic+acid+hybrids&doi=10.1016%2Fj.ejmech.2017.03.053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and in vitro and in vivo antitumour activity study of 11-hydroxyl esterified bergenin/cinnamic acid hybrids</span></div><div class="casAuthors">Liang, Chengyuan; Pei, Shaomeng; Ju, Weihui; Jia, Minyi; Tian, Danni; Tang, Yonghong; Mao, Gennian</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">319-328</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Fourteen bergenin/cinnamic acid hybrids were synthesized, characterized and evaluated for their antitumor activity both in vitro and in vivo.  The most potent compd., I, arrested HepG2 cells (IC50 = 4.23 ± 0.79 μM) in the G2/M phase and induced cellular apoptosis.  Moreover, compd. I was also found to suppress the tumor growth in Heps xenograft-bearing mice with low toxicity.  In the mechanistic study, I administration ignited a mitochondria-mediated apoptosis pathway of HepG2 cell death.  Furthermore, I activated Akt-dependent pathways and further decreased the expression of the Bcl-2 family of proteins.  The downstream mitochondrial p53 translocation was also significantly activated, accompanied by an increase of the caspase-9, caspase-3 activation.  These data imply that bergenin/cinnamic acid hybrids could serve as novel Akt/Bcl-2 inhibitors for further preclin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3PR_1QN59sLVg90H21EOLACvtfcHk0liVhM6PhFGCTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlvVCru70%253D&md5=00f5f214ba4d86f654dc9b9942d64cfb</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.03.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.03.053%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DC.%26aulast%3DPei%26aufirst%3DS.%26aulast%3DJu%26aufirst%3DW.%26aulast%3DJia%26aufirst%3DM.%26aulast%3DTian%26aufirst%3DD.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DMao%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520in%2520vitro%2520and%2520in%2520vivo%2520antitumour%2520activity%2520study%2520of%252011-hydroxyl%2520esterified%2520bergenin%252Fcinnamic%2520acid%2520hybrids%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D133%26spage%3D319%26epage%3D328%26doi%3D10.1016%2Fj.ejmech.2017.03.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, B. Y.</span></span> <span> </span><span class="NLM_article-title">Synthesis and in vitro antitumor evaluation of dihydroartemisinin-cinnamic acid ester derivatives</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">192</span>– <span class="NLM_lpage">203</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.11.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.1016%2Fj.ejmech.2015.11.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=26595184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVKqt7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2016&pages=192-203&author=C.+C.+Xuauthor=T.+Dengauthor=M.+L.+Fanauthor=W.+B.+Lvauthor=J.+H.+Liuauthor=B.+Y.+Yu&title=Synthesis+and+in+vitro+antitumor+evaluation+of+dihydroartemisinin-cinnamic+acid+ester+derivatives&doi=10.1016%2Fj.ejmech.2015.11.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and in vitro antitumor evaluation of dihydroartemisinin-cinnamic acid ester derivatives</span></div><div class="casAuthors">Xu, Cang-Cang; Deng, Ting; Fan, Meng-Lin; Lv, Wen-Bo; Liu, Ji-Hua; Yu, Bo-Yang</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">192-203</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">To explore novel high efficiency and low toxicity antitumor agents, a series of dihydroartemisinin-cinnamic acid ester derivs. modified on C-12 and/or C-9 position (s) were synthesized and the in vitro antitumor activities against PC-3, SGC-7901, A549 and MDA-MB-435s cancer cell lines were assessed.  The hybrids were prepd. by esterification of 9α-hydroxy-dihydroartemisinin (9α-OH DHA), the biotransformation product of dihydroartemisinin (DHA), and cinnamic acid derivs.  Compd. I (IC50 = 0.20 μM) was the most potent anti-proliferative agent against the human lung carcinoma A549 cells, although it displayed low cytotoxicity on normal hepatic L-02 cells.  The mechanism of action of compd. I was further investigated by anal. of cell apoptosis and intracellular ROS generation.  The results indicated that both ROS and ferrous ion contributed to the compd. I-induced cell death.  Meanwhile, high intracellular ferrous ion and endogenous oxidative stress in A549 cells made them easier to suffer to compd. I-induced apoptosis.  Our promising findings indicated the compd. I could stand as drug candidate against lung cancer for further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOgW88VJiQOrVg90H21EOLACvtfcHk0liSvAFu1eziXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVKqt7jE&md5=0fbcfc286345226fca1f21bf8a7d80d9</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.11.003%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DC.%2BC.%26aulast%3DDeng%26aufirst%3DT.%26aulast%3DFan%26aufirst%3DM.%2BL.%26aulast%3DLv%26aufirst%3DW.%2BB.%26aulast%3DLiu%26aufirst%3DJ.%2BH.%26aulast%3DYu%26aufirst%3DB.%2BY.%26atitle%3DSynthesis%2520and%2520in%2520vitro%2520antitumor%2520evaluation%2520of%2520dihydroartemisinin-cinnamic%2520acid%2520ester%2520derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D107%26spage%3D192%26epage%3D203%26doi%3D10.1016%2Fj.ejmech.2015.11.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, H. M.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of the novel glycyrrhetinic acid-cinnamoyl hybrids as anti-tumor agents</span>. <i>Chem. Cent. J.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">11</span>, <span class="refDoi"> DOI: 10.1186/s13065-016-0222-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.1186%2Fs13065-016-0222-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=26966460" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2016&pages=11&author=W.+B.+Guoauthor=M.+M.+Yanauthor=B.+Xuauthor=F.+H.+Chuauthor=W.+Wangauthor=C.+Z.+Zhangauthor=X.+H.+Jiaauthor=Y.+T.+Hanauthor=H.+J.+Xiangauthor=Y.+Z.+Zhangauthor=P.+L.+Wangauthor=H.+M.+Lei&title=Design%2C+synthesis%2C+and+biological+evaluation+of+the+novel+glycyrrhetinic+acid-cinnamoyl+hybrids+as+anti-tumor+agents&doi=10.1186%2Fs13065-016-0222-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1186%2Fs13065-016-0222-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13065-016-0222-8%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DW.%2BB.%26aulast%3DYan%26aufirst%3DM.%2BM.%26aulast%3DXu%26aufirst%3DB.%26aulast%3DChu%26aufirst%3DF.%2BH.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DC.%2BZ.%26aulast%3DJia%26aufirst%3DX.%2BH.%26aulast%3DHan%26aufirst%3DY.%2BT.%26aulast%3DXiang%26aufirst%3DH.%2BJ.%26aulast%3DZhang%26aufirst%3DY.%2BZ.%26aulast%3DWang%26aufirst%3DP.%2BL.%26aulast%3DLei%26aufirst%3DH.%2BM.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520the%2520novel%2520glycyrrhetinic%2520acid-cinnamoyl%2520hybrids%2520as%2520anti-tumor%2520agents%26jtitle%3DChem.%2520Cent.%2520J.%26date%3D2016%26volume%3D10%26spage%3D11%26doi%3D10.1186%2Fs13065-016-0222-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, M. H.</span></span> <span> </span><span class="NLM_article-title">Advances in structural modifications of celastrol</span>. <i>ARKIVOC</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>I</i></span>,  <span class="NLM_fpage">172</span>– <span class="NLM_lpage">182</span>, <span class="refDoi"> DOI: 10.3998/ark.5550190.p009.540</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.3998%2Fark.5550190.p009.540" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=I&publication_year=2016&pages=172-182&author=X.+Caiauthor=J.+Jinauthor=M.+H.+He&title=Advances+in+structural+modifications+of+celastrol&doi=10.3998%2Fark.5550190.p009.540"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.3998%2Fark.5550190.p009.540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3998%252Fark.5550190.p009.540%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DX.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DM.%2BH.%26atitle%3DAdvances%2520in%2520structural%2520modifications%2520of%2520celastrol%26jtitle%3DARKIVOC%26date%3D2016%26volume%3DI%26spage%3D172%26epage%3D182%26doi%3D10.3998%2Fark.5550190.p009.540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, W.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of C(6)-modified celastrol derivatives as potential antitumor agents</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">10177</span>– <span class="NLM_lpage">10188</span>, <span class="refDoi"> DOI: 10.3390/molecules190710177</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.3390%2Fmolecules190710177" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=25025148" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1GjsbfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=10177-10188&author=K.+Tangauthor=Q.+Huangauthor=J.+Zengauthor=G.+Wuauthor=J.+Huangauthor=J.+Panauthor=W.+Lu&title=Design%2C+synthesis+and+biological+evaluation+of+C%286%29-modified+celastrol+derivatives+as+potential+antitumor+agents&doi=10.3390%2Fmolecules190710177"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of C(6)-modified celastrol derivatives as potential antitumor agents</span></div><div class="casAuthors">Tang, Kaiyong; Huang, Qingqing; Zeng, Jafeng; Wu, Guangming; Huang, Jinwen; Pan, Junfang; Lu, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">10177-10188, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">New six C6-celastrol derivs. were designed, synthesized, and evaluated for their in vitro cytotoxic activities against nine human cancer cell lines (BGC-823, H4, Bel7402, H522, Colo 205, HepG2 and MDA-MB-468).  The results showed that most of the compds. displayed potent inhibition against BGC823, H4, and Bel7402, with IC50s of 1.84-0.39 μM.  The best compd. NST001A was tested in an in vivo antitumor assay on nude mice bearing Colo 205 xenografts, and showed significant inhibition of tumor growth at low concns.  Therefore, celastrol C-6 derivs. are potential drug candidates for treating cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz9ZOksehXRrVg90H21EOLACvtfcHk0liSvAFu1eziXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1GjsbfO&md5=659c939499ed17b2333cec856073d023</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.3390%2Fmolecules190710177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules190710177%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DZeng%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DW.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520C%25286%2529-modified%2520celastrol%2520derivatives%2520as%2520potential%2520antitumor%2520agents%26jtitle%3DMolecules%26date%3D2014%26volume%3D19%26spage%3D10177%26epage%3D10188%26doi%3D10.3390%2Fmolecules190710177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klaić, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morimoto, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silverman, R. B.</span></span> <span> </span><span class="NLM_article-title">Celastrol analogues as inducers of the heat shock response. Design and synthesis of affinity probes for the identification of protein targets</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">928</span>– <span class="NLM_lpage">937</span>, <span class="refDoi"> DOI: 10.1021/cb200539u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb200539u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtFWhsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=928-937&author=L.+Klai%C4%87author=R.+I.+Morimotoauthor=R.+B.+Silverman&title=Celastrol+analogues+as+inducers+of+the+heat+shock+response.+Design+and+synthesis+of+affinity+probes+for+the+identification+of+protein+targets&doi=10.1021%2Fcb200539u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Celastrol Analogues as Inducers of the Heat Shock Response. Design and Synthesis of Affinity Probes for the Identification of Protein Targets</span></div><div class="casAuthors">Klaic, Lada; Morimoto, Richard I.; Silverman, Richard B.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">928-937</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The natural product celastrol (1) possesses numerous beneficial therapeutic properties and affects numerous cellular pathways.  The mechanism of action and cellular target(s) of celastrol, however, remain unresolved.  While a no. of studies have proposed that the activity of celastrol is mediated through reaction with cysteine residues, these observations have been based on studies with specific proteins or by in vitro anal. of a small fraction of the proteome.  In this study, we have investigated the spatial and structural requirements of celastrol for the design of suitable affinity probes to identify cellular binding partners of celastrol.  Although celastrol has several potential sites for modification, some of these were not synthetically amenable or yielded unstable analogs.  Conversion of the carboxylic acid functionality to amides and long-chain analogs, however, yielded bioactive compds. that induced the heat shock response (HSR) and antioxidant response and inhibited Hsp90 activity.  This led to the synthesis of biotinylated celastrols (23 and 24) that were used as affinity reagents in exts. of human Panc-1 cells to identify Annexin II, eEF1A, and β-tubulin as potential targets of celastrol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhmezieJojibVg90H21EOLACvtfcHk0ligNl3e0NhJIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtFWhsL0%253D&md5=b9062d04520d880474c49e85f773e2f8</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fcb200539u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb200539u%26sid%3Dliteratum%253Aachs%26aulast%3DKlai%25C4%2587%26aufirst%3DL.%26aulast%3DMorimoto%26aufirst%3DR.%2BI.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DCelastrol%2520analogues%2520as%2520inducers%2520of%2520the%2520heat%2520shock%2520response.%2520Design%2520and%2520synthesis%2520of%2520affinity%2520probes%2520for%2520the%2520identification%2520of%2520protein%2520targets%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2012%26volume%3D7%26spage%3D928%26epage%3D937%26doi%3D10.1021%2Fcb200539u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, J. D.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of nitrate-oleanolic acid hybrids as inhibitors of HepG2 cell apoptosis</span>. <i>Yao Xue Xue Bao</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">1516</span>– <span class="NLM_lpage">1522</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=21351491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A280%3ADC%252BC3M3itFWrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=1516-1522&author=L.+Chenauthor=J.+Shangauthor=Z.+F.+Wangauthor=Y.+H.+Zhangauthor=J.+D.+Tian&title=Synthesis+and+biological+evaluation+of+nitrate-oleanolic+acid+hybrids+as+inhibitors+of+HepG2+cell+apoptosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of nitrate-oleanolic acid hybrids as inhibitors of HepG2 cell apoptosis</span></div><div class="casAuthors">Chen Li; Shang Juan; Wang Zhi-feng; Zhang Yi-hu; Tian Ji-de</div><div class="citationInfo"><span class="NLM_cas:title">Yao xue xue bao = Acta pharmaceutica Sinica</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1516-22</span>
        ISSN:<span class="NLM_cas:issn">0513-4870</span>.
    </div><div class="casAbstract">To find novel antihepatitis drugs, a series of nitrate-oleanolic acid (OA) hybrids (10a, 10b, 11a-11e and 12a-12c) were designed and synthesized on the basis of previous studies using OA as lead compound, which is widely found in natural plants and liver-specific metabolism.  In the present study, ten novel NO-releasing derivatives of OA were synthesized by connecting nitrate to the OA-3-OH through varying lengths of linkers containing antioxidants which were designed to increase the ability of these target compounds to scavenge free radicals.  The structures of these objective compounds were determined by IR, MS, 1H NMR and elemental analysis.  Their protective effects on anti-Fas mediated HepG2 cell apoptosis were in vitro evaluated by LDH assay.  Compound 12a is the most potent inhibitor.  Its effect on anti-Fas mediated HepG2 cell apoptosis and amount of NO-releasing in vitro are similar to those of positive control NCX-1000.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQuad1QAAjeCQvupmecNw_lfW6udTcc2ebgkKr3yoerIrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M3itFWrsA%253D%253D&md5=e490e67ef7cb6638dbbaf905a5545d89</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DShang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DZ.%2BF.%26aulast%3DZhang%26aufirst%3DY.%2BH.%26aulast%3DTian%26aufirst%3DJ.%2BD.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520nitrate-oleanolic%2520acid%2520hybrids%2520as%2520inhibitors%2520of%2520HepG2%2520cell%2520apoptosis%26jtitle%3DYao%2520Xue%2520Xue%2520Bao%26date%3D2010%26volume%3D45%26spage%3D1516%26epage%3D1522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, X. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of nitric oxide-releasing derivatives of oleanolic acid as inhibitors of HepG2 cell apoptosis</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">2979</span>– <span class="NLM_lpage">2982</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.03.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.1016%2Fj.bmcl.2007.03.068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=17446070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlt1KjtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=2979-2982&author=L.+Chenauthor=Y.+H.+Zhangauthor=X.+W.+Kongauthor=S.+X.+Pengauthor=J.+Tian&title=Synthesis+and+biological+evaluation+of+nitric+oxide-releasing+derivatives+of+oleanolic+acid+as+inhibitors+of+HepG2+cell+apoptosis&doi=10.1016%2Fj.bmcl.2007.03.068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of nitric oxide-releasing derivatives of oleanolic acid as inhibitors of HepG2 cell apoptosis</span></div><div class="casAuthors">Chen, Li; Zhang, Yihua; Kong, Xiangwen; Peng, Sixun; Tian, Jide</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2979-2982</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A total of 106 nitric oxide-releasing derivs. of oleanolic acid were synthesized and their effects on the inhibition of anti-Fas-mediated HepG2 cell apoptosis were evaluated in vitro.  Several compds. inhibited anti-Fas-mediated HepG2 cell apoptosis in a dose-dependent manner.  Within this series of compds., compd. I is the most potent inhibitor.  The development of new NO-releasing derivs. of oleanolic acid may aid in the design of NO-based medicines for the intervention of human liver inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqo719u5LGaV7Vg90H21EOLACvtfcHk0ligNl3e0NhJIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlt1KjtLc%253D&md5=f2659ed548578b2da8102e6e1567f875</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.03.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.03.068%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%2BH.%26aulast%3DKong%26aufirst%3DX.%2BW.%26aulast%3DPeng%26aufirst%3DS.%2BX.%26aulast%3DTian%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520nitric%2520oxide-releasing%2520derivatives%2520of%2520oleanolic%2520acid%2520as%2520inhibitors%2520of%2520HepG2%2520cell%2520apoptosis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D2979%26epage%3D2982%26doi%3D10.1016%2Fj.bmcl.2007.03.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tambe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blott, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fülöp, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flottmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bräse, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopf, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Junker, H. D.</span></span> <span> </span><span class="NLM_article-title">Structure-performance relationships of phenyl cinnamic acid derivatives as MALDI-MS matrices for sulfatide detection</span>. <i>Anal. Bioanal. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>409</i></span>,  <span class="NLM_fpage">1569</span>– <span class="NLM_lpage">1580</span>, <span class="refDoi"> DOI: 10.1007/s00216-016-0096-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.1007%2Fs00216-016-0096-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=27909779" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFylsr3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=409&publication_year=2017&pages=1569-1580&author=S.+Tambeauthor=H.+Blottauthor=A.+F%C3%BCl%C3%B6pauthor=N.+Spangauthor=D.+Flottmannauthor=S.+Br%C3%A4seauthor=C.+Hopfauthor=H.+D.+Junker&title=Structure-performance+relationships+of+phenyl+cinnamic+acid+derivatives+as+MALDI-MS+matrices+for+sulfatide+detection&doi=10.1007%2Fs00216-016-0096-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-performance relationships of phenyl cinnamic acid derivatives as MALDI-MS matrices for sulfatide detection</span></div><div class="casAuthors">Tambe, Suparna; Blott, Henning; Fueloep, Annabelle; Spang, Nils; Flottmann, Dirk; Braese, Stefan; Hopf, Carsten; Junker, Hans-Dieter</div><div class="citationInfo"><span class="NLM_cas:title">Analytical and Bioanalytical Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">409</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1569-1580</span>CODEN:
                <span class="NLM_cas:coden">ABCNBP</span>;
        ISSN:<span class="NLM_cas:issn">1618-2642</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A key aspect for the further development of matrix-assisted laser desorption ionization (MALDI)-mass spectrometry (MS) is a better understanding of the working principles of MALDI matrixes.  To address this issue, a chem. compd. library of 59 structurally related cinnamic acid derivs. was synthesized.  Potential MALDI matrixes were evaluated with sulfatides, a class of anionic lipids which are abundant in complex brain lipid mixts.  For each matrix relative mean S/N ratios of sulfatides were detd. against 9-aminoacridine as a ref. matrix using neg. ion mass spectrometry with 355 and 337 nm laser systems.  The comparison of matrix features with their corresponding relative mean S/N ratios for sulfatide detection identified correlations between matrix substitution patterns, their chem. functionality, and their MALDI-MS performance.  Crystal structures of six selected matrixes provided structural insight in hydrogen bond interactions in the solid state.  Principal component anal. allowed the addnl. identification of correlation trends between structural and phys. matrix properties like no. of exchangeable protons at the head group, MW, logP, UV-Vis, and sulfatide detection sensitivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplktpCW0ujeLVg90H21EOLACvtfcHk0ligNl3e0NhJIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFylsr3E&md5=4ff19671e771bf3ceb130d624b4276ad</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1007%2Fs00216-016-0096-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00216-016-0096-6%26sid%3Dliteratum%253Aachs%26aulast%3DTambe%26aufirst%3DS.%26aulast%3DBlott%26aufirst%3DH.%26aulast%3DF%25C3%25BCl%25C3%25B6p%26aufirst%3DA.%26aulast%3DSpang%26aufirst%3DN.%26aulast%3DFlottmann%26aufirst%3DD.%26aulast%3DBr%25C3%25A4se%26aufirst%3DS.%26aulast%3DHopf%26aufirst%3DC.%26aulast%3DJunker%26aufirst%3DH.%2BD.%26atitle%3DStructure-performance%2520relationships%2520of%2520phenyl%2520cinnamic%2520acid%2520derivatives%2520as%2520MALDI-MS%2520matrices%2520for%2520sulfatide%2520detection%26jtitle%3DAnal.%2520Bioanal.%2520Chem.%26date%3D2017%26volume%3D409%26spage%3D1569%26epage%3D1580%26doi%3D10.1007%2Fs00216-016-0096-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fryszkowska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardiner, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephens, G. M.</span></span> <span> </span><span class="NLM_article-title">A short, chemoenzymatic route to chiral β-aryl-γ-amino acids using reductases from anaerobic bacteria</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">533</span>– <span class="NLM_lpage">535</span>, <span class="refDoi"> DOI: 10.1039/B919526B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.1039%2FB919526B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=20090967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnsV2rtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&pages=533-535&author=A.+Fryszkowskaauthor=K.+Fisherauthor=J.+M.+Gardinerauthor=G.+M.+Stephens&title=A+short%2C+chemoenzymatic+route+to+chiral+%CE%B2-aryl-%CE%B3-amino+acids+using+reductases+from+anaerobic+bacteria&doi=10.1039%2FB919526B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">A short, chemoenzymatic route to chiral β-aryl-γ-amino acids using reductases from anaerobic bacteria</span></div><div class="casAuthors">Fryszkowska, Anna; Fisher, Karl; Gardiner, John M.; Stephens, Gill M.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">533-535</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A short chemoenzymic synthesis of β-aryl-γ-aminobutyric acids has been developed, based on a highly enantioselective biocatalytic redn. of β-aryl-β-cyano-α,β-unsatd. carboxylic acids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6Crc9njYSn7Vg90H21EOLACvtfcHk0lhfzbqqKZMXhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnsV2rtQ%253D%253D&md5=2b40a7f03a10d31b541581c1d042ec3d</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1039%2FB919526B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FB919526B%26sid%3Dliteratum%253Aachs%26aulast%3DFryszkowska%26aufirst%3DA.%26aulast%3DFisher%26aufirst%3DK.%26aulast%3DGardiner%26aufirst%3DJ.%2BM.%26aulast%3DStephens%26aufirst%3DG.%2BM.%26atitle%3DA%2520short%252C%2520chemoenzymatic%2520route%2520to%2520chiral%2520%25CE%25B2-aryl-%25CE%25B3-amino%2520acids%2520using%2520reductases%2520from%2520anaerobic%2520bacteria%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2010%26volume%3D8%26spage%3D533%26epage%3D535%26doi%3D10.1039%2FB919526B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyss, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pahl, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merfort, I.</span></span> <span> </span><span class="NLM_article-title">Helenanolide type sesquiterpene lactones. Part 5: the role of glutathione addition under physiological conditions</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">2849</span>– <span class="NLM_lpage">2855</span>, <span class="refDoi"> DOI: 10.1016/S0968-0896(99)00234-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.1016%2FS0968-0896%2899%2900234-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10658589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADC%252BD3cXntFCgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1999&pages=2849-2855&author=T.+J.+Schmidtauthor=G.+Lyssauthor=H.+L.+Pahlauthor=I.+Merfort&title=Helenanolide+type+sesquiterpene+lactones.+Part+5%3A+the+role+of+glutathione+addition+under+physiological+conditions&doi=10.1016%2FS0968-0896%2899%2900234-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Helenanolide type sesquiterpene lactones. Part 5: The role of glutathione addition under physiological conditions</span></div><div class="casAuthors">Schmidt, Thomas J.; Lyss, Guido; Pahl, Heike L.; Merfort, Irmgard</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2849-2855</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Sesquiterpene lactones (STLs) are known to exert most of their numerous biol. activities through inhibition of enzymes and other functional proteins by forming covalent bonds with free cysteine residues in these macromols.  The question arises how these drugs can alkylate such vital target structures instead of being quickly deactivated by reaction with the cysteine group of glutathione (GSH) which is present in high concns. in all cells.  The authors have measured in this study the pH dependent kinetics of GSH addn. to the cyclopentenone and α-methylene-γ-lactone group of helenanolide type sesquiterpene lactones using UV-spectrophotometry.  The reaction with GSH at physiol. pH proceeds very quickly but is reversible so that a fraction of STL mols. will always be available for reaction with protein targets.  In agreement with these chem. data, helenalin-mono- and -bis-glutathionyl adducts were demonstrated to inhibit the nuclear transcription factor NF-κB at concns. similar to the free sesquiterpene lactone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqkVtGdFq5Y7Vg90H21EOLACvtfcHk0lhfzbqqKZMXhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXntFCgtA%253D%253D&md5=773a60cca35a2e3238602eb7885cd9d0</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2FS0968-0896%2899%2900234-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0896%252899%252900234-5%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DT.%2BJ.%26aulast%3DLyss%26aufirst%3DG.%26aulast%3DPahl%26aufirst%3DH.%2BL.%26aulast%3DMerfort%26aufirst%3DI.%26atitle%3DHelenanolide%2520type%2520sesquiterpene%2520lactones.%2520Part%25205%253A%2520the%2520role%2520of%2520glutathione%2520addition%2520under%2520physiological%2520conditions%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D1999%26volume%3D7%26spage%3D2849%26epage%3D2855%26doi%3D10.1016%2FS0968-0896%2899%2900234-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span> <span> </span><span class="NLM_article-title">New developments in Hsp90 inhibitors as anti-cancer therapeutics: mechanisms, clinical perspective and more potential</span>. <i>Drug Resist. Updates</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">17</span>– <span class="NLM_lpage">27</span>, <span class="refDoi"> DOI: 10.1016/j.drup.2008.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.1016%2Fj.drup.2008.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=19179103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A280%3ADC%252BD1M3jvV2mtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2009&pages=17-27&author=Y.+Liauthor=T.+Zhangauthor=S.+J.+Schwartzauthor=D.+Sun&title=New+developments+in+Hsp90+inhibitors+as+anti-cancer+therapeutics%3A+mechanisms%2C+clinical+perspective+and+more+potential&doi=10.1016%2Fj.drup.2008.12.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">New developments in Hsp90 inhibitors as anti-cancer therapeutics: mechanisms, clinical perspective and more potential</span></div><div class="casAuthors">Li Yanyan; Zhang Tao; Schwartz Steven J; Sun Duxin</div><div class="citationInfo"><span class="NLM_cas:title">Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">17-27</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The molecular chaperone Hsp90 (heat shock protein 90) is a promising target in cancer therapy.  Preclinical and clinical evaluations of a variety of Hsp90 inhibitors have shown anti-tumor effect as a single agent and in combination with chemotherapy.  Current Hsp90 inhibitors are categorized into several classes based on distinct modes of inhibition, including (i) blockade of ATP binding, (ii) disruption of co-chaperone/Hsp90 interactions, (iii) antagonism of client/Hsp90 associations and (iv) interference with post-translational modifications of Hsp90.  The different functions of Hsp90 isoforms and the isoform selectivity of drugs need further investigation.  The correlation of cell surface Hsp90 with cancer metastasis and the emerging involvement of Hsp90 inhibition in cancer stem cells have become exciting areas that could be exploited.  Therefore, the aim of this review is (1) to summarize the up-to-date knowledge of mechanistic studies and clinical prospect of currently available Hsp90 inhibitors, (2) to enhance our perspectives for designing and discovering novel Hsp90 inhibitors, and (3) to provide an insight into less-understood potential of Hsp90 inhibition in cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ5kNKTb14uEhcr74wzj5o5fW6udTcc2eYr3J1bU9bdrbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M3jvV2mtg%253D%253D&md5=4d848faff412f714fb669add9d0cc4c7</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.drup.2008.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drup.2008.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DSchwartz%26aufirst%3DS.%2BJ.%26aulast%3DSun%26aufirst%3DD.%26atitle%3DNew%2520developments%2520in%2520Hsp90%2520inhibitors%2520as%2520anti-cancer%2520therapeutics%253A%2520mechanisms%252C%2520clinical%2520perspective%2520and%2520more%2520potential%26jtitle%3DDrug%2520Resist.%2520Updates%26date%3D2009%26volume%3D12%26spage%3D17%26epage%3D27%26doi%3D10.1016%2Fj.drup.2008.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grenert, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fadden, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haystead, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mimnaugh, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krutzsch, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochel, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulte, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sausville, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neckers, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toft, D. O.</span></span> <span> </span><span class="NLM_article-title">The amino-terminal domain of heat shock protein 90 (hsp90) that binds GA is an ATP/ADP switch domain that regulates hsp90 conformation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>272</i></span>,  <span class="NLM_fpage">23843</span>– <span class="NLM_lpage">23850</span>, <span class="refDoi"> DOI: 10.1074/jbc.272.38.23843</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.1074%2Fjbc.272.38.23843" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=9295332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADyaK2sXmtlOhs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=23843-23850&author=J.+P.+Grenertauthor=W.+P.+Sullivanauthor=P.+Faddenauthor=T.+A.+Haysteadauthor=J.+Clarkauthor=E.+Mimnaughauthor=H.+Krutzschauthor=H.+J.+Ochelauthor=T.+W.+Schulteauthor=E.+Sausvilleauthor=L.+M.+Neckersauthor=D.+O.+Toft&title=The+amino-terminal+domain+of+heat+shock+protein+90+%28hsp90%29+that+binds+GA+is+an+ATP%2FADP+switch+domain+that+regulates+hsp90+conformation&doi=10.1074%2Fjbc.272.38.23843"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The amino-terminal domain of heat shock protein 90 (hsp90) that binds geldanamycin is an ATP/ADP switch domain that regulates hsp90 conformation</span></div><div class="casAuthors">Grenert, James P.; Sullivan, William P.; Fadden, Patrick; Haystead, Timothy A. J.; Clark, Jenny; Mimnaugh, Edward; Krutzsch, Henry; Ochel, Hans-Joachim; Schulte, Theodor W.; Sausville, Edward; Neckers, Leonard M.; Toft, David O.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">272</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">23843-23850</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Many functions of the chaperone, heat shock protein 90 (hsp90), are inhibited by the drug geldanamycin that specifically binds hsp90.  We have studied an amino-terminal domain of hsp90 whose crystal structure has recently been solved and detd. to contain a geldanamycin-binding site.  We demonstrate that, in soln., drug binding is exclusive to this domain.  This domain also binds ATP linked to Sepharose through the γ-phosphate.  Binding is specific for ATP and ADP and is inhibited by geldanamycin.  Mutation of four glycine residues within two proposed ATP binding motifs diminishes both geldanamycin binding and the ATP-dependent conversion of hsp90 to a conformation capable of binding to co-chaperone p23.  Since p23 binding requires regions outside the 1-221 domain of hsp90, these results indicate a common site for nucleotides and geldanamycin that regulates the conformation of other hsp90 domains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGleeyqVA0kbVg90H21EOLACvtfcHk0lhH1m1TSqHMQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmtlOhs7w%253D&md5=bd742afe61df98e05096902b746d595f</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1074%2Fjbc.272.38.23843&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.272.38.23843%26sid%3Dliteratum%253Aachs%26aulast%3DGrenert%26aufirst%3DJ.%2BP.%26aulast%3DSullivan%26aufirst%3DW.%2BP.%26aulast%3DFadden%26aufirst%3DP.%26aulast%3DHaystead%26aufirst%3DT.%2BA.%26aulast%3DClark%26aufirst%3DJ.%26aulast%3DMimnaugh%26aufirst%3DE.%26aulast%3DKrutzsch%26aufirst%3DH.%26aulast%3DOchel%26aufirst%3DH.%2BJ.%26aulast%3DSchulte%26aufirst%3DT.%2BW.%26aulast%3DSausville%26aufirst%3DE.%26aulast%3DNeckers%26aufirst%3DL.%2BM.%26aulast%3DToft%26aufirst%3DD.%2BO.%26atitle%3DThe%2520amino-terminal%2520domain%2520of%2520heat%2520shock%2520protein%252090%2520%2528hsp90%2529%2520that%2520binds%2520GA%2520is%2520an%2520ATP%252FADP%2520switch%2520domain%2520that%2520regulates%2520hsp90%2520conformation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D23843%26epage%3D23850%26doi%3D10.1074%2Fjbc.272.38.23843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trott, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, A. J.</span></span> <span> </span><span class="NLM_article-title">AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">455</span>– <span class="NLM_lpage">461</span>, <span class="refDoi"> DOI: 10.1002/jcc.21334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.1002%2Fjcc.21334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=19499576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGnur3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=455-461&author=O.+Trottauthor=A.+J.+Olson&title=AutoDock+Vina%3A+improving+the+speed+and+accuracy+of+docking+with+a+new+scoring+function%2C+efficient+optimization+and+multithreading&doi=10.1002%2Fjcc.21334"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span></div><div class="casAuthors">Trott, Oleg; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">455-461</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">AutoDock Vina, a new program for mol. docking and virtual screening, is presented.  AutoDock Vina achieves an approx. 2 orders of magnitude speed-up compared with the mol. docking software previously developed in the authors' lab (AutoDock 4), while also significantly improving the accuracy of the binding mode predictions, judging by the authors' tests on the training set used in AutoDock 4 development.  Further speed-up is achieved from parallelism, by using multithreading on multicore machines.  AutoDock Vina automatically calcs. the grid maps and clusters the results in a way transparent to the user.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLecOIkUxIlrVg90H21EOLACvtfcHk0lhH1m1TSqHMQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGnur3O&md5=c6974af8a1235f7aa09918d3e6f70dc4</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21334%26sid%3Dliteratum%253Aachs%26aulast%3DTrott%26aufirst%3DO.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutoDock%2520Vina%253A%2520improving%2520the%2520speed%2520and%2520accuracy%2520of%2520docking%2520with%2520a%2520new%2520scoring%2520function%252C%2520efficient%2520optimization%2520and%2520multithreading%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2010%26volume%3D31%26spage%3D455%26epage%3D461%26doi%3D10.1002%2Fjcc.21334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 9 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Xiao-Long Hu, Qi-Wei He, Huan Long, Li-Xin Zhang, Rong Wang, Bao-Lin Wang, Jia-Hao Feng, Quan Wang, Ji-Qin Hou, Xiao-Qi Zhang, Wen-Cai Ye, <span class="NLM_string-name hlFld-ContribAuthor">Hao Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of Celastrol Derivatives with Improved Cytotoxic Selectivity and Antitumor Activities. </span><span class="cited-content_cbyCitation_journal-name">Journal of Natural Products</span><span> <strong>2021,</strong> <em>84 </em>
                                    (7)
                                     , 1954-1966. <a href="https://doi.org/10.1021/acs.jnatprod.1c00262" title="DOI URL">https://doi.org/10.1021/acs.jnatprod.1c00262</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jnatprod.1c00262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jnatprod.1c00262%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Natural%2520Products%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BCelastrol%252BDerivatives%252Bwith%252BImproved%252BCytotoxic%252BSelectivity%252Band%252BAntitumor%252BActivities%26aulast%3DHu%26aufirst%3DXiao-Long%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D19032021%26date%3D25062021%26volume%3D84%26issue%3D7%26spage%3D1954%26epage%3D1966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paolo  Coghi</span>, <span class="hlFld-ContribAuthor ">Jerome P.L.  Ng</span>, <span class="hlFld-ContribAuthor ">Onat  Kadioglu</span>, <span class="hlFld-ContribAuthor ">Betty Yuen Kwan  Law</span>, <span class="hlFld-ContribAuthor ">Alena Congling  Qiu</span>, <span class="hlFld-ContribAuthor ">Mohamed E.M.  Saeed</span>, <span class="hlFld-ContribAuthor ">Xi  Chen</span>, <span class="hlFld-ContribAuthor ">Chi Kio  Ip</span>, <span class="hlFld-ContribAuthor ">Thomas  Efferth</span>, <span class="hlFld-ContribAuthor ">Liang  Liu</span>, <span class="hlFld-ContribAuthor ">Vincent Kam Wai  Wong</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, computational docking and biological evaluation of celastrol derivatives as dual inhibitors of SERCA and P-glycoprotein in cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>224 </em>, 113676. <a href="https://doi.org/10.1016/j.ejmech.2021.113676" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113676</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113676&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113676%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252Bcomputational%252Bdocking%252Band%252Bbiological%252Bevaluation%252Bof%252Bcelastrol%252Bderivatives%252Bas%252Bdual%252Binhibitors%252Bof%252BSERCA%252Band%252BP-glycoprotein%252Bin%252Bcancer%252Btherapy%26aulast%3DCoghi%26aufirst%3DPaolo%26date%3D2021%26volume%3D224%26spage%3D113676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael A.  Serwetnyk</span>, <span class="hlFld-ContribAuthor ">Brian S.J.  Blagg</span>. </span><span class="cited-content_cbyCitation_article-title">The disruption of protein−protein interactions with co-chaperones and client substrates as a strategy towards Hsp90 inhibition. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2021,</strong> <em>11 </em>
                                    (6)
                                     , 1446-1468. <a href="https://doi.org/10.1016/j.apsb.2020.11.015" title="DOI URL">https://doi.org/10.1016/j.apsb.2020.11.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2020.11.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2020.11.015%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DThe%252Bdisruption%252Bof%252Bprotein%2525E2%252588%252592protein%252Binteractions%252Bwith%252Bco-chaperones%252Band%252Bclient%252Bsubstrates%252Bas%252Ba%252Bstrategy%252Btowards%252BHsp90%252Binhibition%26aulast%3DSerwetnyk%26aufirst%3DMichael%2BA.%26date%3D2021%26volume%3D11%26issue%3D6%26spage%3D1446%26epage%3D1468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Wang</span>, <span class="hlFld-ContribAuthor ">Qiuyue  Zhang</span>, <span class="hlFld-ContribAuthor ">Qidong  You</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the HSP90–CDC37–kinase chaperone cycle: A promising therapeutic strategy for cancer. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2021,</strong> <em>95 </em><a href="https://doi.org/10.1002/med.21807" title="DOI URL">https://doi.org/10.1002/med.21807</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21807%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DTargeting%252Bthe%252BHSP90%2525E2%252580%252593CDC37%2525E2%252580%252593kinase%252Bchaperone%252Bcycle%25253A%252BA%252Bpromising%252Btherapeutic%252Bstrategy%252Bfor%252Bcancer%26aulast%3DWang%26aufirst%3DLei%26date%3D2021%26date%3D2021%26volume%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yun  Lu</span>, <span class="hlFld-ContribAuthor ">Yuan  Liu</span>, <span class="hlFld-ContribAuthor ">Jiawei  Zhou</span>, <span class="hlFld-ContribAuthor ">Dan  Li</span>, <span class="hlFld-ContribAuthor ">Wei  Gao</span>. </span><span class="cited-content_cbyCitation_article-title">Biosynthesis, total synthesis, structural modifications, bioactivity, and mechanism of action of the quinone‐methide triterpenoid celastrol. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2021,</strong> <em>41 </em>
                                    (2)
                                     , 1022-1060. <a href="https://doi.org/10.1002/med.21751" title="DOI URL">https://doi.org/10.1002/med.21751</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21751%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DBiosynthesis%25252C%252Btotal%252Bsynthesis%25252C%252Bstructural%252Bmodifications%25252C%252Bbioactivity%25252C%252Band%252Bmechanism%252Bof%252Baction%252Bof%252Bthe%252Bquinone%2525E2%252580%252590methide%252Btriterpenoid%252Bcelastrol%26aulast%3DLu%26aufirst%3DYun%26date%3D2021%26date%3D2020%26volume%3D41%26issue%3D2%26spage%3D1022%26epage%3D1060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Na  Li</span>, <span class="hlFld-ContribAuthor ">Cheng  Chen</span>, <span class="hlFld-ContribAuthor ">Huiting  zhu</span>, <span class="hlFld-ContribAuthor ">Zhixian  Shi</span>, <span class="hlFld-ContribAuthor ">Jianbo  Sun</span>, <span class="hlFld-ContribAuthor ">Li  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel celastrol-triazole derivatives with Hsp90-Cdc37 disruption to induce tumor cell apoptosis. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em> </em>, 104867. <a href="https://doi.org/10.1016/j.bioorg.2021.104867" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.104867</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.104867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.104867%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252Bcelastrol-triazole%252Bderivatives%252Bwith%252BHsp90-Cdc37%252Bdisruption%252Bto%252Binduce%252Btumor%252Bcell%252Bapoptosis%26aulast%3DLi%26aufirst%3DNa%26date%3D2021%26spage%3D104867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiuyue  Zhang</span>, <span class="hlFld-ContribAuthor ">Xuexuan  Wu</span>, <span class="hlFld-ContribAuthor ">Jianrui  Zhou</span>, <span class="hlFld-ContribAuthor ">Lixiao  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaoli  Xu</span>, <span class="hlFld-ContribAuthor ">Lianshan  Zhang</span>, <span class="hlFld-ContribAuthor ">Qidong  You</span>, <span class="hlFld-ContribAuthor ">Lei  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and bioevaluation of inhibitors targeting HSP90-CDC37 protein-protein interaction based on a hydrophobic core. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>210 </em>, 112959. <a href="https://doi.org/10.1016/j.ejmech.2020.112959" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112959</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112959&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112959%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbioevaluation%252Bof%252Binhibitors%252Btargeting%252BHSP90-CDC37%252Bprotein-protein%252Binteraction%252Bbased%252Bon%252Ba%252Bhydrophobic%252Bcore%26aulast%3DZhang%26aufirst%3DQiuyue%26date%3D2021%26volume%3D210%26spage%3D112959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dong-Jun  Fu</span>, <span class="hlFld-ContribAuthor ">Yun-Feng  Zhang</span>, <span class="hlFld-ContribAuthor ">An-Qi  Chang</span>, <span class="hlFld-ContribAuthor ">Jun  Li</span>. </span><span class="cited-content_cbyCitation_article-title">β-Lactams as promising anticancer agents: Molecular hybrids, structure activity relationships and potential targets. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>201 </em>, 112510. <a href="https://doi.org/10.1016/j.ejmech.2020.112510" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112510</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112510%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3D%2525CE%2525B2-Lactams%252Bas%252Bpromising%252Banticancer%252Bagents%25253A%252BMolecular%252Bhybrids%25252C%252Bstructure%252Bactivity%252Brelationships%252Band%252Bpotential%252Btargets%26aulast%3DFu%26aufirst%3DDong-Jun%26date%3D2020%26volume%3D201%26spage%3D112510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rui  Liu</span>, <span class="hlFld-ContribAuthor ">Xiao-Lu  Lu</span>, <span class="hlFld-ContribAuthor ">Xian-Hua  Huang</span>, <span class="hlFld-ContribAuthor ">Wei  He</span>, <span class="hlFld-ContribAuthor ">Jing-Jing  Duan</span>, <span class="hlFld-ContribAuthor ">Jin  Zhang</span>, <span class="hlFld-ContribAuthor ">Jian  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Complex structure of human Hsp90N and a novel small inhibitor FS5. </span><span class="cited-content_cbyCitation_journal-name">Nuclear Science and Techniques</span><span> <strong>2020,</strong> <em>31 </em>
                                    (3)
                                     <a href="https://doi.org/10.1007/s41365-020-0739-3" title="DOI URL">https://doi.org/10.1007/s41365-020-0739-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s41365-020-0739-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs41365-020-0739-3%26sid%3Dliteratum%253Aachs%26jtitle%3DNuclear%2520Science%2520and%2520Techniques%26atitle%3DComplex%252Bstructure%252Bof%252Bhuman%252BHsp90N%252Band%252Ba%252Bnovel%252Bsmall%252Binhibitor%252BFS5%26aulast%3DLiu%26aufirst%3DRui%26date%3D2020%26date%3D2020%26volume%3D31%26issue%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/medium/jm9b01290_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01290&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/medium/jm9b01290_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0015.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01290&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Various bromohydrin, EDCI, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, rt, 7 h; (b) NH<sub>4</sub>OAc, tolune, 100 °C, reflux, 12 h; (c) CH<sub>3</sub>OH, K<sub>2</sub>CO<sub>3</sub>, 60 °C, reflux, 6 h; (d) bromohydrin, EDCI, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, rt, 7 h or trans-1,4-dibromo-2-butene, K<sub>2</sub>CO<sub>3</sub>, Bu<sub>4</sub>N<sup>+</sup>Br<sup>–</sup>, acetone, 50 °C, reflux,7 h; (e) celastrol, NaHCO<sub>3</sub>, DMF, 60 °C, 7 h.</p></p></figure><figure data-id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/medium/jm9b01290_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Comparison of inhibition rates of target compounds. (A) Inhibition rates of <b>1</b>–<b>45</b> and CEL at 1.5 μM in A549 cells. IR: inhibition rate. (B) Average inhibition rates of <b>31</b>–<b>45</b> classified by the different groups in benzene. (C) Inhibition rate of <b>31</b>–<b>45</b><sub>.</sub> (D) Inhibition rate of <b>1</b>–<b>45</b> classified by lengths of linker.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01290&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/medium/jm9b01290_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Effects of <b>41</b> on the level of Hsp90–Cdc37 complex in vitro. (A) Effects of <b>41</b> on the binding of ATP and Hsp90. Purified Hsp90α was pulled down by γ-phosphate-linked ATP-Sepharose in the presence of <b>41</b> or CEL. Hsp90α was detected by Western blot. (B) Effects of <b>41</b> on the amount of Cdc37 associated with Hsp90. A549 cells were treated with DMSO or <b>41</b> for 6 h. Cell lysates were immunoprecipitated by Hsp90α antibody. Western blot was done for detection of Hsp90 and Cdc37. (C) Quantitative analysis of co-immunoprecipitation. Data are expressed as the mean ± SD (<i>n</i> = 3). **<i>P</i> < 0.01 vs DMSO group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01290&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/medium/jm9b01290_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effects of <b>41</b> and CEL on Hsp90–Cdc37clients. A549 cells were treated with DMSO, <b>41</b>, and CEL for 12 h, and the relative levels of p-Akt and Cdk4 expression were determined by Western blot assays using Hsp90 as a control. Data are representative images and expressed as the means ± SD of each group of cells from three separate experiments. (A) Western blot analysis of the relative levels of p-AKT and Cdk4 expression. (B) Quantitative analysis. **<i>P</i> < 0.01 vs the DMSO group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01290&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/medium/jm9b01290_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0016.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01290&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 3-Bromo-1-propanol, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, overnight; (b) K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>OH, 70 °C, 6 h; (c) 1,3-dibromopropane, K<sub>2</sub>CO<sub>3,</sub> acetone, reflux, overnight; (D) biotin, DCC, DMAP, DMF, 30 °C, 24 h. (e) CEL, NaHCO<sub>3</sub>, DMF, 60 °C, 12 h.</p></p></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/medium/jm9b01290_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. <b>41-Bio</b> binds to Cdc37. The recombinant Cdc37 protein (5 mg) was incubated with different concentrations of <b>41</b> for 2 h before or after incubation with <b>41-Bio</b> (0.5 μM) for 2 h and then pulled down using streptavidin beads. The total proteins (input) and bound proteins (Bind P) were immunoblotted. Data are expressed as the mean ± SD (<i>n</i> = 3). **<i>P</i> < 0.01 vs <b>41</b> (0.5 μM) group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01290&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/medium/jm9b01290_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Overlay of <sup>1</sup>H NMR spectrum of <b>41</b> with and without <span class="smallcaps smallerCapital">dl</span>-dithiothreitol (DTT) in DMSO-<i>d</i><sub>6</sub>. <b>41</b> (0.02 mmol) and DTT (0.04 mmol) were dissolved in DMSO-<i>d</i><sub>6</sub>. Then the <sup>1</sup>H NMR spectrum of the mixture was detected after reaction in ultrasound for 20 min.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01290&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/medium/jm9b01290_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0006.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. UV spectrum of <b>41</b> monitored after addition of GSH, Cdc37, and Hsp90. <b>41</b> (100 μM) and GSH (100 μM) or Cdc37 (1.5 μM) or Hsp90 (1.5 μM) were dissolved in PBS (1% DMSO). Then the solution was incubated at 37 °C for 0, 5, 15, and 30 min. The UV spectrum of the solution (200–500 nm) was monitored. (A) The UV spectrum of <b>41</b> was monitored after incubation with GSH, Cdc37, and Hsp90. (B) Analysis of the UV assay. A0, absorbance of the solution at 440 nm with 0 min. A, absorbance of the solution at 440 nm with the corresponding time. Data are expressed as the mean ± SD (<i>n</i> = 3). **<i>P</i> < 0.01 vs 0 min group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01290&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/medium/jm9b01290_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0007.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Molecular docking of <b>41</b> to Hsp90<sub>N</sub>-Cdc37<sub>M</sub>. (A) Chemical structure of <b>41</b>. (B) Binding mode of <b>41</b> with the Hsp90<sub>N</sub>–Cdc37<sub>M</sub> complex (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2K5B">2K5B</a>). The complex is shown in a cartoon representation. The side chain R166 (yellow), R167 (green), and W168 (purple) of Cdc37<sub>M</sub> and <b>41</b> (gray) are shown in a stick type. The expected hydrogen bonds are indicated by the dashed yellow lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01290&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/medium/jm9b01290_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0008.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Antiproliferative activity of <b>41-H</b> in comparison with that of <b>41</b>, methyl thioglycolate, and the mixture of <b>41</b> and methyl thioglycolate in A549 cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01290&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/medium/jm9b01290_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0009.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Structure of Cdc37<sub>M</sub> (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2W0G">2W0G</a>). (A) Location of Cys183. (B) Location of Cys203.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01290&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/medium/jm9b01290_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0010.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Effects of <b>41</b> on clients of Hsp90–Cdc37 and apoptosis-related proteins in A549 cells. A549 cells were treated with DMSO or <b>41</b> for 12 h, and the relative levels of Hsp90, p-AKT, Cdk4, Bcl-2, Bax and Caspase-3 expression were determined by Western blot assays using β-actin as a control. Data are representative images and expressed as the means ± SD of each group of cells from three separate experiments. (A) Western blot analysis of the relative levels of Hsp90, p-Akt, Cdk4, Bcl-2, Bax and Caspase-3 expression. (B) Quantitative analysis. *<i>P</i> < 0.05, **<i>P</i> < 0.01, vs the DMSO-treated control group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01290&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/medium/jm9b01290_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0011.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Effects on Δψ<sub>m</sub> of <b>41</b> in A549 cells. A549 cells were treated with DMSO or <b>41</b> for 24 h and then analyzed by fluorescence microscopy and flow cytometry after JC-1 staining. (A) Flow cytometry analysis of A549 cells treated with DMSO and <b>41</b>. (B) Quantification of cells (%) with red and green aggregates. The values are presented as mean ± SD (<i>n</i> = 3). **<i>P</i> < 0.01 vs the DMSO group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01290&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/medium/jm9b01290_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0012.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Morphological apoptosis induced by <b>41</b> in A549 cells. A549 cells were treated with <b>41</b> or DMSO for 48 h. Fluorescence microscopy images of A549 cells stained by Hoechst 33342 and PI. The apoptotic cells were stained by Hoechst 33342 in bright blue, and the dead cells were stained by PI in red.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01290&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/medium/jm9b01290_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0013.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Apoptotic effects of <b>41</b> and CEL in A549 cells. After treatment with DMSO, <b>41</b>, or CEL for 48 h, A549 cells were collected and stained with Annexin V/PI, followed by flow cytometric analysis. (A) Flow cytometry analysis of A549 cells treated with DMSO, <b>41</b>, and CEL. (B) Representative histograms for the numbers of living cells and apoptotic cells (%). The values are presented as mean ± SD (<i>n</i> = 3). **<i>P</i> < 0.05 vs the DMSO group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01290&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/medium/jm9b01290_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0014.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Effect of <b>41</b> on cell cycle progression of A549 cells. Treatment of A549 cells with DMSO and <b>41</b> (0.2, 0.4, and 0.8 μM) for 24 h, intracellular DNA was stained with PI. Cell cycle distribution was analyzed by flow cytometry. (A) Flow cytometry analysis of cell cycle distribution of <b>41</b> on A549. (B) Quantification of cells (%) in each cell phase. The values are presented as mean ± SD (<i>n</i> = 3). *<i>P</i> < 0.01, **<i>P</i> < 0.05 vs the DMSO group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01290/20191205/images/large/jm9b01290_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01290&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i99">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71378" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71378" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 31 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferrarini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heltai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zocchi, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rugarli, C.</span></span> <span> </span><span class="NLM_article-title">Unusual expression and localization of heat-shock proteins in human tumor cells</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">613</span>– <span class="NLM_lpage">619</span>, <span class="refDoi"> DOI: 10.1002/ijc.2910510418</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.1002%2Fijc.2910510418" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1601523" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADyaK38XlvV2hs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1992&pages=613-619&author=M.+Ferrariniauthor=S.+Heltaiauthor=M.+R.+Zocchiauthor=C.+Rugarli&title=Unusual+expression+and+localization+of+heat-shock+proteins+in+human+tumor+cells&doi=10.1002%2Fijc.2910510418"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Unusual expression and localization of heat-shock proteins in human tumor cells</span></div><div class="casAuthors">Ferrarini, Marina; Heltai, Silvia; Zocchi, M. Raffaella; Rugarli, Claudio</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">613-19</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    </div><div class="casAbstract">It has been suggested that members of HSP families represent the surface target of immune responses leading to tumor rejection in mice.  The authors report that tumor cells, compared with normal cells, constitutively expressed 2- to 10-fold higher levels of intracellular HSP90.  Moreover, in the absence of environmental stress, 2 lines (out of 6) expressed the "inducible" HSP72, which was also detectable in fresh tumor cells.  HSP72 expression was not regulated during the cell cycle, in contrast with what has been obsd. with normal cells.  Both HSP90 and HSP72 proteins exhibited a heterogeneous pattern of intracellular distribution in most cells, HSP72 being confined mainly to the nuclear compartment.  Finally, both HSP90 and, to a lesser extent, HSP72 (that are generally believed to be located intracellularly) were detected at the surface of some tumor cell lines.  It is concluded that tumor cells differ from normal cells in their pattern of HSP expression; this might imply a role of HSPs in eliciting an immune response against cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdlQHEKHA7jLVg90H21EOLACvtfcHk0lhVisr6_XpU9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XlvV2hs7s%253D&md5=4ace8651e9b125c68985102a0b3055f3</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1002%2Fijc.2910510418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.2910510418%26sid%3Dliteratum%253Aachs%26aulast%3DFerrarini%26aufirst%3DM.%26aulast%3DHeltai%26aufirst%3DS.%26aulast%3DZocchi%26aufirst%3DM.%2BR.%26aulast%3DRugarli%26aufirst%3DC.%26atitle%3DUnusual%2520expression%2520and%2520localization%2520of%2520heat-shock%2520proteins%2520in%2520human%2520tumor%2520cells%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D1992%26volume%3D51%26spage%3D613%26epage%3D619%26doi%3D10.1002%2Fijc.2910510418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kosano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stensgard, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlesworth, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toft, D.</span></span> <span> </span><span class="NLM_article-title">The assembly of progesterone receptor-hsp90 complexes using purified proteins</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>273</i></span>,  <span class="NLM_fpage">32973</span>– <span class="NLM_lpage">32979</span>, <span class="refDoi"> DOI: 10.1074/jbc.273.49.32973</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.1074%2Fjbc.273.49.32973" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=9830049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADyaK1cXnvFOms70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=32973-32979&author=H.+Kosanoauthor=B.+Stensgardauthor=M.+C.+Charlesworthauthor=N.+McMahonauthor=D.+Toft&title=The+assembly+of+progesterone+receptor-hsp90+complexes+using+purified+proteins&doi=10.1074%2Fjbc.273.49.32973"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The assembly of progesterone receptor-hsp90 complexes using purified proteins</span></div><div class="casAuthors">Kosano, Hiroshi; Stensgard, Bridget; Charlesworth, M. Cristine; McMahon, Nancy; Toft, David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">273</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">32973-32979</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The progesterone receptor can be reconstituted into hsp90-contg. complexes in vitro, and the resulting complexes are needed to maintain hormone binding activity.  This process requires ATP/Mg2+, K+, and several axillary proteins.  The authors have developed a defined system for the assembly of progesterone receptor complexes using purified proteins.  Five proteins are needed to form complexes that are capable of maintaining hormone binding activity.  These include hsp70 and its cochaperone, hsp40, the hsp70/hsp90-binding protein, Hop, hsp90, and the hsp90-binding protein, p23.  The proteins Hip and FKBP52 were not required for this in vitro process even though they have been obsd. in receptor complexes.  Each of the five proteins showed a characteristic concn. dependence.  Similar concns. of hsp70, hsp90, and p23 were needed for optimal assembly, but hsp40 and Hop were effective at about 1/10 the concn. of the other proteins, suggesting that these two proteins act catalytically or are needed at levels similar to the receptor concn.  ATP was required for the functioning of both hsp70 and hsp90.  The binding of hsp70 to the receptor requires hsp40 and about 10 μM ATP; however, hsp90 binding appears to occur subsequent to hsp70 binding and is optimal with 1 mM ATP.  A three-step model is presented to describe the assembly process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_LWDQTbsh57Vg90H21EOLACvtfcHk0lgYfsKHeLrPnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnvFOms70%253D&md5=1a2a42e700ef3e6a8b624934e6e8f58c</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1074%2Fjbc.273.49.32973&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.273.49.32973%26sid%3Dliteratum%253Aachs%26aulast%3DKosano%26aufirst%3DH.%26aulast%3DStensgard%26aufirst%3DB.%26aulast%3DCharlesworth%26aufirst%3DM.%2BC.%26aulast%3DMcMahon%26aufirst%3DN.%26aulast%3DToft%26aufirst%3DD.%26atitle%3DThe%2520assembly%2520of%2520progesterone%2520receptor-hsp90%2520complexes%2520using%2520purified%2520proteins%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D32973%26epage%3D32979%26doi%3D10.1074%2Fjbc.273.49.32973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fliss, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrett, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caplan, A. J.</span></span> <span> </span><span class="NLM_article-title">The Cdc37 protein kinase-binding domain is sufficient for protein kinase activity and cell viability</span>. <i>J. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>159</i></span>,  <span class="NLM_fpage">1051</span>– <span class="NLM_lpage">1059</span>, <span class="refDoi"> DOI: 10.1083/jcb.200210121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.1083%2Fjcb.200210121" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=12499358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjt1eh" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=2002&pages=1051-1059&author=P.+Leeauthor=J.+Raoauthor=A.+Flissauthor=E.+Yangauthor=S.+Garrettauthor=A.+J.+Caplan&title=The+Cdc37+protein+kinase-binding+domain+is+sufficient+for+protein+kinase+activity+and+cell+viability&doi=10.1083%2Fjcb.200210121"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The Cdc37 protein kinase-binding domain is sufficient for protein kinase activity and cell viability</span></div><div class="casAuthors">Lee, Paul; Rao, Jie; Fliss, Albert; Yang, Emy; Garrett, Stephen; Caplan, Avrom J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">159</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1051-1059</span>CODEN:
                <span class="NLM_cas:coden">JCLBA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9525</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Cdc37 is a mol. chaperone required for folding of protein kinases.  It functions in assocn. with Hsp90, although little is known of its mechanism of action or where it fits into a folding pathway involving other Hsp90 cochaperones.  Using a genetic approach with Saccharomyces cerevisiae, we show that CDC37 over-expression suppressed a defect in v-Src folding in yeast deleted for STI1, which recruits Hsp90 to misfolded clients.  Expression of CDC37 truncation mutants that were deleted for the Hsp90-binding site stabilized v-Src and led to some folding in both sti1Δ and hsc82Δ strains.  The protein kinase-binding domain of Cdc37 was sufficient for yeast cell viability and permitted efficient signaling through the yeast MAP kinase-signaling pathway.  We propose a model in which Cdc37 can function independently of Hsp90, although its ability to do so is restricted by its normally low expression levels.  This may be a form of regulation by which cells restrict access to Cdc37 until it has passed through a triage involving other chaperones such as Hsp70 and Hsp90.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2L6CbtJfYKbVg90H21EOLACvtfcHk0lgYfsKHeLrPnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjt1eh&md5=060e9efc016e1db0c7a5a85d05d8dd5f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1083%2Fjcb.200210121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.200210121%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DP.%26aulast%3DRao%26aufirst%3DJ.%26aulast%3DFliss%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DE.%26aulast%3DGarrett%26aufirst%3DS.%26aulast%3DCaplan%26aufirst%3DA.%2BJ.%26atitle%3DThe%2520Cdc37%2520protein%2520kinase-binding%2520domain%2520is%2520sufficient%2520for%2520protein%2520kinase%2520activity%2520and%2520cell%2520viability%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2002%26volume%3D159%26spage%3D1051%26epage%3D1059%26doi%3D10.1083%2Fjcb.200210121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pearl, L. H.</span></span> <span> </span><span class="NLM_article-title">Hsp90 and Cdc37 -- a chaperone cancer conspiracy</span>. <i>Curr. Opin. Genet. Dev.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">61</span>, <span class="refDoi"> DOI: 10.1016/j.gde.2004.12.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.1016%2Fj.gde.2004.12.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=15661534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmvFersw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=55-61&author=L.+H.+Pearl&title=Hsp90+and+Cdc37+%2D%2D+a+chaperone+cancer+conspiracy&doi=10.1016%2Fj.gde.2004.12.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp90 and Cdc37 - a chaperone cancer conspiracy</span></div><div class="casAuthors">Pearl, Laurence H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Genetics & Development</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-61</span>CODEN:
                <span class="NLM_cas:coden">COGDET</span>;
        ISSN:<span class="NLM_cas:issn">0959-437X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The Hsp90 mol. chaperone system is involved in the activation of an important set of cell regulatory proteins, including many whose dysregulation drives cancer.  Recruitment of protein kinases to the Hsp90 system is mediated by the co-chaperone adaptor Cdc37 - an essential protein whose overexpression is itself, oncogenic.  Current structural, biochem. and biol. studies of Cdc37 are beginning to unravel the nature of its interactions with Hsp90 and protein kinase clients, and implicate it as a key permissive factor in cell transformation by dysregulated protein kinases.  The central role of the Hsp90-Cdc37 chaperone complex makes it an important target for future anti-cancer drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsaofLA0wLnrVg90H21EOLACvtfcHk0lgZV_MZfbnUqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmvFersw%253D%253D&md5=2795e3e44b6b0bbbe12dda55cb335769</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.gde.2004.12.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.gde.2004.12.011%26sid%3Dliteratum%253Aachs%26aulast%3DPearl%26aufirst%3DL.%2BH.%26atitle%3DHsp90%2520and%2520Cdc37%2520--%2520a%2520chaperone%2520cancer%2520conspiracy%26jtitle%3DCurr.%2520Opin.%2520Genet.%2520Dev.%26date%3D2005%26volume%3D15%26spage%3D55%26epage%3D61%26doi%3D10.1016%2Fj.gde.2004.12.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calderwood, S. K.</span></span> <span> </span><span class="NLM_article-title">Cdc37 as a co-chaperone to Hsp90</span>. <i>Subcell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">103</span>– <span class="NLM_lpage">112</span>, <span class="refDoi"> DOI: 10.1007/978-3-319-11731-7_5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.1007%2F978-3-319-11731-7_5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=25487018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADC%252BC28XmsVOls7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2015&pages=103-112&author=S.+K.+Calderwood&title=Cdc37+as+a+co-chaperone+to+Hsp90&doi=10.1007%2F978-3-319-11731-7_5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Cdc37 as a Co-chaperone to Hsp90</span></div><div class="casAuthors">Calderwood, Stuart K.</div><div class="citationInfo"><span class="NLM_cas:title">Subcellular Biochemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">Networking of Chaperones by Co-Chaperones</span>),
    <span class="NLM_cas:pages">103-112</span>CODEN:
                <span class="NLM_cas:coden">SBCBAG</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The co-chaperone p50/Cdc37 is an important partner for Hsp90, assisting in mol. chaperone activities, particularly with regard to the regulation of protein kinases.  The Hsp90/Cdc37complex controls the folding of a large proportion of protein kinases and thus stands at the hub of a multitude of intracellular signaling networks.  Its effects thus reach beyond the housekeeping pathways of protein folding into regulation of a wide range of cellular processes.  Due to its influence in cell growth pathways Cdc37 has attracted much attention as a potential intermediate in carcinogenesis.  Cdc37 is an attractive potential target in cancer due to: (1) it may be expressed to high level in some types of cancer and (2) Cdc37 controls multiple signaling pathways.  This indicates a potential for: (1) selectivity due to its elevated expression and (2) robustness as the co-chaperone may control multiple growth signaling pathways and thus be less prone to evolution of resistance than other oncoproteins.  Cdc37 may also be involved in other aspects of pathophysiol.  Protein aggregation disorders have been linked to mol. chaperones and to age related declines in mol. chaperones and co-chaperones.  Cdc37 appears to be a potential agent in longevity due to its links to protein folding and autophagy and it will be informative to study the role of Cdc37 maintenance/decline in aging organisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTkfM0nCIL_7Vg90H21EOLACvtfcHk0lgZV_MZfbnUqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmsVOls7Y%253D&md5=7b5f610cd03de410184737db89c38cd7</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1007%2F978-3-319-11731-7_5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-319-11731-7_5%26sid%3Dliteratum%253Aachs%26aulast%3DCalderwood%26aufirst%3DS.%2BK.%26atitle%3DCdc37%2520as%2520a%2520co-chaperone%2520to%2520Hsp90%26jtitle%3DSubcell.%2520Biochem.%26date%3D2015%26volume%3D78%26spage%3D103%26epage%3D112%26doi%3D10.1007%2F978-3-319-11731-7_5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q. D.</span></span> <span> </span><span class="NLM_article-title">Targeting Hsp90-Cdc37: a promising therapeutic strategy by inhibiting Hsp90 chaperone function</span>. <i>Curr. Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1572</span>– <span class="NLM_lpage">1585</span>, <span class="refDoi"> DOI: 10.2174/1389450117666160527125522</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.2174%2F1389450117666160527125522" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=27231111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Sru7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=1572-1585&author=L.+Wangauthor=L.+Liauthor=K.+Guauthor=X.+L.+Xuauthor=Y.+Sunauthor=Q.+D.+You&title=Targeting+Hsp90-Cdc37%3A+a+promising+therapeutic+strategy+by+inhibiting+Hsp90+chaperone+function&doi=10.2174%2F1389450117666160527125522"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Hsp90-Cdc37: A Promising Therapeutic Strategy by Inhibiting Hsp90 Chaperone Function</span></div><div class="casAuthors">Wang, Lei; Li, Li; Gu, Kai; Xu, Xiao-Li; Sun, Yuan; You, Qi-Dong</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1572-1585</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Background & Objective: The Hsp90 chaperone protein regulates the folding, maturation and stability of a wide variety of oncoproteins.  In recent years, many Hsp90 inhibitors have entered into the clin. trials while all of them target ATPase showing similar binding capacity and kinds of side-effects so that none have reached to the market.  During the regulation progress, numerous protein- protein interactions (PPI) such as Hsp90 and client proteins or cochaperones are involved.  With the Hsp90-cochaperones PPI networks being more and more clear, many cancerous proteins have been reported to be tightly correlated to Hsp90-cochaperones PPI.  Among them, Hsp90-Cdc37 PPI has been widely reported to assoc. with numerous protein kinases, making it a novel target for the treatment of cancers.  Results and Conclusion: In this paper, we briefly review the strategies and modulators targeting Hsp90-Cdc37 complex including direct and indirect regulation mechanism.  Through these discussions we expect to present inspirations for new insights into an alternative way to inhibit Hsp90 chaperone function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpi2anLn7Vf0LVg90H21EOLACvtfcHk0lglg7oum-j7Rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Sru7nO&md5=a6636ba125e2894ba7ccdafc04c9e3b1</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2174%2F1389450117666160527125522&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389450117666160527125522%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DGu%26aufirst%3DK.%26aulast%3DXu%26aufirst%3DX.%2BL.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DYou%26aufirst%3DQ.%2BD.%26atitle%3DTargeting%2520Hsp90-Cdc37%253A%2520a%2520promising%2520therapeutic%2520strategy%2520by%2520inhibiting%2520Hsp90%2520chaperone%2520function%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2017%26volume%3D18%26spage%3D1572%26epage%3D1585%26doi%3D10.2174%2F1389450117666160527125522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y. L.</span></span> <span> </span><span class="NLM_article-title">Antiangiogenic effect of celastrol on the growth of human glioma: An <i>in vitro</i> and <i>in vivo</i> study</span>. <i>Chin. Med. J. (Engl.)</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">1666</span>– <span class="NLM_lpage">1673</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=19719969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVGqtLjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2009&pages=1666-1673&author=Y.+X.+Zhouauthor=Y.+L.+Huang&title=Antiangiogenic+effect+of+celastrol+on+the+growth+of+human+glioma%3A+An+in+vitro+and+in+vivo+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Antiangiogenic effect of celastrol on the growth of human glioma: an in vitro and in vivo study</span></div><div class="casAuthors">Zhou, You-xin; Huang, Yu-lun</div><div class="citationInfo"><span class="NLM_cas:title">Chinese Medical Journal (Beijing, China, English Edition)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1666-1673</span>CODEN:
                <span class="NLM_cas:coden">CMJODS</span>;
        ISSN:<span class="NLM_cas:issn">0366-6999</span>.
    
            (<span class="NLM_cas:orgname">Chinese Medical Association</span>)
        </div><div class="casAbstract">Background: Celastrol is a major active component of Tripterygium wilfordii named "Thunder God Vine", which is widely used to treat rheumatoid arthritis in China.  The present study aims to demonstrate that celastrol has potent anticancer activity against glioma in vitro and in vivo.  Methods: Proliferation, migration, and tube formation of ECV-304 cells were detd. by MTT and matrigel assays.  The antiangiogenesis effect of celastrol was assessed by the chick chorioallantoic membrane assay and the in vivo matrigel plug assay.  Tumor microvessels (MVD) were detd. immunohistochem. with anti-CD34 antibody.  Vascular endothelial growth factor (VEGF) expression was defined as pos. if distinct staining of the cytoplasm was obsd. in at least 10% of tumor cells at the deepest invasive site, central portion and superficial part of the tumor.  MVD was estd. by averaging the counts of three times at a ×200 field in the most vascularized area of the deepest invasive site.  Results: Celastrol purified from T. wilfordii inhibited the proliferation of vascular endothelial cells (ECV-304) with an IC50 value of 1.33 μg/mL.  Celastrol, at the concn. of 0.2 μg/mL, significantly inhibited cell migration and tube formation.  Celastrol inhibited angiogenesis in a dose-dependent manner both in vitro and in vivo.  S.c. administration of celastrol 5 days a week for 4 consecutive weeks significantly reduced tumor vol. in a dose-dependent manner in the SHG-44 xenograft model.  Celastrol at each different dose level lowered the d. of MVD significantly in tumor bearing nude mice compared to the control group.  Immunohistochem. expts. further revealed that celastrol also decreased the level of VEGFR-1 and VEGFR-2 expression, but not the level of VEGF expression.  Conclusions: Celastrol elicits antiangiogenic effects in vitro and in vivo, and could be of potential use in the treatment of malignant cancers such as glioblastoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoH_0tUNx9XkrVg90H21EOLACvtfcHk0lglg7oum-j7Rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVGqtLjL&md5=80bd61d59a05723a8b714186f3278f11</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DY.%2BX.%26aulast%3DHuang%26aufirst%3DY.%2BL.%26atitle%3DAntiangiogenic%2520effect%2520of%2520celastrol%2520on%2520the%2520growth%2520of%2520human%2520glioma%253A%2520An%2520in%2520vitro%2520and%2520in%2520vivo%2520study%26jtitle%3DChin.%2520Med.%2520J.%2520%2528Engl.%2529%26date%3D2009%26volume%3D122%26spage%3D1666%26epage%3D1673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, J.</span></span> <span> </span><span class="NLM_article-title">Celastrol exerts synergistic effects with PHA-665752 and inhibits tumor growth of c-Met-deficient hepatocellular carcinoma <i>in vivo</i></span>. <i>Mol. Biol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">4203</span>– <span class="NLM_lpage">4209</span>, <span class="refDoi"> DOI: 10.1007/s11033-013-2501-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.1007%2Fs11033-013-2501-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=23649759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADC%252BC3sXps1Cntrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2013&pages=4203-4209&author=H.+L.+Jiangauthor=J.+Z.+Jinauthor=D.+Wuauthor=D.+Xuauthor=G.+F.+Linauthor=H.+Yuauthor=D.+Y.+Maauthor=J.+Liang&title=Celastrol+exerts+synergistic+effects+with+PHA-665752+and+inhibits+tumor+growth+of+c-Met-deficient+hepatocellular+carcinoma+in+vivo&doi=10.1007%2Fs11033-013-2501-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Celastrol exerts synergistic effects with PHA-665752 and inhibits tumor growth of c-Met-deficient hepatocellular carcinoma in vivo</span></div><div class="casAuthors">Jiang, Hong-Lei; Jin, Jun-Zhe; Wu, Dan; Xu, Dong; Lin, Guo-Fu; Yu, Hao; Ma, Dong-Yan; Liang, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology Reports</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">4203-4209</span>CODEN:
                <span class="NLM_cas:coden">MLBRBU</span>;
        ISSN:<span class="NLM_cas:issn">0301-4851</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">PHA665752 (PHA), a selective small mol. c-Met Inhibitor, potently inhibited HGF-stimulated and constitutive c-Met phosphorylation, as well as HGF and c-Met-driven phenotypes of a variety of tumor cells including hepatocellular carcinoma cells.  However, these effects were impaired in c-Met-deficient cancer cells.  In the present study, we investigated the potential anti-human c-Met-deficient hepatocellular carcinoma effects of Celastrol, a novel triterpene, and its combination with PHA.  Human hepatocellular carcinoma cells BEL-7402 (c-Met-pos.) and Huh7 (c-Met-deficient) were treated with different dose of PHA with or without equal dose of Celastrol, and cell growth, cell cycle and apoptosis were evaluated, resp., by MTT assay, flow cytometry and Caspase3/7 activity.  Nude mice bearing Huh7 xenografts were used to assess the in vivo anti-tumor activity.  Our results showed that Celastrol at high concn. (>1.0 μM) induced G2/M arrest and apoptosis with the activation of Caspase3/7 in Huh7 cells whereas at low concn. (<1.0 μM) had no obvious effects.  Low concn. Celastrol presented significant combined effects with PHA on Huh7 cells and Huh7 xenografts in terms of growth inhibition, migration inhibition and apoptosis induction.  These results suggest that Celastrol and its combination with PHA present the therapeutic potential on c-Met-deficient hepatocellular carcinoma, and deserve further preclin. and clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrO8hrtfMWjIrVg90H21EOLACvtfcHk0ljnVuCsAYKo3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXps1Cntrk%253D&md5=095b2df1c1b758ff9ebd547351ac5abf</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1007%2Fs11033-013-2501-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11033-013-2501-y%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DH.%2BL.%26aulast%3DJin%26aufirst%3DJ.%2BZ.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DD.%26aulast%3DLin%26aufirst%3DG.%2BF.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DMa%26aufirst%3DD.%2BY.%26aulast%3DLiang%26aufirst%3DJ.%26atitle%3DCelastrol%2520exerts%2520synergistic%2520effects%2520with%2520PHA-665752%2520and%2520inhibits%2520tumor%2520growth%2520of%2520c-Met-deficient%2520hepatocellular%2520carcinoma%2520in%2520vivo%26jtitle%3DMol.%2520Biol.%2520Rep.%26date%3D2013%26volume%3D40%26spage%3D4203%26epage%3D4209%26doi%3D10.1007%2Fs11033-013-2501-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, Q. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dou, Q. P.</span></span> <span> </span><span class="NLM_article-title">Celastrol, a triterpene extracted from the Chinese “Thunder of God Vine,” is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">4758</span>– <span class="NLM_lpage">4765</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-05-4529</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.1158%2F0008-5472.CAN-05-4529" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=16651429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvF2ktrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=4758-4765&author=H.+Yangauthor=D.+Chenauthor=Q.+C.+Cuiauthor=X.+Yuanauthor=Q.+P.+Dou&title=Celastrol%2C+a+triterpene+extracted+from+the+Chinese+%E2%80%9CThunder+of+God+Vine%2C%E2%80%9D+is+a+potent+proteasome+inhibitor+and+suppresses+human+prostate+cancer+growth+in+nude+mice&doi=10.1158%2F0008-5472.CAN-05-4529"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Celastrol, a Triterpene Extracted from the Chinese "Thunder of God Vine," Is a Potent Proteasome Inhibitor and Suppresses Human Prostate Cancer Growth in Nude Mice</span></div><div class="casAuthors">Yang, Huanjie; Chen, Di; Cui, Qiuzhi Cindy; Yuan, Xiao; Dou, Q. Ping</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4758-4765</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Interest in the use of traditional medicines for cancer prevention and treatment is increasing.  In vitro, in vivo, and clin. studies suggest the potential use of proteasome inhibitors as novel anticancer drugs.  Celastrol, an active compd. extd. from the root bark of the Chinese medicine "Thunder of God Vine" (Tripterygium wilfordii Hook F.), was used for years as a natural remedy for inflammatory conditions.  Although Celastrol has been shown to induce leukemia cell apoptosis, the mol. target involved has not been identified.  Furthermore, whether Celastrol has antitumor activity in vivo has never been conclusively shown.  Here, we report, for the first time, that Celastrol potently and preferentially inhibits the chymotrypsin-like activity of a purified 20S proteasome (IC50 = 2.5 μmol/L) and human prostate cancer cellular 26S proteasome (at 1-5 μmol/L).  Inhibition of the proteasome activity by Celastrol in PC-3 (androgen receptor- or AR-neg.) or LNCaP (AR-pos.) cells results in the accumulation of ubiquitinated proteins and three natural proteasome substrates (IκB-α, Bax, and p27), accompanied by suppression of AR protein expression (in LNCaP cells) and induction of apoptosis.  Treatment of PC-3 tumor-bearing nude mice with Celastrol (1-3 mg/kg/d, i.p., 1-31 days) resulted in significant inhibition (65-93%) of the tumor growth.  Multiple assays using the animal tumor tissue samples from both early and end time points showed in vivo inhibition of the proteasomal activity and induction of apoptosis after Celastrol treatment.  Our results show that Celastrol is a natural proteasome inhibitor that has a great potential for cancer prevention and treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfMTz0hvh_grVg90H21EOLACvtfcHk0ljnVuCsAYKo3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvF2ktrs%253D&md5=08d3772b69fa1e92dc313266b9968a1d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-05-4529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-05-4529%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DCui%26aufirst%3DQ.%2BC.%26aulast%3DYuan%26aufirst%3DX.%26aulast%3DDou%26aufirst%3DQ.%2BP.%26atitle%3DCelastrol%252C%2520a%2520triterpene%2520extracted%2520from%2520the%2520Chinese%2520%25E2%2580%259CThunder%2520of%2520God%2520Vine%252C%25E2%2580%259D%2520is%2520a%2520potent%2520proteasome%2520inhibitor%2520and%2520suppresses%2520human%2520prostate%2520cancer%2520growth%2520in%2520nude%2520mice%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D4758%26epage%3D4765%26doi%3D10.1158%2F0008-5472.CAN-05-4529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sreeramulu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gande, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Göbel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwalbe, H.</span></span> <span> </span><span class="NLM_article-title">Molecular mechanism of inhibition of the human protein complex Hsp90-Cdc37, a kinome chaperone-cochaperone, by Triterpene Celastrol</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">5853</span>– <span class="NLM_lpage">5855</span>, <span class="refDoi"> DOI: 10.1002/anie.200900929</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.1002%2Fanie.200900929" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=19585625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptFGltb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=5853-5855&author=S.+Sreeramuluauthor=S.+L.+Gandeauthor=M.+G%C3%B6belauthor=H.+Schwalbe&title=Molecular+mechanism+of+inhibition+of+the+human+protein+complex+Hsp90-Cdc37%2C+a+kinome+chaperone-cochaperone%2C+by+Triterpene+Celastrol&doi=10.1002%2Fanie.200900929"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Mechanism of Inhibition of the Human Protein Complex Hsp90-Cdc37, a Kinome Chaperone-Cochaperone, by Triterpene Celastrol</span></div><div class="casAuthors">Sreeramulu, Sridhar; Gande, Santosh Lakshmi; Goebel, Michael; Schwalbe, Harald</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">5853-5855, S5853/1-S5853/11</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Inhibition of the ATPase activity of the kinome chaperone Hsp90 (kinome = set of all protein kinases in an organism) has long been known as mol. target for anticancer therapy.  Cdc37, a cochaperone of Hsp90 in mammalian cells, targets protein kinases and is upregulated in various cancers.  Gene-based expression studies have identified the triterpene celastrol, which represents a new class of non ATP-competitive inhibitors of Hsp90.  Herein, we describe in detail how celastrol disrupts the human Hsp90-Cdc37 complex.  We report that celastrol binds to Cdc37 but not to HSP90N as previously described.  This study is important as it will shift efforts in medicinal chem. towards the correct target within the protein-protein complex.  Our results indicates that the N-terminal kinase- binding and middle Hsp90N-binding domain of Cdc37 are the mol. target for the triterpene celastrol.  In light of the considerable potential of Cdc37 as a drug target and the binding of celastrol to it, these results can now be used to further understand the mol. basis for inhibiting this key Cdc37-Hsp90 complex in cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWgmOS-yFB6rVg90H21EOLACvtfcHk0ljuGe1O4rIdPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptFGltb4%253D&md5=d5264a2213c19a8b33ca56305ac2a29c</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1002%2Fanie.200900929&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200900929%26sid%3Dliteratum%253Aachs%26aulast%3DSreeramulu%26aufirst%3DS.%26aulast%3DGande%26aufirst%3DS.%2BL.%26aulast%3DG%25C3%25B6bel%26aufirst%3DM.%26aulast%3DSchwalbe%26aufirst%3DH.%26atitle%3DMolecular%2520mechanism%2520of%2520inhibition%2520of%2520the%2520human%2520protein%2520complex%2520Hsp90-Cdc37%252C%2520a%2520kinome%2520chaperone-cochaperone%252C%2520by%2520Triterpene%2520Celastrol%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2009%26volume%3D48%26spage%3D5853%26epage%3D5855%26doi%3D10.1002%2Fanie.200900929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span> <span> </span><span class="NLM_article-title">A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">162</span>– <span class="NLM_lpage">170</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-07-0484</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.1158%2F1535-7163.MCT-07-0484" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=18202019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsVyhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=162-170&author=T.+Zhangauthor=A.+Hamzaauthor=X.+Caoauthor=B.+Wangauthor=S.+Yuauthor=C.+Zhanauthor=D.+Sun&title=A+novel+Hsp90+inhibitor+to+disrupt+Hsp90%2FCdc37+complex+against+pancreatic+cancer+cells&doi=10.1158%2F1535-7163.MCT-07-0484"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells</span></div><div class="casAuthors">Zhang, Tao; Hamza, Adel; Cao, Xianhua; Wang, Bing; Yu, Shuwen; Zhan, Chang-Guo; Sun, Duxin</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">162-170</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Pancreatic cancer is an aggressive disease with multiple biochem. and genetic alterations.  Thus, a single agent to hit one mol. target may not be sufficient to treat this disease.  The purpose of this study is to identify a novel Hsp90 inhibitor to disrupt protein-protein interactions of Hsp90 and its cochaperones for down-regulating many oncogenes simultaneously against pancreatic cancer cells.  Here, we reported that celastrol disrupted Hsp90-Cdc37 interaction in the superchaperone complex to exhibit antitumor activity in vitro and in vivo.  Mol. docking and mol. dynamic simulations showed that celastrol blocked the crit. interaction of Glu33 (Hsp90) and Arg167 (Cdc37).  Immunopptn. confirmed that celastrol (10 μmol/L) disrupted the Hsp90-Cdc37 interaction in the pancreatic cancer cell line Panc-1.  In contrast to classic Hsp90 inhibitor (geldanamycin), celastrol (0.1-100 μmol/L) did not interfere with ATP binding to Hsp90.  However, celastrol (1-5 μmol/L) induced Hsp90 client protein degrdn. (Cdk4 and Akt) by 70% to 80% and increased Hsp70 expression by 12-fold.  Celastrol induced apoptosis in vitro and significantly inhibited tumor growth in Panc-1 xenografts.  Moreover, celastrol (3 mg/kg) effectively suppressed tumor metastasis by more than 80% in RIP1-Tag2 transgenic mouse model with pancreatic islet cell carcinogenesis.  The data suggest that celastrol is a novel Hsp90 inhibitor to disrupt Hsp90-Cdc37 interaction against pancreatic cancer cells. [Mol Cancer Ther 2008;7(1):162-70].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYaUNr9Bi1cbVg90H21EOLACvtfcHk0ljuGe1O4rIdPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsVyhtQ%253D%253D&md5=2af27701d6ccd4397c7a7486d1335730</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-07-0484&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-07-0484%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DHamza%26aufirst%3DA.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DZhan%26aufirst%3DC.%26aulast%3DSun%26aufirst%3DD.%26atitle%3DA%2520novel%2520Hsp90%2520inhibitor%2520to%2520disrupt%2520Hsp90%252FCdc37%2520complex%2520against%2520pancreatic%2520cancer%2520cells%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D162%26epage%3D170%26doi%3D10.1158%2F1535-7163.MCT-07-0484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sreeramulu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonker, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lancaster, C. R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwalbe, H.</span></span> <span> </span><span class="NLM_article-title">The human Cdc37-Hsp90 complex studied by NMR</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">3885</span>– <span class="NLM_lpage">3896</span>, <span class="refDoi"> DOI: 10.1074/jbc.M806715200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.1074%2Fjbc.M806715200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=19073599" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Oru7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=3885-3896&author=S.+Sreeramuluauthor=H.+R.+Jonkerauthor=T.+Langerauthor=C.+Richterauthor=C.+R.+D.+Lancasterauthor=H.+Schwalbe&title=The+human+Cdc37-Hsp90+complex+studied+by+NMR&doi=10.1074%2Fjbc.M806715200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The Human Cdc37·Hsp90 Complex Studied by Heteronuclear NMR Spectroscopy</span></div><div class="casAuthors">Sreeramulu, Sridhar; Jonker, Hendrik R. A.; Langer, Thomas; Richter, Christian; Lancaster, C. Roy D.; Schwalbe, Harald</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3885-3896</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The cell division cycle protein 37 (Cdc37) and the 90-kDa heat shock protein (Hsp90) are mol. chaperones, which are crucial elements in the protein signaling pathway.  The largest class of client proteins for Cdc37 and Hsp90 are protein kinases.  The catalytic domains of these kinases are stabilized by Cdc37, and their proper folding and functioning is dependent on Hsp90.  Here, we present the x-ray crystal structure of the 16-kDa middle domain of human Cdc37 at 1.88 Å resoln. and the structure of this domain in complex with the 23-kDa N-terminal domain of human Hsp90 based on heteronuclear soln. state NMR data and docking.  Our results demonstrate that the middle domain of Cdc37 exists as a monomer.  NMR and mutagenesis expts. reveal Leu-205 in Cdc37 as a key residue enabling complex formation.  These findings can be very useful in the development of small mol. inhibitors against cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0h2OpThcpv7Vg90H21EOLACvtfcHk0lh1hjor-imF8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Oru7g%253D&md5=aa7c4ab0d6585cd00dedca91c37372ea</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M806715200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M806715200%26sid%3Dliteratum%253Aachs%26aulast%3DSreeramulu%26aufirst%3DS.%26aulast%3DJonker%26aufirst%3DH.%2BR.%26aulast%3DLanger%26aufirst%3DT.%26aulast%3DRichter%26aufirst%3DC.%26aulast%3DLancaster%26aufirst%3DC.%2BR.%2BD.%26aulast%3DSchwalbe%26aufirst%3DH.%26atitle%3DThe%2520human%2520Cdc37-Hsp90%2520complex%2520studied%2520by%2520NMR%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D3885%26epage%3D3896%26doi%3D10.1074%2Fjbc.M806715200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and antitumor evaluation of novel celastrol derivatives</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>174</i></span>,  <span class="NLM_fpage">265</span>– <span class="NLM_lpage">276</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.04.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.1016%2Fj.ejmech.2019.04.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=31051401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADC%252BC1MXovVOhurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=174&publication_year=2019&pages=265-276&author=M.+Xuauthor=N.+Liauthor=Z.+Zhaoauthor=Z.+Shiauthor=J.+Sunauthor=L.+Chen&title=Design%2C+synthesis+and+antitumor+evaluation+of+novel+celastrol+derivatives&doi=10.1016%2Fj.ejmech.2019.04.050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and antitumor evaluation of novel celastrol derivatives</span></div><div class="casAuthors">Xu, Manyi; Li, Na; Zhao, Zihao; Shi, Zhixian; Sun, Jianbo; Chen, Li</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">174</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">265-276</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">On the basis of the hybridization strategy of natural products, a total of 32 novel celastrol hybrids, I [X = (CH2)3, (CH2)2, (CH2)4, trans-CH2CH:CHCH2, R1, R2 = H, Me, OMe, F, R3 = H, MeO, R4 = CN, H] and II [R5 = H, MeO, R6 = CN, H], were designed, synthesized and evaluated for their antitumor activities.  Most of these derivs. exhibited significant antiproliferative activities compared to celastrol, among which compd. II [X = (CH2)2, R5 = MeO, R6 = H] (III) displayed the strongest inhibitory capability [IC50 = 0.15 ± 0.03 μM (A549), 0.17 ± 0.03 μM (MCF-7), 0.26 ± 0.02 μM (HepG2)], which exhibited equal or superior anti-cancer activities in comparison to 2-cyano-3,12-dioxoolean-1,9(11)-dien-28-oic acid Me ester (CDDO-Me).  The mechanism of pharmacol. activity indicated that III possessed the ability to disrupt Hsp90-Cdc37 complex, which was stronger than celastrol.  Meanwhile, compd. III could induce abnormal regulation of clients (p-Akt and Cdk4) of Hsp90 and cell cycle arrest at G0/G1 phase in a concn.-dependent manner.  In addn., compd. III could also induce cell apoptosis through the death receptor pathway on A549 cells.  Taken together, our results demonstrated that III might be a promising novel candidate for further drugability research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreDY1adjaE3LVg90H21EOLACvtfcHk0lh1hjor-imF8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXovVOhurk%253D&md5=3bb63a9f19a1c64d4ba20bb51eb6f9ee</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.04.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.04.050%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DShi%26aufirst%3DZ.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DL.%26atitle%3DDesign%252C%2520synthesis%2520and%2520antitumor%2520evaluation%2520of%2520novel%2520celastrol%2520derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D174%26spage%3D265%26epage%3D276%26doi%3D10.1016%2Fj.ejmech.2019.04.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, Q. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X. L.</span></span> <span> </span><span class="NLM_article-title">Optimization and biological evaluation of celastrol derivatives as Hsp90-Cdc37 interaction disruptors with improved druglike properties</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">5431</span>– <span class="NLM_lpage">5439</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.08.070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.1016%2Fj.bmc.2016.08.070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=27647369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFamurrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=5431-5439&author=F.+Jiangauthor=H.+J.+Wangauthor=Q.+C.+Baoauthor=L.+Wangauthor=Y.+H.+Jinauthor=Q.+Zhangauthor=D.+Jiangauthor=Q.+D.+Youauthor=X.+L.+Xu&title=Optimization+and+biological+evaluation+of+celastrol+derivatives+as+Hsp90-Cdc37+interaction+disruptors+with+improved+druglike+properties&doi=10.1016%2Fj.bmc.2016.08.070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization and biological evaluation of celastrol derivatives as Hsp90-Cdc37 interaction disruptors with improved druglike properties</span></div><div class="casAuthors">Jiang, Fen; Wang, Hui-Jie; Bao, Qi-Chao; Wang, Lei; Jin, Yu-Hui; Zhang, Qiong; Jiang, Di; You, Qi-Dong; Xu, Xiao-Li</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5431-5439</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) as a mol. target for oncol. therapeutics has attracted much attention in the last decade.  The Hsp90 multichaperone complex has important roles in the growth and/or survival of cancer cells.  Cdc37, as a cochaperone, assocs. kinase clients to Hsp90 and promotes the development of malignant tumors.  Disrupting the Hsp90-Cdc37 interaction provides an alternative strategy to inhibit the function of Hsp90 for cancer therapy.  Celastrol, as a natural product, can disrupt the Hsp90-Cdc37 interaction and induce degrdn. of kinase clients.  The study conducted here attempted to elucidate the structure-activity relationship of celastrol derivs. as Hsp90-Cdc37 disruptors and to improve the druglike properties.  23 Celastrol derivs. were designed, synthesized, and the biol. activities and physicochem. properties were detd.  The deriv. CEL20 showed improved Hsp90-Cdc37 disruption activity, anti-proliferative activities as well as druglike properties.  Addnl., CEL20 induced clients degrdn., cell cycle arrest and apoptosis in Panc-1 cells.  This study can provide ref. for the discovery of novel Hsp90-Cdc37 disruptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzu8IFI5qzR7Vg90H21EOLACvtfcHk0linGAnNEwnuWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFamurrL&md5=94fadc51317b113c4e79fdb1e338c6ab</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.08.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.08.070%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DH.%2BJ.%26aulast%3DBao%26aufirst%3DQ.%2BC.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DJin%26aufirst%3DY.%2BH.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DJiang%26aufirst%3DD.%26aulast%3DYou%26aufirst%3DQ.%2BD.%26aulast%3DXu%26aufirst%3DX.%2BL.%26atitle%3DOptimization%2520and%2520biological%2520evaluation%2520of%2520celastrol%2520derivatives%2520as%2520Hsp90-Cdc37%2520interaction%2520disruptors%2520with%2520improved%2520druglike%2520properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D5431%26epage%3D5439%26doi%3D10.1016%2Fj.bmc.2016.08.070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sayama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikubo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otani, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uwamizu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kishi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makide, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirokawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohwada, T.</span></span> <span> </span><span class="NLM_article-title">Probing the hydrophobic binding pocket of G-protein-coupled lysophosphatidylserine receptor GPR34/LPS1 by docking-aided structure-activity analysis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">6384</span>– <span class="NLM_lpage">6399</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00693</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00693" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFOitr3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=6384-6399&author=M.+Sayamaauthor=A.+Inoueauthor=S.+Nakamuraauthor=S.+Jungauthor=M.+Ikuboauthor=Y.+Otaniauthor=A.+Uwamizuauthor=T.+Kishiauthor=K.+Makideauthor=J.+Aokiauthor=T.+Hirokawaauthor=T.+Ohwada&title=Probing+the+hydrophobic+binding+pocket+of+G-protein-coupled+lysophosphatidylserine+receptor+GPR34%2FLPS1+by+docking-aided+structure-activity+analysis&doi=10.1021%2Facs.jmedchem.7b00693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Probing the Hydrophobic Binding Pocket of G-Protein-Coupled Lysophosphatidylserine Receptor GPR34/LPS1 by Docking-Aided Structure-Activity Analysis</span></div><div class="casAuthors">Sayama, Misa; Inoue, Asuka; Nakamura, Sho; Jung, Sejin; Ikubo, Masaya; Otani, Yuko; Uwamizu, Akiharu; Kishi, Takayuki; Makide, Kumiko; Aoki, Junken; Hirokawa, Takatsugu; Ohwada, Tomohiko</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6384-6399</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The ligands of certain G-protein-coupled receptors (GPCRs) have been identified as endogenous lipids, such as lysophosphatidylserine (LysoPS).  Here, the authors analyzed the mol. basis of the structure-activity relationship of ligands of GPR34, one of the LysoPS receptor subtypes, focusing on recognition of the long-chain fatty acid moiety by the hydrophobic pocket.  By introducing benzene ring(s) into the fatty acid moiety of 2-deoxy-LysoPS, the authors explored the binding site's preference for the hydrophobic shape.  A tribenzene-contg. fatty acid surrogate with modifications of the terminal arom. moiety showed potent agonistic activity toward GPR34.  Computational docking of these derivs. with a homol. modeling/mol. dynamics-based virtual binding site of GPR34 indicated that a kink in the benzene-based lipid surrogates matches the L-shaped hydrophobic pocket of GPR34.  A tetrabenzene-based lipid analog bearing a bulky tert-Bu group at the 4-position of the terminal benzene ring exhibited potent GPR34 agonistic activity, validating the present hydrophobic binding pocket model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyzugwFt3kErVg90H21EOLACvtfcHk0linGAnNEwnuWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFOitr3L&md5=4ac2932dfe0071b589cbea4e028c1641</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00693%26sid%3Dliteratum%253Aachs%26aulast%3DSayama%26aufirst%3DM.%26aulast%3DInoue%26aufirst%3DA.%26aulast%3DNakamura%26aufirst%3DS.%26aulast%3DJung%26aufirst%3DS.%26aulast%3DIkubo%26aufirst%3DM.%26aulast%3DOtani%26aufirst%3DY.%26aulast%3DUwamizu%26aufirst%3DA.%26aulast%3DKishi%26aufirst%3DT.%26aulast%3DMakide%26aufirst%3DK.%26aulast%3DAoki%26aufirst%3DJ.%26aulast%3DHirokawa%26aufirst%3DT.%26aulast%3DOhwada%26aufirst%3DT.%26atitle%3DProbing%2520the%2520hydrophobic%2520binding%2520pocket%2520of%2520G-protein-coupled%2520lysophosphatidylserine%2520receptor%2520GPR34%252FLPS1%2520by%2520docking-aided%2520structure-activity%2520analysis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D6384%26epage%3D6399%26doi%3D10.1021%2Facs.jmedchem.7b00693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giroud, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haap, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapp, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweizer, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schirmeister, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diederich, F.</span></span> <span> </span><span class="NLM_article-title">Fluorine scan of inhibitors of the cysteine protease human cathepsin L: dipolar and quadrupolar effects in the π-stacking of fluorinated phenyl rings on peptide amide bonds</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1042</span>– <span class="NLM_lpage">1047</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201600132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.1002%2Fcmdc.201600132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=27095165" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtlSit7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=1042-1047&author=M.+Giroudauthor=M.+Harderauthor=B.+Kuhnauthor=W.+Haapauthor=N.+Trappauthor=W.+B.+Schweizerauthor=T.+Schirmeisterauthor=F.+Diederich&title=Fluorine+scan+of+inhibitors+of+the+cysteine+protease+human+cathepsin+L%3A+dipolar+and+quadrupolar+effects+in+the+%CF%80-stacking+of+fluorinated+phenyl+rings+on+peptide+amide+bonds&doi=10.1002%2Fcmdc.201600132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine Scan of Inhibitors of the Cysteine Protease Human Cathepsin L: Dipolar and Quadrupolar Effects in the π-Stacking of Fluorinated Phenyl Rings on Peptide Amide Bonds</span></div><div class="casAuthors">Giroud, Maude; Harder, Michael; Kuhn, Bernd; Haap, Wolfgang; Trapp, Nils; Schweizer, W. Bernd; Schirmeister, Tanja; Diederich, Francois</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1042-1047</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The π-stacking of fluorinated benzene rings on protein backbone amide groups was investigated, using a dual approach comprising enzyme-ligand binding studies complemented by high-level quantum chem. calcns.  In the exptl. study, the Ph substituent of triazine nitrile inhibitors of human cathepsin L (hCatL), which stacks onto the peptide amide bond Gly67-Gly68 at the entrance of the S3 pocket, was systematically fluorinated, and differences in inhibitory potency were measured in a fluorimetric assay.  Binding affinity is influenced by lipophilicity (clog P), the dipole and quadrupole moments of the fluorinated rings, but also by addnl. interactions of the introduced fluorine atoms with the local environment of the pocket.  Generally, the higher the degree of fluorination, the better the binding affinities.  Gas phase calcns. strongly support the contributions of the mol. quadrupole moments of the fluorinated Ph rings to the π-stacking interaction with the peptide bond.  These findings provide useful guidelines for enhancing π-stacking on protein amide fragments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpc4SJd8KW76LVg90H21EOLACvtfcHk0linGAnNEwnuWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtlSit7o%253D&md5=298c19d0abfdee7fa7c9593b21da62f0</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201600132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201600132%26sid%3Dliteratum%253Aachs%26aulast%3DGiroud%26aufirst%3DM.%26aulast%3DHarder%26aufirst%3DM.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DHaap%26aufirst%3DW.%26aulast%3DTrapp%26aufirst%3DN.%26aulast%3DSchweizer%26aufirst%3DW.%2BB.%26aulast%3DSchirmeister%26aufirst%3DT.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DFluorine%2520scan%2520of%2520inhibitors%2520of%2520the%2520cysteine%2520protease%2520human%2520cathepsin%2520L%253A%2520dipolar%2520and%2520quadrupolar%2520effects%2520in%2520the%2520%25CF%2580-stacking%2520of%2520fluorinated%2520phenyl%2520rings%2520on%2520peptide%2520amide%2520bonds%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D1042%26epage%3D1047%26doi%3D10.1002%2Fcmdc.201600132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baltas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedos-Belval, F.</span></span> <span> </span><span class="NLM_article-title">Cinnamic acid derivatives as anticancer agents</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1672</span>– <span class="NLM_lpage">1703</span>, <span class="refDoi"> DOI: 10.2174/092986711795471347</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.2174%2F092986711795471347" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=21434850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpslOiu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=1672-1703&author=P.+Deauthor=M.+Baltasauthor=F.+Bedos-Belval&title=Cinnamic+acid+derivatives+as+anticancer+agents&doi=10.2174%2F092986711795471347"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Cinnamic acid derivatives as anticancer agents-A review</span></div><div class="casAuthors">De, P.; Baltas, M.; Bedos-Belval, F.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1672-1703</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Cinnamic acid and its phenolic analogs are natural substances.  Chem., in cinnamic acids the 3-Ph acrylic acid functionality offers three main reactive sites; substitution at the Ph ring, addn. at the α,β- unsatn. and the reactions of the carboxylic acid functionality.  Owing to these chem. aspects cinnamic acid derivs. received much attention in medicinal research as traditional as well as recent synthetic antitumor agents.  We obsd. that in spite of their rich medicinal tradition, cinnamic acid derivs. and their anticancer potentials remained underutilized for several decades since the first published clin. use in 1905.  In last two decades, there has been huge attention towards various cinnamoyl derivs. and their antitumor efficacy.  This review provides a comprehensive and unprecedented literature compilation concerning the synthesis and biol. evaluation of various cinnamoyl acids, esters, amides, hydrazides and related derivs. in anticancer research.  We envisage that our effort in this review contributes a much needed and timely addn. to the literature of medicinal research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofVNxBeUgmSbVg90H21EOLACvtfcHk0lghQyCarXSyFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpslOiu7g%253D&md5=cf3c672b3ca0e9fa010877c8de234a34</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.2174%2F092986711795471347&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711795471347%26sid%3Dliteratum%253Aachs%26aulast%3DDe%26aufirst%3DP.%26aulast%3DBaltas%26aufirst%3DM.%26aulast%3DBedos-Belval%26aufirst%3DF.%26atitle%3DCinnamic%2520acid%2520derivatives%2520as%2520anticancer%2520agents%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D1672%26epage%3D1703%26doi%3D10.2174%2F092986711795471347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pei, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ju, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, G.</span></span> <span> </span><span class="NLM_article-title">Synthesis and in vitro and in vivo antitumour activity study of 11-hydroxyl esterified bergenin/cinnamic acid hybrids</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">319</span>– <span class="NLM_lpage">328</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.03.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.1016%2Fj.ejmech.2017.03.053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=28395218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlvVCru70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2017&pages=319-328&author=C.+Liangauthor=S.+Peiauthor=W.+Juauthor=M.+Jiaauthor=D.+Tianauthor=Y.+Tangauthor=G.+Mao&title=Synthesis+and+in+vitro+and+in+vivo+antitumour+activity+study+of+11-hydroxyl+esterified+bergenin%2Fcinnamic+acid+hybrids&doi=10.1016%2Fj.ejmech.2017.03.053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and in vitro and in vivo antitumour activity study of 11-hydroxyl esterified bergenin/cinnamic acid hybrids</span></div><div class="casAuthors">Liang, Chengyuan; Pei, Shaomeng; Ju, Weihui; Jia, Minyi; Tian, Danni; Tang, Yonghong; Mao, Gennian</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">319-328</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Fourteen bergenin/cinnamic acid hybrids were synthesized, characterized and evaluated for their antitumor activity both in vitro and in vivo.  The most potent compd., I, arrested HepG2 cells (IC50 = 4.23 ± 0.79 μM) in the G2/M phase and induced cellular apoptosis.  Moreover, compd. I was also found to suppress the tumor growth in Heps xenograft-bearing mice with low toxicity.  In the mechanistic study, I administration ignited a mitochondria-mediated apoptosis pathway of HepG2 cell death.  Furthermore, I activated Akt-dependent pathways and further decreased the expression of the Bcl-2 family of proteins.  The downstream mitochondrial p53 translocation was also significantly activated, accompanied by an increase of the caspase-9, caspase-3 activation.  These data imply that bergenin/cinnamic acid hybrids could serve as novel Akt/Bcl-2 inhibitors for further preclin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3PR_1QN59sLVg90H21EOLACvtfcHk0lghQyCarXSyFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlvVCru70%253D&md5=00f5f214ba4d86f654dc9b9942d64cfb</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.03.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.03.053%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DC.%26aulast%3DPei%26aufirst%3DS.%26aulast%3DJu%26aufirst%3DW.%26aulast%3DJia%26aufirst%3DM.%26aulast%3DTian%26aufirst%3DD.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DMao%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520in%2520vitro%2520and%2520in%2520vivo%2520antitumour%2520activity%2520study%2520of%252011-hydroxyl%2520esterified%2520bergenin%252Fcinnamic%2520acid%2520hybrids%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D133%26spage%3D319%26epage%3D328%26doi%3D10.1016%2Fj.ejmech.2017.03.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, B. Y.</span></span> <span> </span><span class="NLM_article-title">Synthesis and in vitro antitumor evaluation of dihydroartemisinin-cinnamic acid ester derivatives</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">192</span>– <span class="NLM_lpage">203</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.11.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.1016%2Fj.ejmech.2015.11.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=26595184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVKqt7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2016&pages=192-203&author=C.+C.+Xuauthor=T.+Dengauthor=M.+L.+Fanauthor=W.+B.+Lvauthor=J.+H.+Liuauthor=B.+Y.+Yu&title=Synthesis+and+in+vitro+antitumor+evaluation+of+dihydroartemisinin-cinnamic+acid+ester+derivatives&doi=10.1016%2Fj.ejmech.2015.11.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and in vitro antitumor evaluation of dihydroartemisinin-cinnamic acid ester derivatives</span></div><div class="casAuthors">Xu, Cang-Cang; Deng, Ting; Fan, Meng-Lin; Lv, Wen-Bo; Liu, Ji-Hua; Yu, Bo-Yang</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">192-203</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">To explore novel high efficiency and low toxicity antitumor agents, a series of dihydroartemisinin-cinnamic acid ester derivs. modified on C-12 and/or C-9 position (s) were synthesized and the in vitro antitumor activities against PC-3, SGC-7901, A549 and MDA-MB-435s cancer cell lines were assessed.  The hybrids were prepd. by esterification of 9α-hydroxy-dihydroartemisinin (9α-OH DHA), the biotransformation product of dihydroartemisinin (DHA), and cinnamic acid derivs.  Compd. I (IC50 = 0.20 μM) was the most potent anti-proliferative agent against the human lung carcinoma A549 cells, although it displayed low cytotoxicity on normal hepatic L-02 cells.  The mechanism of action of compd. I was further investigated by anal. of cell apoptosis and intracellular ROS generation.  The results indicated that both ROS and ferrous ion contributed to the compd. I-induced cell death.  Meanwhile, high intracellular ferrous ion and endogenous oxidative stress in A549 cells made them easier to suffer to compd. I-induced apoptosis.  Our promising findings indicated the compd. I could stand as drug candidate against lung cancer for further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOgW88VJiQOrVg90H21EOLACvtfcHk0lghQyCarXSyFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVKqt7jE&md5=0fbcfc286345226fca1f21bf8a7d80d9</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.11.003%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DC.%2BC.%26aulast%3DDeng%26aufirst%3DT.%26aulast%3DFan%26aufirst%3DM.%2BL.%26aulast%3DLv%26aufirst%3DW.%2BB.%26aulast%3DLiu%26aufirst%3DJ.%2BH.%26aulast%3DYu%26aufirst%3DB.%2BY.%26atitle%3DSynthesis%2520and%2520in%2520vitro%2520antitumor%2520evaluation%2520of%2520dihydroartemisinin-cinnamic%2520acid%2520ester%2520derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D107%26spage%3D192%26epage%3D203%26doi%3D10.1016%2Fj.ejmech.2015.11.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, H. M.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of the novel glycyrrhetinic acid-cinnamoyl hybrids as anti-tumor agents</span>. <i>Chem. Cent. J.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">11</span>, <span class="refDoi"> DOI: 10.1186/s13065-016-0222-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.1186%2Fs13065-016-0222-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=26966460" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2016&pages=11&author=W.+B.+Guoauthor=M.+M.+Yanauthor=B.+Xuauthor=F.+H.+Chuauthor=W.+Wangauthor=C.+Z.+Zhangauthor=X.+H.+Jiaauthor=Y.+T.+Hanauthor=H.+J.+Xiangauthor=Y.+Z.+Zhangauthor=P.+L.+Wangauthor=H.+M.+Lei&title=Design%2C+synthesis%2C+and+biological+evaluation+of+the+novel+glycyrrhetinic+acid-cinnamoyl+hybrids+as+anti-tumor+agents&doi=10.1186%2Fs13065-016-0222-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1186%2Fs13065-016-0222-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13065-016-0222-8%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DW.%2BB.%26aulast%3DYan%26aufirst%3DM.%2BM.%26aulast%3DXu%26aufirst%3DB.%26aulast%3DChu%26aufirst%3DF.%2BH.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DC.%2BZ.%26aulast%3DJia%26aufirst%3DX.%2BH.%26aulast%3DHan%26aufirst%3DY.%2BT.%26aulast%3DXiang%26aufirst%3DH.%2BJ.%26aulast%3DZhang%26aufirst%3DY.%2BZ.%26aulast%3DWang%26aufirst%3DP.%2BL.%26aulast%3DLei%26aufirst%3DH.%2BM.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520the%2520novel%2520glycyrrhetinic%2520acid-cinnamoyl%2520hybrids%2520as%2520anti-tumor%2520agents%26jtitle%3DChem.%2520Cent.%2520J.%26date%3D2016%26volume%3D10%26spage%3D11%26doi%3D10.1186%2Fs13065-016-0222-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, M. H.</span></span> <span> </span><span class="NLM_article-title">Advances in structural modifications of celastrol</span>. <i>ARKIVOC</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>I</i></span>,  <span class="NLM_fpage">172</span>– <span class="NLM_lpage">182</span>, <span class="refDoi"> DOI: 10.3998/ark.5550190.p009.540</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.3998%2Fark.5550190.p009.540" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=I&publication_year=2016&pages=172-182&author=X.+Caiauthor=J.+Jinauthor=M.+H.+He&title=Advances+in+structural+modifications+of+celastrol&doi=10.3998%2Fark.5550190.p009.540"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.3998%2Fark.5550190.p009.540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3998%252Fark.5550190.p009.540%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DX.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DM.%2BH.%26atitle%3DAdvances%2520in%2520structural%2520modifications%2520of%2520celastrol%26jtitle%3DARKIVOC%26date%3D2016%26volume%3DI%26spage%3D172%26epage%3D182%26doi%3D10.3998%2Fark.5550190.p009.540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, W.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of C(6)-modified celastrol derivatives as potential antitumor agents</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">10177</span>– <span class="NLM_lpage">10188</span>, <span class="refDoi"> DOI: 10.3390/molecules190710177</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.3390%2Fmolecules190710177" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=25025148" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1GjsbfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=10177-10188&author=K.+Tangauthor=Q.+Huangauthor=J.+Zengauthor=G.+Wuauthor=J.+Huangauthor=J.+Panauthor=W.+Lu&title=Design%2C+synthesis+and+biological+evaluation+of+C%286%29-modified+celastrol+derivatives+as+potential+antitumor+agents&doi=10.3390%2Fmolecules190710177"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of C(6)-modified celastrol derivatives as potential antitumor agents</span></div><div class="casAuthors">Tang, Kaiyong; Huang, Qingqing; Zeng, Jafeng; Wu, Guangming; Huang, Jinwen; Pan, Junfang; Lu, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">10177-10188, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">New six C6-celastrol derivs. were designed, synthesized, and evaluated for their in vitro cytotoxic activities against nine human cancer cell lines (BGC-823, H4, Bel7402, H522, Colo 205, HepG2 and MDA-MB-468).  The results showed that most of the compds. displayed potent inhibition against BGC823, H4, and Bel7402, with IC50s of 1.84-0.39 μM.  The best compd. NST001A was tested in an in vivo antitumor assay on nude mice bearing Colo 205 xenografts, and showed significant inhibition of tumor growth at low concns.  Therefore, celastrol C-6 derivs. are potential drug candidates for treating cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz9ZOksehXRrVg90H21EOLACvtfcHk0ljvUxUsTsHiTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1GjsbfO&md5=659c939499ed17b2333cec856073d023</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.3390%2Fmolecules190710177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules190710177%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DZeng%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DW.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520C%25286%2529-modified%2520celastrol%2520derivatives%2520as%2520potential%2520antitumor%2520agents%26jtitle%3DMolecules%26date%3D2014%26volume%3D19%26spage%3D10177%26epage%3D10188%26doi%3D10.3390%2Fmolecules190710177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klaić, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morimoto, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silverman, R. B.</span></span> <span> </span><span class="NLM_article-title">Celastrol analogues as inducers of the heat shock response. Design and synthesis of affinity probes for the identification of protein targets</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">928</span>– <span class="NLM_lpage">937</span>, <span class="refDoi"> DOI: 10.1021/cb200539u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb200539u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtFWhsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=928-937&author=L.+Klai%C4%87author=R.+I.+Morimotoauthor=R.+B.+Silverman&title=Celastrol+analogues+as+inducers+of+the+heat+shock+response.+Design+and+synthesis+of+affinity+probes+for+the+identification+of+protein+targets&doi=10.1021%2Fcb200539u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Celastrol Analogues as Inducers of the Heat Shock Response. Design and Synthesis of Affinity Probes for the Identification of Protein Targets</span></div><div class="casAuthors">Klaic, Lada; Morimoto, Richard I.; Silverman, Richard B.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">928-937</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The natural product celastrol (1) possesses numerous beneficial therapeutic properties and affects numerous cellular pathways.  The mechanism of action and cellular target(s) of celastrol, however, remain unresolved.  While a no. of studies have proposed that the activity of celastrol is mediated through reaction with cysteine residues, these observations have been based on studies with specific proteins or by in vitro anal. of a small fraction of the proteome.  In this study, we have investigated the spatial and structural requirements of celastrol for the design of suitable affinity probes to identify cellular binding partners of celastrol.  Although celastrol has several potential sites for modification, some of these were not synthetically amenable or yielded unstable analogs.  Conversion of the carboxylic acid functionality to amides and long-chain analogs, however, yielded bioactive compds. that induced the heat shock response (HSR) and antioxidant response and inhibited Hsp90 activity.  This led to the synthesis of biotinylated celastrols (23 and 24) that were used as affinity reagents in exts. of human Panc-1 cells to identify Annexin II, eEF1A, and β-tubulin as potential targets of celastrol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhmezieJojibVg90H21EOLACvtfcHk0ljvUxUsTsHiTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtFWhsL0%253D&md5=b9062d04520d880474c49e85f773e2f8</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fcb200539u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb200539u%26sid%3Dliteratum%253Aachs%26aulast%3DKlai%25C4%2587%26aufirst%3DL.%26aulast%3DMorimoto%26aufirst%3DR.%2BI.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DCelastrol%2520analogues%2520as%2520inducers%2520of%2520the%2520heat%2520shock%2520response.%2520Design%2520and%2520synthesis%2520of%2520affinity%2520probes%2520for%2520the%2520identification%2520of%2520protein%2520targets%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2012%26volume%3D7%26spage%3D928%26epage%3D937%26doi%3D10.1021%2Fcb200539u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, J. D.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of nitrate-oleanolic acid hybrids as inhibitors of HepG2 cell apoptosis</span>. <i>Yao Xue Xue Bao</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">1516</span>– <span class="NLM_lpage">1522</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=21351491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A280%3ADC%252BC3M3itFWrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=1516-1522&author=L.+Chenauthor=J.+Shangauthor=Z.+F.+Wangauthor=Y.+H.+Zhangauthor=J.+D.+Tian&title=Synthesis+and+biological+evaluation+of+nitrate-oleanolic+acid+hybrids+as+inhibitors+of+HepG2+cell+apoptosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of nitrate-oleanolic acid hybrids as inhibitors of HepG2 cell apoptosis</span></div><div class="casAuthors">Chen Li; Shang Juan; Wang Zhi-feng; Zhang Yi-hu; Tian Ji-de</div><div class="citationInfo"><span class="NLM_cas:title">Yao xue xue bao = Acta pharmaceutica Sinica</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1516-22</span>
        ISSN:<span class="NLM_cas:issn">0513-4870</span>.
    </div><div class="casAbstract">To find novel antihepatitis drugs, a series of nitrate-oleanolic acid (OA) hybrids (10a, 10b, 11a-11e and 12a-12c) were designed and synthesized on the basis of previous studies using OA as lead compound, which is widely found in natural plants and liver-specific metabolism.  In the present study, ten novel NO-releasing derivatives of OA were synthesized by connecting nitrate to the OA-3-OH through varying lengths of linkers containing antioxidants which were designed to increase the ability of these target compounds to scavenge free radicals.  The structures of these objective compounds were determined by IR, MS, 1H NMR and elemental analysis.  Their protective effects on anti-Fas mediated HepG2 cell apoptosis were in vitro evaluated by LDH assay.  Compound 12a is the most potent inhibitor.  Its effect on anti-Fas mediated HepG2 cell apoptosis and amount of NO-releasing in vitro are similar to those of positive control NCX-1000.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQuad1QAAjeCQvupmecNw_lfW6udTcc2eZknhGlIcLfxbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M3itFWrsA%253D%253D&md5=e490e67ef7cb6638dbbaf905a5545d89</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DShang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DZ.%2BF.%26aulast%3DZhang%26aufirst%3DY.%2BH.%26aulast%3DTian%26aufirst%3DJ.%2BD.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520nitrate-oleanolic%2520acid%2520hybrids%2520as%2520inhibitors%2520of%2520HepG2%2520cell%2520apoptosis%26jtitle%3DYao%2520Xue%2520Xue%2520Bao%26date%3D2010%26volume%3D45%26spage%3D1516%26epage%3D1522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, X. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of nitric oxide-releasing derivatives of oleanolic acid as inhibitors of HepG2 cell apoptosis</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">2979</span>– <span class="NLM_lpage">2982</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.03.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.1016%2Fj.bmcl.2007.03.068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=17446070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlt1KjtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=2979-2982&author=L.+Chenauthor=Y.+H.+Zhangauthor=X.+W.+Kongauthor=S.+X.+Pengauthor=J.+Tian&title=Synthesis+and+biological+evaluation+of+nitric+oxide-releasing+derivatives+of+oleanolic+acid+as+inhibitors+of+HepG2+cell+apoptosis&doi=10.1016%2Fj.bmcl.2007.03.068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of nitric oxide-releasing derivatives of oleanolic acid as inhibitors of HepG2 cell apoptosis</span></div><div class="casAuthors">Chen, Li; Zhang, Yihua; Kong, Xiangwen; Peng, Sixun; Tian, Jide</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2979-2982</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A total of 106 nitric oxide-releasing derivs. of oleanolic acid were synthesized and their effects on the inhibition of anti-Fas-mediated HepG2 cell apoptosis were evaluated in vitro.  Several compds. inhibited anti-Fas-mediated HepG2 cell apoptosis in a dose-dependent manner.  Within this series of compds., compd. I is the most potent inhibitor.  The development of new NO-releasing derivs. of oleanolic acid may aid in the design of NO-based medicines for the intervention of human liver inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqo719u5LGaV7Vg90H21EOLACvtfcHk0lhxoeaC7km-Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlt1KjtLc%253D&md5=f2659ed548578b2da8102e6e1567f875</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.03.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.03.068%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%2BH.%26aulast%3DKong%26aufirst%3DX.%2BW.%26aulast%3DPeng%26aufirst%3DS.%2BX.%26aulast%3DTian%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520nitric%2520oxide-releasing%2520derivatives%2520of%2520oleanolic%2520acid%2520as%2520inhibitors%2520of%2520HepG2%2520cell%2520apoptosis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D2979%26epage%3D2982%26doi%3D10.1016%2Fj.bmcl.2007.03.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tambe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blott, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fülöp, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flottmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bräse, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopf, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Junker, H. D.</span></span> <span> </span><span class="NLM_article-title">Structure-performance relationships of phenyl cinnamic acid derivatives as MALDI-MS matrices for sulfatide detection</span>. <i>Anal. Bioanal. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>409</i></span>,  <span class="NLM_fpage">1569</span>– <span class="NLM_lpage">1580</span>, <span class="refDoi"> DOI: 10.1007/s00216-016-0096-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.1007%2Fs00216-016-0096-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=27909779" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFylsr3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=409&publication_year=2017&pages=1569-1580&author=S.+Tambeauthor=H.+Blottauthor=A.+F%C3%BCl%C3%B6pauthor=N.+Spangauthor=D.+Flottmannauthor=S.+Br%C3%A4seauthor=C.+Hopfauthor=H.+D.+Junker&title=Structure-performance+relationships+of+phenyl+cinnamic+acid+derivatives+as+MALDI-MS+matrices+for+sulfatide+detection&doi=10.1007%2Fs00216-016-0096-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-performance relationships of phenyl cinnamic acid derivatives as MALDI-MS matrices for sulfatide detection</span></div><div class="casAuthors">Tambe, Suparna; Blott, Henning; Fueloep, Annabelle; Spang, Nils; Flottmann, Dirk; Braese, Stefan; Hopf, Carsten; Junker, Hans-Dieter</div><div class="citationInfo"><span class="NLM_cas:title">Analytical and Bioanalytical Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">409</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1569-1580</span>CODEN:
                <span class="NLM_cas:coden">ABCNBP</span>;
        ISSN:<span class="NLM_cas:issn">1618-2642</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A key aspect for the further development of matrix-assisted laser desorption ionization (MALDI)-mass spectrometry (MS) is a better understanding of the working principles of MALDI matrixes.  To address this issue, a chem. compd. library of 59 structurally related cinnamic acid derivs. was synthesized.  Potential MALDI matrixes were evaluated with sulfatides, a class of anionic lipids which are abundant in complex brain lipid mixts.  For each matrix relative mean S/N ratios of sulfatides were detd. against 9-aminoacridine as a ref. matrix using neg. ion mass spectrometry with 355 and 337 nm laser systems.  The comparison of matrix features with their corresponding relative mean S/N ratios for sulfatide detection identified correlations between matrix substitution patterns, their chem. functionality, and their MALDI-MS performance.  Crystal structures of six selected matrixes provided structural insight in hydrogen bond interactions in the solid state.  Principal component anal. allowed the addnl. identification of correlation trends between structural and phys. matrix properties like no. of exchangeable protons at the head group, MW, logP, UV-Vis, and sulfatide detection sensitivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplktpCW0ujeLVg90H21EOLACvtfcHk0lhxoeaC7km-Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFylsr3E&md5=4ff19671e771bf3ceb130d624b4276ad</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1007%2Fs00216-016-0096-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00216-016-0096-6%26sid%3Dliteratum%253Aachs%26aulast%3DTambe%26aufirst%3DS.%26aulast%3DBlott%26aufirst%3DH.%26aulast%3DF%25C3%25BCl%25C3%25B6p%26aufirst%3DA.%26aulast%3DSpang%26aufirst%3DN.%26aulast%3DFlottmann%26aufirst%3DD.%26aulast%3DBr%25C3%25A4se%26aufirst%3DS.%26aulast%3DHopf%26aufirst%3DC.%26aulast%3DJunker%26aufirst%3DH.%2BD.%26atitle%3DStructure-performance%2520relationships%2520of%2520phenyl%2520cinnamic%2520acid%2520derivatives%2520as%2520MALDI-MS%2520matrices%2520for%2520sulfatide%2520detection%26jtitle%3DAnal.%2520Bioanal.%2520Chem.%26date%3D2017%26volume%3D409%26spage%3D1569%26epage%3D1580%26doi%3D10.1007%2Fs00216-016-0096-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fryszkowska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardiner, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephens, G. M.</span></span> <span> </span><span class="NLM_article-title">A short, chemoenzymatic route to chiral β-aryl-γ-amino acids using reductases from anaerobic bacteria</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">533</span>– <span class="NLM_lpage">535</span>, <span class="refDoi"> DOI: 10.1039/B919526B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.1039%2FB919526B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=20090967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnsV2rtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&pages=533-535&author=A.+Fryszkowskaauthor=K.+Fisherauthor=J.+M.+Gardinerauthor=G.+M.+Stephens&title=A+short%2C+chemoenzymatic+route+to+chiral+%CE%B2-aryl-%CE%B3-amino+acids+using+reductases+from+anaerobic+bacteria&doi=10.1039%2FB919526B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">A short, chemoenzymatic route to chiral β-aryl-γ-amino acids using reductases from anaerobic bacteria</span></div><div class="casAuthors">Fryszkowska, Anna; Fisher, Karl; Gardiner, John M.; Stephens, Gill M.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">533-535</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A short chemoenzymic synthesis of β-aryl-γ-aminobutyric acids has been developed, based on a highly enantioselective biocatalytic redn. of β-aryl-β-cyano-α,β-unsatd. carboxylic acids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6Crc9njYSn7Vg90H21EOLACvtfcHk0liWwip7Xazg5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnsV2rtQ%253D%253D&md5=2b40a7f03a10d31b541581c1d042ec3d</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1039%2FB919526B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FB919526B%26sid%3Dliteratum%253Aachs%26aulast%3DFryszkowska%26aufirst%3DA.%26aulast%3DFisher%26aufirst%3DK.%26aulast%3DGardiner%26aufirst%3DJ.%2BM.%26aulast%3DStephens%26aufirst%3DG.%2BM.%26atitle%3DA%2520short%252C%2520chemoenzymatic%2520route%2520to%2520chiral%2520%25CE%25B2-aryl-%25CE%25B3-amino%2520acids%2520using%2520reductases%2520from%2520anaerobic%2520bacteria%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2010%26volume%3D8%26spage%3D533%26epage%3D535%26doi%3D10.1039%2FB919526B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyss, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pahl, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merfort, I.</span></span> <span> </span><span class="NLM_article-title">Helenanolide type sesquiterpene lactones. Part 5: the role of glutathione addition under physiological conditions</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">2849</span>– <span class="NLM_lpage">2855</span>, <span class="refDoi"> DOI: 10.1016/S0968-0896(99)00234-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.1016%2FS0968-0896%2899%2900234-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10658589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADC%252BD3cXntFCgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1999&pages=2849-2855&author=T.+J.+Schmidtauthor=G.+Lyssauthor=H.+L.+Pahlauthor=I.+Merfort&title=Helenanolide+type+sesquiterpene+lactones.+Part+5%3A+the+role+of+glutathione+addition+under+physiological+conditions&doi=10.1016%2FS0968-0896%2899%2900234-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Helenanolide type sesquiterpene lactones. Part 5: The role of glutathione addition under physiological conditions</span></div><div class="casAuthors">Schmidt, Thomas J.; Lyss, Guido; Pahl, Heike L.; Merfort, Irmgard</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2849-2855</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Sesquiterpene lactones (STLs) are known to exert most of their numerous biol. activities through inhibition of enzymes and other functional proteins by forming covalent bonds with free cysteine residues in these macromols.  The question arises how these drugs can alkylate such vital target structures instead of being quickly deactivated by reaction with the cysteine group of glutathione (GSH) which is present in high concns. in all cells.  The authors have measured in this study the pH dependent kinetics of GSH addn. to the cyclopentenone and α-methylene-γ-lactone group of helenanolide type sesquiterpene lactones using UV-spectrophotometry.  The reaction with GSH at physiol. pH proceeds very quickly but is reversible so that a fraction of STL mols. will always be available for reaction with protein targets.  In agreement with these chem. data, helenalin-mono- and -bis-glutathionyl adducts were demonstrated to inhibit the nuclear transcription factor NF-κB at concns. similar to the free sesquiterpene lactone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqkVtGdFq5Y7Vg90H21EOLACvtfcHk0liWwip7Xazg5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXntFCgtA%253D%253D&md5=773a60cca35a2e3238602eb7885cd9d0</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2FS0968-0896%2899%2900234-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0896%252899%252900234-5%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DT.%2BJ.%26aulast%3DLyss%26aufirst%3DG.%26aulast%3DPahl%26aufirst%3DH.%2BL.%26aulast%3DMerfort%26aufirst%3DI.%26atitle%3DHelenanolide%2520type%2520sesquiterpene%2520lactones.%2520Part%25205%253A%2520the%2520role%2520of%2520glutathione%2520addition%2520under%2520physiological%2520conditions%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D1999%26volume%3D7%26spage%3D2849%26epage%3D2855%26doi%3D10.1016%2FS0968-0896%2899%2900234-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span> <span> </span><span class="NLM_article-title">New developments in Hsp90 inhibitors as anti-cancer therapeutics: mechanisms, clinical perspective and more potential</span>. <i>Drug Resist. Updates</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">17</span>– <span class="NLM_lpage">27</span>, <span class="refDoi"> DOI: 10.1016/j.drup.2008.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.1016%2Fj.drup.2008.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=19179103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A280%3ADC%252BD1M3jvV2mtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2009&pages=17-27&author=Y.+Liauthor=T.+Zhangauthor=S.+J.+Schwartzauthor=D.+Sun&title=New+developments+in+Hsp90+inhibitors+as+anti-cancer+therapeutics%3A+mechanisms%2C+clinical+perspective+and+more+potential&doi=10.1016%2Fj.drup.2008.12.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">New developments in Hsp90 inhibitors as anti-cancer therapeutics: mechanisms, clinical perspective and more potential</span></div><div class="casAuthors">Li Yanyan; Zhang Tao; Schwartz Steven J; Sun Duxin</div><div class="citationInfo"><span class="NLM_cas:title">Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">17-27</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The molecular chaperone Hsp90 (heat shock protein 90) is a promising target in cancer therapy.  Preclinical and clinical evaluations of a variety of Hsp90 inhibitors have shown anti-tumor effect as a single agent and in combination with chemotherapy.  Current Hsp90 inhibitors are categorized into several classes based on distinct modes of inhibition, including (i) blockade of ATP binding, (ii) disruption of co-chaperone/Hsp90 interactions, (iii) antagonism of client/Hsp90 associations and (iv) interference with post-translational modifications of Hsp90.  The different functions of Hsp90 isoforms and the isoform selectivity of drugs need further investigation.  The correlation of cell surface Hsp90 with cancer metastasis and the emerging involvement of Hsp90 inhibition in cancer stem cells have become exciting areas that could be exploited.  Therefore, the aim of this review is (1) to summarize the up-to-date knowledge of mechanistic studies and clinical prospect of currently available Hsp90 inhibitors, (2) to enhance our perspectives for designing and discovering novel Hsp90 inhibitors, and (3) to provide an insight into less-understood potential of Hsp90 inhibition in cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ5kNKTb14uEhcr74wzj5o5fW6udTcc2eaSW5VmgESWeLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M3jvV2mtg%253D%253D&md5=4d848faff412f714fb669add9d0cc4c7</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.drup.2008.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drup.2008.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DSchwartz%26aufirst%3DS.%2BJ.%26aulast%3DSun%26aufirst%3DD.%26atitle%3DNew%2520developments%2520in%2520Hsp90%2520inhibitors%2520as%2520anti-cancer%2520therapeutics%253A%2520mechanisms%252C%2520clinical%2520perspective%2520and%2520more%2520potential%26jtitle%3DDrug%2520Resist.%2520Updates%26date%3D2009%26volume%3D12%26spage%3D17%26epage%3D27%26doi%3D10.1016%2Fj.drup.2008.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grenert, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fadden, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haystead, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mimnaugh, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krutzsch, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochel, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulte, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sausville, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neckers, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toft, D. O.</span></span> <span> </span><span class="NLM_article-title">The amino-terminal domain of heat shock protein 90 (hsp90) that binds GA is an ATP/ADP switch domain that regulates hsp90 conformation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>272</i></span>,  <span class="NLM_fpage">23843</span>– <span class="NLM_lpage">23850</span>, <span class="refDoi"> DOI: 10.1074/jbc.272.38.23843</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.1074%2Fjbc.272.38.23843" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=9295332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADyaK2sXmtlOhs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=23843-23850&author=J.+P.+Grenertauthor=W.+P.+Sullivanauthor=P.+Faddenauthor=T.+A.+Haysteadauthor=J.+Clarkauthor=E.+Mimnaughauthor=H.+Krutzschauthor=H.+J.+Ochelauthor=T.+W.+Schulteauthor=E.+Sausvilleauthor=L.+M.+Neckersauthor=D.+O.+Toft&title=The+amino-terminal+domain+of+heat+shock+protein+90+%28hsp90%29+that+binds+GA+is+an+ATP%2FADP+switch+domain+that+regulates+hsp90+conformation&doi=10.1074%2Fjbc.272.38.23843"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The amino-terminal domain of heat shock protein 90 (hsp90) that binds geldanamycin is an ATP/ADP switch domain that regulates hsp90 conformation</span></div><div class="casAuthors">Grenert, James P.; Sullivan, William P.; Fadden, Patrick; Haystead, Timothy A. J.; Clark, Jenny; Mimnaugh, Edward; Krutzsch, Henry; Ochel, Hans-Joachim; Schulte, Theodor W.; Sausville, Edward; Neckers, Leonard M.; Toft, David O.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">272</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">23843-23850</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Many functions of the chaperone, heat shock protein 90 (hsp90), are inhibited by the drug geldanamycin that specifically binds hsp90.  We have studied an amino-terminal domain of hsp90 whose crystal structure has recently been solved and detd. to contain a geldanamycin-binding site.  We demonstrate that, in soln., drug binding is exclusive to this domain.  This domain also binds ATP linked to Sepharose through the γ-phosphate.  Binding is specific for ATP and ADP and is inhibited by geldanamycin.  Mutation of four glycine residues within two proposed ATP binding motifs diminishes both geldanamycin binding and the ATP-dependent conversion of hsp90 to a conformation capable of binding to co-chaperone p23.  Since p23 binding requires regions outside the 1-221 domain of hsp90, these results indicate a common site for nucleotides and geldanamycin that regulates the conformation of other hsp90 domains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGleeyqVA0kbVg90H21EOLACvtfcHk0lh3jk6Eihhp-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmtlOhs7w%253D&md5=bd742afe61df98e05096902b746d595f</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1074%2Fjbc.272.38.23843&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.272.38.23843%26sid%3Dliteratum%253Aachs%26aulast%3DGrenert%26aufirst%3DJ.%2BP.%26aulast%3DSullivan%26aufirst%3DW.%2BP.%26aulast%3DFadden%26aufirst%3DP.%26aulast%3DHaystead%26aufirst%3DT.%2BA.%26aulast%3DClark%26aufirst%3DJ.%26aulast%3DMimnaugh%26aufirst%3DE.%26aulast%3DKrutzsch%26aufirst%3DH.%26aulast%3DOchel%26aufirst%3DH.%2BJ.%26aulast%3DSchulte%26aufirst%3DT.%2BW.%26aulast%3DSausville%26aufirst%3DE.%26aulast%3DNeckers%26aufirst%3DL.%2BM.%26aulast%3DToft%26aufirst%3DD.%2BO.%26atitle%3DThe%2520amino-terminal%2520domain%2520of%2520heat%2520shock%2520protein%252090%2520%2528hsp90%2529%2520that%2520binds%2520GA%2520is%2520an%2520ATP%252FADP%2520switch%2520domain%2520that%2520regulates%2520hsp90%2520conformation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D23843%26epage%3D23850%26doi%3D10.1074%2Fjbc.272.38.23843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trott, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, A. J.</span></span> <span> </span><span class="NLM_article-title">AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">455</span>– <span class="NLM_lpage">461</span>, <span class="refDoi"> DOI: 10.1002/jcc.21334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=10.1002%2Fjcc.21334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=19499576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGnur3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=455-461&author=O.+Trottauthor=A.+J.+Olson&title=AutoDock+Vina%3A+improving+the+speed+and+accuracy+of+docking+with+a+new+scoring+function%2C+efficient+optimization+and+multithreading&doi=10.1002%2Fjcc.21334"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span></div><div class="casAuthors">Trott, Oleg; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">455-461</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">AutoDock Vina, a new program for mol. docking and virtual screening, is presented.  AutoDock Vina achieves an approx. 2 orders of magnitude speed-up compared with the mol. docking software previously developed in the authors' lab (AutoDock 4), while also significantly improving the accuracy of the binding mode predictions, judging by the authors' tests on the training set used in AutoDock 4 development.  Further speed-up is achieved from parallelism, by using multithreading on multicore machines.  AutoDock Vina automatically calcs. the grid maps and clusters the results in a way transparent to the user.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLecOIkUxIlrVg90H21EOLACvtfcHk0lh3jk6Eihhp-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGnur3O&md5=c6974af8a1235f7aa09918d3e6f70dc4</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21334%26sid%3Dliteratum%253Aachs%26aulast%3DTrott%26aufirst%3DO.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutoDock%2520Vina%253A%2520improving%2520the%2520speed%2520and%2520accuracy%2520of%2520docking%2520with%2520a%2520new%2520scoring%2520function%252C%2520efficient%2520optimization%2520and%2520multithreading%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2010%26volume%3D31%26spage%3D455%26epage%3D461%26doi%3D10.1002%2Fjcc.21334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2K5B" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2K5B','PDB','2K5B'); return false;">PDB: 2K5B</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2W0G" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2W0G','PDB','2W0G'); return false;">PDB: 2W0G</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i95"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01290">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_57327"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.9b01290?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01290</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Structural characterization of the compounds (<sup>1</sup>H NMR, <sup>13</sup>C NMR, ESI/HRMS spectra of the final compounds <b>1</b>–<b>48</b>, <b>41-H</b>, and <b>41-Bio</b>); synthetic route of compound <b>41-H</b>; HPLC analysis of target compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01290/suppl_file/jm9b01290_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular string files for all the final target compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01290/suppl_file/jm9b01290_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01290/suppl_file/jm9b01290_si_001.pdf">jm9b01290_si_001.pdf (4.4 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01290/suppl_file/jm9b01290_si_002.csv">jm9b01290_si_002.csv (8.2 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b01290&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-23%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b01290" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b01290" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                6MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677b56b2bd4b24bb","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
